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1.

INTRODUCTION

Peptide hormones such as vasopressin and oxytocin which are
found in hypothalamic and pituitary neuroendocrine cells of the central
nervous system are known to have physiological roles in homeostasis.
Recent advances in peptide sequencing and solid state peptide synthesis
techniques have led to important developments in peptide neurobiology.

Techniques have been developed which enable the measurement
of minute amounts of specific peptides

(radioimm~~oassay)

and the visu-

alization, histologically and cytologically, of specific peptides within
nervous tissue (immunohistochemistry).

With the use of radioimmunoassay

and immunohistochemistry many peptides once believed to be contained
solely in hypothalamic or other neuroendocrine cells in the central nerVOUS

system have now been found in neurons throughout the central and

peripheral nervous systems.

This has led to the suggestion that they

may function as neurotransmitter or neuromodulatory agents.

In the past

ten years the number of peptides for which a neurotransmitter role has
been proposed has grown from one (substance P) to at least twelve (see
table 1)

(Scharrer, 1977; Iversen, Nicoll and Vale, 1978; Hughes, 1978;

Walker, 1978).

In order to demonstrate that any of the neuropeptides are neurotransmitter substances, several criteria must be met.

First, the pep-

tide under study must be contained within nerve terminals.

In addition,

it should also be contained within synaptic vesicles which are a char1

Table l.

Peptide

The names and &~ino-acid sequence of some proposed peptide 2
neurotransmitters, and some of their analogs (all sequences
begin with N terminal).
Sequence

angiotensin

Asn-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-LeuVal-Tyr-Ser

S-endorphin

Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-GlnThr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Gly-Ala-IleIle-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu-OH

)'-endorphin

Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-GlnThr-Pro-Leu-Val-Thr-Leu

a-endorphin

Tyr-Gly-Gly-Phe-Net-Thr-Ser-Gly-Lys-Ser-GlnThr-Pro-Leu-Val-Thr

met-enkephalin

Tyr-Gly-Gly-Phe-Met

leu-enkephalin

Tyr-Gly-Gly-Phe-Leu

gastrin

Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-AlaTyr-Gly-Trp-Met-Asp-Phe-NH2
HSO

LHRF

pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2

neurotensin

Glu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Pro-Ile-Leu-OH

oxytocin

eys-Tyr-Ile-Gly-Asn-Cys-Pro-Leu-Gly-NH2

somatostatin

substance P

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH 2

substance P free acid

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-!1et

substance P pentapeptidel

Phe-Phe-Gly-Leu-Met-NH2

TRF

pGlu-His-Pro-NH2

vasopressin

Cys-Tyr-Phe-Glu(NH2)-Asp(NH2)-Cys-Pro-Lys-GlyNH2

VIP

His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-~Jr-Thr

Arg-Leu-Arg-Lys-Gly-Net-Ala-Val-Lys-Lys-TyrLeu-Asn-Ser-Ile-Leu-Asn-NH2

acteristic feature of the presynaptic nerve terminal.

A second crite-

3

rion which must be met is that the substance be released from the terminal in response to a depolarization of the presynaptic neuron.

This

release must be dependent on the presence of extracellular calcium ions.
The most common method by which the release of various putative transmitters has been studied is by depolarizing the cells with a solution
having a high concentration of potassium ions.

The use of high potassium solutions to evoke release can be
criti~ised

for the following reasons:

(a) Osmotic imbalances during

the release period must be considered and corrected., (b) Viability of
the preparation after such a powerful stimulus should be tested., (c)
Reproducible release from the same preparation is usually not observed.,
(d) In addition to being calcium-dependent, the release of the proposed
transmitter should be decreased by tetrodotoxin.

Sensitivity of re-

lease to tetrodotoxin indicates that the depolarization and subsequent
release can be ascribed to action potential generation.

Techniques

such as application of veratridine or electrical stimulation are less
drastic than the use of high potassium solutions, and they affect
neurons more specifically, thereby reducing the possibility of extraneous release from other types of cells in the preparation.

The third criterionwhich must be met is the capability of the
presynaptic neuron to synthesize the proposed transmitter; that is to
say, the enzymes which are known to be necessary for synthesis of the
transmitter must be present.

The fourth requirement is that a process

by which the transmitter is inactivated either pre- or post-synaptically

is present at the proposed synapse.

Finally, the action of the neuro-

4

peptide on neuronal excitability and postsynaptic membrane properties
must mimic the response to presynaptic nerve stimulation.

This crite-

rion requires the use of electrophysiological techniques; this is the
approach taken in the present study.

Electrophysiological studies may be carried out in vivo or in
vitro.

There are advantages and disadvantages to each approach.

Stud-

ies in vivo leave the anatomy intact and the neurons remain in. an environment which approximates normality; functional connections between
different areas of the central and peripheral nervous sys·tems are intact.
The actions of the peptides on the neuron can be studied in relation to
the cell's responses to physiological as well as artificial stimuli.
Neurons may even be studied in animals which are conscious and behaving
normally.

There are also certain limitations to

i~

vivo recordings.

The concentration of peptides near the cell being studied is difficult
to quantitate when administered systemically or by local application,
synaptic influences are sometimes not distinguishable from direct actions on the cell, metabolic and hormonal factors as well as the anesthetic used may interfere with peptide action, the neuronal effects seen
after administration of the peptide may be secondary to blood pressure
or respiratory changes, diffusional barriers may limit the use of some
drugs, and investigation of the ionic mechanisms of any observed effects
is rendered difficult.

Studies of neurons in vitro eliminate most of the above problems;
however, different problems arise.

Studies of single neurons in vitro

are limited to peripheral ganglia, brain slices, or immature neurons
grown in tissue culture.

5

In each case, the isolated preparation is

maintained in an artificial environment which approximates the conditions in vivo.

Even so, explanted adult neurons eventually lose via-

bility in vitro, and the rate at which they do this may limit the experimental approach.

The strongest criticism of in vitro techniques is

that it is difficult to ascribe functional significance to the effects
observed because the neurons are more or less removed from any normal
physiological connections.

Studies of peripheral ganglia, on the other

hand, have demonstrated that those neurons recorded in vivo or in vitro
have similar properties including membrane potential, input resistance
and synaptic potentials (Skok, 1973).

The loss of synaptic transmission

in the autonomic ganglia after being maintained in vitro for 15-20 hr
correlates well with the degradation of presynaptic terminals after sectioning of the preganglionic fibers (Skok, 1973).

It appears that stud-

ies of synaptic mechanisms in peripheral ganglia in vitro are not different from recordings made in vivo.

Therefore, meaningful results from

studies on synaptic mechanisms can be attained with isolated autonomic
ganglia.

The present investigation has utilized the in vitro approach to
study the action of several endogenous neuropeptides and related substances on the electrical properties of single autonomic neurons.

This

approach was chosen over in vivo electrophysiological techniques for
several reasons.

Basic information such as, the direct effects that

these peptides have on single neurons, the time course of action and
the effective concentration range can be more readily obtained from in

vitro studies.

A study of the physiological role of the neuropeptides

6

is also possible with in vitro techniques using autonomic ganglia since
many of the neuropeptides are contained in nerve terminals of these ganglia (see below) .

The myenteric plexus of the guinea pig ileum is well-

suited to study the action of the various neuropeptides for reasons
which will become apparent as each individual peptide is discussed.

1.1.

OPIATES AND ENDOGENOUS OPIOID PEPTIDES

1.1.1.

Opiate Binding Sites

There is a large body of evidence which indicates that the
actions of opiates and endogenous opioid peptides are mediated by a
common receptor or group of receptors.

Areas with high numbers of opi-

ate binding sites were found in the mesolirnbic

syst~m

of the brain;

speci£ically the amygdala, hypothalamus, periaqueductal gray, head of
the caudate nucleus and thalamus (Kuhar, Pert and Snyder, 1973; Pert,
Kuhar and Snyder, 1975).

Certain afferent systems were also shown to

be rich in opiate binding sites including the dorsal horn of the spinal
cord, the trigeminal nucleus and nuclei of the vagus nerve such as the
nucleus tractus solitarius (Atweh and Kuhar, 1977).

A presynaptic loca-

tion of these binding sites was inferred when dorsal root section resulted in a 50% decrease in receptor binding in the dorsal spinal cord
(LaMotte, Pert and Snyder, 1976).

Similar inferences have been made

from the finding that vagotomy leads to a marked reduction in autoradiographic binding of opiates in the nucleus tractus solitarius and nucleus

a~iguus

(Atweh, Murrin and Kuhar, 1978).

Opiate receptor binding has also been studied in the myenteric
plexus of the guinea pig ileum (Creese and Snyder, 1975).

Several meth-

ods were used to study the opiate receptors in the ileum.

The results

indicate that the binding properties of receptors in the ileum are much
the same as those in the central nervous system.
7

First, the inhibition

8

of H3 -labeled naloxone binding was stereospecific; that is, the active

(-)-isomers of three agonist.s were 10-1,000 times more effective in dis3
placing H -naloxone binding than the corresponding (+)-isomers.

Second,

a series of opiates having dif;eering binding affinities in the rat brain
were compared to the binding in the ileum.

A significant correlation

between the relative order of binding affinities was found between the
two tissues.

Finally,

~here

was good correlation between the ability of

agonists to inhibit the electrically induced contraction of the longitudinal muscle-myenteric plexus preparation and their affinities for the receptor in the ileum.

Autoradiographic localization of opiate binding sites in the central nervous system has proved useful in determining the pathways which
contain opiate receptors.

Unfortunately, no reliable autoradiographic

studies on myenteric ganglia have been done.

9

1.1.2.

Endogenous Opioid Peptides

Studies on the distribution of opiate binding sites

d~~onstrated

that opiate binding was not associated with any one specific transmitter
system {Kuhar, Pert and Snyder, 1973).

The demonstration of stereospe-

cific opiate binding sites led to attempts to find endogenous opiatelike substances in the brain.

An endogenous ligand for the opiate re-

ceptor was isolated from brain tissue, purified, sequenced and synthesized. {Hughes, Smith, Kosterlitz, Fothergill, Morgan al'ld Morris, 1975).
This ligand was found to be a mixture of two pentapeptides which have
been termed methionine-enkephalin (met-enkephalin) and leucine-enkephalin (leu-enkephalin)

(for structures see Table 1).

The structure of

met-enkephalin was sho>-m to be completely represented in the pituitary
hormone S-lipotropin and this led to the discovery of a family of endogenous opioid peptides which inclued a-, S-and

~-endorphin

(Table 1).

The opiate-like activity of these peptides has been tested on
peripheral, behavioral and opiate binding models of opiate action.

Al-

though the peptides had potent opiate-like activity on isolated preparations such as the guinea pig ileum and mouse vas deferens, the opioid
peptides had little significant opiate-like activity when administered
systemically (Buscher, Hill, Romer, Cardinaux, Classe, Hauser and Pless,
1976).

Intracerebral administration of enkephalin resulted in transient

antinociception which was reversed or prevented by the narcotic antagonist
naloxone.

The pentapeptides were found to be metabolically labile, thus

accounting for their lack of effect when administered systemically (Miller,

10

Chang and CUatrecasas, 1977).

The enkephalin molecule is metabolized

rapidly by carboxypeptidases and also aminopeptidases (Hughes, Kosterlitz,
McKnight, So sa, Lord and ivaterfie ld, 1978) •

The rapid metabolism of en-

kephalin is consistent with a neurotransmitter role, but no specific inactivating enzyme for enkephalin has been isolated yet.
tible region of the

e~~ephalin

The most suscep-

molecule appears to be the amino terminus

where aminopeptidases cleave the tyrosine from the enkephalin.

Enkephalin

analogs having a (D-Ala) residue in position two are metabolically stable
(Pert, Pert, Chang and Fong, 1976).

With this substitution, aminopepti-

2
dases are unable to cleave the tyrosine-D-alanine bond and the (D-Ala) enkephalin analogs have potent and long-lasting analgesic activity in
vivo (Pert et al., 1976).

S-endorphin, the largest of the endogenous opioid peptides, was
first isolated from pituitarJ extracts (Lee and Chung, 1976).

The ques-

tion arose whether S-endorphin was the precursor of met-enkephalin.

How-

ever, the difference in distribution of neurons which contain enkephalinlike immunoreactivity argues against a precursor role for s·-endorphin
(Rossier, Vargo, Minick, Ling, Bloom and Guillemin, 1977; Bloom, Battenberg, Rossier, Ling and Guillemin, 1978).

A pituitary precursor of B--en-

dorphin itself, however, has been postulated (Guillemin, Vargo, Rossier,
Minick, Ling, Rivier, Vale and Bloom, 1977).

Antibodies to S-endorplun,

8-lipotropin and corticotropin (ACTH) all crossreacted with a large peptide (31,000 daltons) in extracts from a mouse pituitary tumor (Mains,
Eipper and Ling, 1977).

Tryptic digests of this 31,000 dalton peptide

resulted in ACTH, 8-lipotropin, and other endorphin fragments.

Further-

more, the concomitant release of S-endorphin and ACTH from the pituitary

ll

gland during acute stress or long-term adrenalectomy further supports a
common precursor (Guillemin et al., 1977).

However, the effects of 8-

endorphin released during acute stress have not as yet been determined.
It seems clear, however, that 8-€ndorphin secreted by the pituitary into
the blood does not result in changes in the levels of S-endorphin in the
central nervous system (Rossier, French, Rivier, Ling, Guillemin and Bloom,
1977).

Since S-endorphin does not cross the blood brain barrier, it may

be possible that it may have no action at all or it may have an action on
peripheral opiate receptors.

The synthesis of leu- and met-enkephalin has been studied in the
3
rat brain and guinea pig myenteric plexus using (H ) tyrosine (Hughes
et al., 1978).

There is a lag time of 1-2 hr after administration of the

labeled tyrosine before labeled leu- or met-enkephalin is found.

The

synthesis of both peptides was blocked by cycloheximide or puromycin indieating that the pathway is ribosomal.

The classical synthetic pathway for

proteins is by the ribosomes of the endoplasmic reticulum.

Although it is

possible that the enkephalins as pentapeptides are synthesized by the
classical pathway, it seems more probable, in light of the lag time, that
the pentapeptides are products of a pro-enkephalin molecule.

Immunohistochemical localization of leu- and met-enkephalin indicates that the amount of these peptides varies markedly in different areas
of the central nervous system (Elde, Hokfelt, Johansson and Terenius, 1976;
Simantov, Kuhar, Uhl and Snyder, 1977).

In general, the amount of and lo-

cation in which the opioid peptides were found correlated with the density
and localization of opiate receptor binding.

There were some

~xceptions.

12

The central nucleus of the amygdala contained many immunoflourescent
(enkephalin containing) fibers; however, the receptor binding was more
evenly distributed in the amygdala (Simantov et al., 1977}.

The ventral

gray portion of the spinal cord has enkephalin containing fibers; however, there is little opiate receptor binding (Simantov et al. , 1977).
The globus pallidus has the most enkephalin of any area in the brain;
however, there are only moderate amounts of receptor binding (Kuhar et

-al.,

1973; Elde et al., 1976; Simantov et al., 1977).

--

-·-

These few quanti-

tative differences in the distribution of enkephalin and density of opiate receptors may represent limitations in the techniques used or may
also suggest that the opioid peptides act by a mechanism independent of
the opiate receptor in some areas.

Subcellular fractionation studies indicate that most enkephalin
is contained v1ithin the crude synaptosomal fraction of brain homogenates
(Smith, Hughes, Kosterlitz and Sosa, 1976; Osborn, Holt and Herz, 1978}.
A sizable (25%} amount of the recoverable enkephalin was also found in
the crude microsomal (p3) fraction (Osborn et al., 1978).

This fraction

also contains a considerable density of opiate receptor binding sites;
however, it was thought that the amount of enkephalin found in this fraction was more than that which would be expected to be bound to the opiate receptors.

It was also not possible to account for the enkephalin

in the microsomal fraction by contamination, since the supernatant con-

tained only small

&~ounts

of enkephalin.

The localization of enkephalin

in the microsomes may represent an early storage form of enkephalin.
Experiments using incorporation of labeled tyrosine are required to test
this hypothesis.

Ultrastructural immunohistochemical studies may also
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aid in demonstrating the relevance of the enkephalin found in the microsomal fractions.

A calcium-dependent potassium evoked release of met- and leuenkephalin from slices of rat striatum has been demonstrated (Henderson,
Hughes and Kosterlitz, 1978; Iversen, Iversen, Bloom, Vargo and Guillemin,
1978; Osborn, Holt and Herz, 1978}.

Release was also found to be evoked

by veratridine and this release was blocked by tetrodotoxin, suggesting
that the source of the enkephalin was neuronal (Henderson et al., 1978}.
These. results satisfy one criterion which must be met before a neurotransmitter role can be assigned to the enkephalins.

Leu- and met-enkephalin have been

sho~m

to be contained in the

nerve terminals of the myenteric plexus using immunohistochemical (Elde
et al., 1976} and biochemical methods (Hughes, Kosterlitz and Smith, 1977}.
There is a limited amount of evidence which indicates that enkephalin is
released by nerve stimulation from the myenteric plexus of the guinea pig
ileum.

The contractile response to nerve stimulation (at 0.1 Hz} of the

longitudinal muscle-myenteric plexus preparation exhibits an inhibition
following a 5 min period of stimulation at 10 Hz (Puig, Gascon, Craviso
and Mussachio, 1977}.

This inhibition in contractile response following

the period of stimulation is also prevented by naloxone, and by theactive
(-}-isomer of an opiate antagonist GPA-1943, but is not prevented by the
inactive isomer GPA-1847.

This. was taken as evidence indicating that

nerve stimulation resulted in release of an endogenous opioid, possibly
enkephalin.
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Direct measurement of enkephalin released

fro~

the guinea pig

myenteric plexus by nerve stimulation has been reported in a single study
(Schulz, vfuster, Simantov, Snyder and Herz, 1977).

Tne amount of enke-

phalin released in these experiments was quite variable in the three
tissues studied.

others have also indicated that release of enkephalin

from the myenteric plexus for direct measurement is unreliable and variable (Hughes et al., 1978).

Using cycloheximide to stop synthesis of

enkephalin, the amount of enkephalin present in the myenteric plexus was
compared between electrically stimulated and unstimulated tissues.

A sig-

nificant reduction in the amount of enkephalin found in the stimulated
preparations was taken as evidence for its release.

The depletion of en-

kephalin from stimulated preparations was also blocked by treatment of the
tissue with tetrodotoxin, indicating that the release was from stimulation
of neurons.

1.1.3.

Actions of Opiates on Single Neurons In Vivo

Single neuron studies on the action of morphine v1ere few prior
to the description of stereospecific opiate binding sites (Pert and
Snyder, 1973; Simon, Hiller and Edelman, 1973) •

As the distribution of

opiate binding sites was described, electrophysiological studies on single cells were directed toward areas which were high in opiate

bL~ding

sites.

The localization of receptor binding sites and knmvn physiological pathways involved in pain perception aided the direction of electrophysiological experiments.

However, opiates have many effects on neu-

ronal tissue and it became important to demonstrate that the effects observed were directly relevant to the spectrum of effects observed when
pharmacological doses of opiates were given to normal animals including
man.

The relevance of electrophysiological studies on the action of nar-

cotic analgesics therefore required fulfillment of the following criteria.
First, the action of the opiates on the cell being studied must be at a
concentration comparable to that which reaches that site when a pharmacologically relevant dose of opiates is given to the whole animal.

Sec-

ond, the action of the opiate agonists must be reversed by specific opiate antagonists in appropriate concentrations.

Third, the action of the

opiates must be stereospecific; that is, the (-)-isomer must be more active than the (+)-isomer of enantiomeric agonists.

Likev;ise, the (-)-

isomer of the anantiomeric antagonists should produce a larger degree of
antagonism than the (+)-isomer.
15

16
With in vivo experiments, it is often difficult to show that the
action of an opiate is directly on the cell whose activity is being recorded.

Systemic administration may result in any nwuber of indirect

effects at distant sites.

The alternative method of application of opi-

ates in such experiments is by iontophoresis.

This limits any such in-

direct effects to sites near that of the recording.

This advantage of

iontophoresis over systemic administration is offset by the problem that
with iontophoresis the local concentration of drug around the cell is
unknown.

A comparison between the effects on a given neuron produced by

an analgesiC dose Of narcotiCS given systemically 1

and

the effeCtS pro-

duced by iontophoretic application often results in a nuch clearer picture of the site and mechanism of opiate action.

tJnfortunately, few

studies in vivo have used both routes of administration.

When administered either systemically or by iontophoresis, morphine decreases the firing rate of most neurons whether they are spontaneously active or when they are induced to fire wit.lc nociceptive stimuli or excitatory agents such as glutamate.

One site >.;here the action

of morphine has been studied carefully is the locus coeruleus.

Noxious

stimuli transiently increased the firing rate of neurons of thatarea
(Korf, Bunney and Aghajanian, 1974).

This increase in firing rate and

also the spontaneous firing rate were inhibited by morphine given systemically (Korf, Bunney and Aghajanian, 1974) or iontophoretically (Bird
and Kuhar, 1977).

Other regions of the central nervous system where the

inhibitory action of morphine has been studied by systemic as well as
iontophoretic applications are the mesencephalic reticular formation
(Haigler, 1976), sensorimotor cortex (Satoh, Zieglgansberger and Herz,
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1976), spinal motor neurons (Zieglgansberger and Bayerl, 1976), and
lamina IV and V cells from the spinal cord (Duggan, Hall and Headley,
1977) .

The action of morphine applied by iontophoresis in many other

areas of the brain has been studied (Table 2) .

Table 2.

The action of opiates and opioid peptides studied in various
locations in the central nervous system.

abbreviat.:i,ons:

H
E
Ion
Sys
t

i

t+
x

-

opiates
opioid peptides
administered iontophoretically
administered systemically
firing rate increased
- (iring rate decreased
- variable effects
indicates reversal by naloxone
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Reference
Duggan, Hall and Headley,
1976; 1977a; 1977b.
Davies and Dray, 1978.
Randic and Hiletic, 1978.
Zieglgansberger and Bayerl,
1976.
Davies and Dray_, 1976; 1978.
Bradley, Briggs, Gayton and
Lambert, 1976.

++

Lateral Reticular Fonnation

+

Medulla
at

++

trat

++

NRGC and Pontis
Cauda lis
Locus Coeruleus

X

i

!

X

x
2/8

Scott-Young, Bird and Kuhar,
1977.
Guyenet and Aghajanian, 1977.

X

+
H

Periaqueductal
Gray
Hypothalamus
Thalamus

Hippocampus

Striatum
(Caudate}
Cortex

at.

I .
fJUlnea
ig

H

X

++

X

++
++
+

rat
rat

t ""
HH

p:-at

trat

++
++
++
+

f-rat

+

X

++

X

~at

rat, cat

Nicollet al., 1977.
Fredrickson and Norris, 1976.
Carette and Poulain, 1978.

lrat
rat
rat

~at

X

+

I

Hill, Pepper and Mitchell,
1976.
Gent and \iolstencroft, 1976.

I

Cerebellum

Nicoll, Siggins, Ling, Bloom
and Guillemin, 1977.

X

X

X

X
X

..

Hill and Penper 1978 .
'
Nicoll et al., 1977.
Hill, Pepper and Mitchell,
1976.
Nicoll et al., 1977.
Zieglgansberger, French,
Siggins and Bloom, 1978.

X

X

X

X

X

X

Nicoll et al. , 1977.
Fredrickson and Norris, 1976.

X

Nicoll et al. , 1977.
Hill, Pepper and Mitchell,
1976.
Zieglgansberger, Fry, Herz,
Moroder and Wunsch, 1976.
Davies and Dray, 1978.

X
X

X

19
1.1.4.

Actions of Opioid Peptides on Single Neurons In Vivo

Electrophysiological studies of the enkephalins and S-endorphin
on single neurons in the central nervous system showed that their effects
were similar to those of morphine (Table 2} •

The route of administra-

tion of the peptides has been limited to local applications by iontophoresis or pressure injection.

Due to the rapid metabolic degradation

of the enkephalins, systemic application was unsuccessful.

Development

of stable analogs, however, has made systemic administration possible.
A study of thalamic neurons demonstrated that iontophoretic as well as
2
5
systemic administration of D-ala , D-leu -enkephalin depressed the increase in firing rate evoked by a noxious stimuli (Hill and Pepper,
1978) .

This depression was reversed by naloxone given either system-

ically or iontophoretically.

The results obtained with the enkephalin

analog were similar to those seen with morphine (Hill and Pepper, 1976}
and enkephalin (Hill, Pepper and Mitchell, 1976).

There is a generally good correlation between the density of
opiate binding sites and the proportion of cells which are responsive
to either morphine or the opioid peptides (Nicoll, Siggins, Ling, Bloom
and Guillemin, 1977).

It appears that morphine and the opioid peptides

have the same action on nerve cells tested throughout the central nervous system.

That is to say, both morphine and the opioid peptides de-

crease firing whether it is spontaneous or evoked by physiological stimuli or excitatory amino acids.

At the two sites where excitatory ef-

fects of morphine predominate, the opioid peptides also excite (Nicoll
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et al., 1977).

--

These sites are the pyramidal cells of the rat hippocam-

pus (Nicollet al., 1977) and the cat Renshaw cell (Davies and Dray,
1978).

There is now evidence that the excitation of hippocampal neurons

is due to an inhibition of a tonically active inhibitory interneuron
(Zieglgansberger, French, Siggins and Bloom, 1978).

An inhibition of an

inhibitory interneuron may explain the finding that a small proportion
of cells are excited by iontophoretic application of morphine or enkephalin at other sites (brainstem, cortex, cerebellum, caudate nucleus)
(Nicollet al., 1977).

Similar considerations may explain the increase

in firing of brainstem neurons evoked by morphine, enkephalin, acetylcholine and D,L-homocysteic acid, since the excitations produced by
acetlycholine as well as morphine and enkephalin were blocked by naloxone (Davies and Dray, 1978).

In spontaneously active cells, the time course of effects produced by enkephalin administered iontophoretically was generally fast.
Effects, whether excitatory or inhibitory, began soon after the onset of
iontophoretic current (10-30 s)

and the firing rate returned to con-

trol \vi thin 1 min after termination of the current. some Lamina IV and V
cells in the spinal cord of cat are excited by noxious stimuli.

Morphine

and enkephalin block the increase in firing rate produced by noxious
stimuli, but the time course of this effect is much longer than the inhibition of spontaneously firing cells (Duggan, Hall and Headley,
The time course of the inhibition produced by morphine

~Dd

1977~).

enkephalin on

lamina IV and V cells was 30 min and 4-10 min, respectively.

In all previous studies, the release of enkephalin from the
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iontophoresis electrode has not been measured, and therefore the concentrations at the active site are unknown.

The responses to iontophor-

etically applied enkephalin may be opiate receptor-mediated
if they are blocked by the narcotic antagonist naloxone.

However, sys-

temic administration of naloxone in a dose sufficient to block the usual
pharmacological effects of morphine is more desirable.

Because the con-

centrations of agonist and antagonist near the cell being studied are
not known when both are applied by iontophoresis, antagonism by iontophoretic administration of naloxone is of limited value.

Indeed, ionto-

phoretic application of naloxone antagonises the inhibitions of neurons
in the olfactory

bulb

of rat produced by o--aminobutyric acid (GABA)

(Dingledine, Iversen and Breuker, 1978).

In that study naloxone re-

versed the effect of morphine in only 2 of 14 cells tested.

Another example of the difficulties inherent in iontophoretic
administration of agonists and antagonists comes from the work of Duggan, Hall and Headley (1976; 1977) on cat spinal cord.

Iontophoretic

application of an enkephalin analog near the cell bodies of lamina IV
and V cells decreased both spontaneous firing and the increase in firing
rate evoked by noxious or non-noxious stimulation.

These effects were

determined to be of limited significance for three reasons.

First, the

effects were not selective for either of the two sensory modalities tested
whereas systemic application of morphine selectively blocked nociceptive
responses.

Second, other agents such as glycine and

GA~A

also blocked

increases in firing rate produced by each sensory modality.

Third, the

inhibitions produced by enkephalin applied by iontophoresis near the
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cell body were antagonized by iontophoretic administration o= naloxone
but were not affected by intravenous administration of naloxone in doses
up to 0.6 mg/kg.

This dose of naloxone blocked the effect of systemi-

cally applied morphine and the effects of enkephalin when iontophoresed
into the substantia gelatinosa.

These experiments suggest that the con-

centration of enkephalin near the cell body was greater than that neeessary to cause blockade of noxious input and high enough to depress
other modalities.

On the other hand, iontophoresis of morphine and en-

kephalin into the substantia gelatinosa selectively depressed nociceptive responses of lamina IV and V cells and this was reversed by low
doses of naloxone given systemically (Duggan

et al., l977a).
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1.1.5.

Actions of Opiates and Opioid Peptides on Single Neurons In Vitro

In vitro studies have been carried out on peripheral morphinesensitive neurons of the myenteric plexus of the guinea pig ileum, and
on spinal and dorsal root ganglion neurons maintained in culture, all of
which have previously been

shown

to contain opiate receptors.

In cultured dorsal root ganglion neurons two separate studies
have indicated a possible presynaptic site of action for the opiates and
opioid peptides (Crain, Peterson, Crain
Nelson, 1978).

and Simmon, 1977; MacDonald and

A complex multi-unit potential was recorded in the dor-

sal horn area of fetal mouse spinal cord explants after electrically
stimulating the attached dorsal root ganglion (Crain et

~.,

1977).

This potential was markedly diminished by morphine; the diminution was
stereospecific and naloxone-reversible.

The concentrations used in the

bathing solution were comparable to those which are effective on the
contractile response of the guinea pig ileum.

Interestingly, the evoked

dorsal cord potential was increased by low concentrations of naloxone
alone which suggests that an inhibitory endogenous opioid system may
have developed in these cultures.

In the second study, simultaneous

intracellular recordings from dorsal root ganglion cells and spinal cord
cells in culture were made.

Direct intracellular stimulation of the

dorsal root ganglion cell resulted in a mono-synaptic depolarizing potential recorded in the spinal cord cell (MacDonald and Nelson, 1978).
The excitatory postsynaptic potential (e.p.s.p.) recorded in the spinal
cord cell was depressed by iontophoretic application of etorphine in a
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naloxone-reversible manner.

The authors concluded that the depression

of the e.p.s.p. was due to a decrease in quantal content of the e.p.s.p.:
however, calculations of quanta! content and quantal size were done by
assuming a Poisson distribution and these calculations may be erroneous
since there is no evidence that a Poisson distribution of transmitter
release occurs in this preparation.

No evidence of any postsynaptic

effects during application of etorphine were observed.

In another experiment on cultured mouse spinal cord cells, leuenkep~alin

was applied iontophoretically near the surface of spinal cord

neurons (Barker, Neale, Smith and MacDonald, 1978) •

Leu-enkephalin de-

creased the depolarization induced by iontophoretic application of glutamate.

This effect was partially reversed by iontophoretic application of

naloxone in only some experiments and an opiate receptor-mediated effect
may or may not

:oe

involved.

The action of opiates on single myent.eric

neurons has also been studied (see Section 1.3.3.).
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1.1.6.

The Significance of the Endogenous Opioid ?eptides

The evidence concerning the location, release and actions of the
endogenous opioid peptides strongly supports a neurotransmitter or neuromodulator role for these peptides.
ever, has been demonstrated.

No functional opioid synapse, how-

Also, naloxone has little or no action of

its own when administered to normal human subjects.

The endogenous opi-

oid system, however, has been proposed to mediate the analgesia produced
by acupuncture in man (Mayer, Price and Rafii, 1977) cat

~~d

mouse (Pom-

eranz, 1978) and by electrical stimulation of the periaqueductal gray in
man (Akil, Watson, Berger and Barchas, 1978).

Administration of naloxone

was shown to partially reverse the analgesic effects caused by stimulation produced analgesia in all species tested.

The partial reversal, by

naloxone, of stimulus produced analgesia (SPA) indicates at least part
of the analgesic effect seen could be due to release of opioid peptides.
The release of opioid peptides into cerebrospinal fluid

follo~ing

cen-

tral stimulation also indicates that an endogenous opioid system may
play a role in SPA (Terenius, 1978).

Several approaches have been used to study the nature of the
antinociceptive effects of acupuncture (Mayer et al., 1977; Pomeranz,
1978).

First, the increase in firing rate of nociceptive spinal cord

cells in lamina IV and V of cat produced by painful

stimulatio~

was

blocked by acupuncture in a naloxone-reversible manner (Pomeranz, 1978).
Second, the latency of response to a noxious stimulus (heat) in awake
mice was increased by acupuncture and this increase in late~cy was

26

blocked by prior treatment with naloxone (Pomeranz, 1978).

Third, a

strain of mice (CBXK) which had a deficit of opiate receptors was used
to study acupuncture.

This strain of mice showed no significant change

in antinociceptive response after acupuncture (Pomeranz, 1978).

Finally,

naloxone antagonized the increase in pain threshold caused by acupuncture in healthy humans (Mayer, et

~l·r

1977}.

The most striking effect

of the studies on acupuncture was the time course of effects.

The on-

set and offset of analgesia produced by acupuncture were in the order of
minutes to hours.

It therefore appears that the antinociceptive responses,behaviorally and at a single cell level,to SPA and acupuncture are, at least
in part, mediated by release of endogenous opioids.

The site which may

be involved in the release of the opioid has not yet been determined.
It is of interest to note that hypophysectomy abolished the response to
acupuncture in mice (Pomeranz, Cheng and Law, 1977).

Since the pitui-

tary is known to contain large amounts of S-endorphin, it may be possible that release of S-endorphin from the pituitary is important in
acupuncture analgesia.

The metabolic stability of 8-endorphin may also

account for the prolonged effects produced by acupuncture.

1.2.

NEUR0PEPTIDES

1.2.1.

1.2.1.1.
smooth muscle

Substance P

General Background.

Substance P, a hypotensive and

stimulating agent was first extracted from brain and in-

testine by von Euler and Gaddum (1931).

It was not

Q~til

1970 that this

peptide was isolated in a pure form (Chang and Leeman, 1970).
ture

~as

The struc-

determined to be an undecapeptide (Chang, Leeman and Niall, 1971)

(Table 1) and it was subsequently synthesized (Tregear, Niall, Potts,
Leeman and Chang, 1971).

The availability of pure, synthetic substance

P allowed the development of many avenues of research.

A radioimmuno-

assay was developed wnicn allowed minute quantities to oe measured from
gross tissue extracts (Powell, Leeman, Tregear, Niall and Potts, 1973).
The distribution of substance P in the central nervous system has been
studied by measuring the amount of substance P contained in discrete
nuclei isolated by microdissection (Brownstein, Mroz, Kiaer, Palkovits
and Leeman, 1976; Nakata, Kusuka, Seqawa, Yajima and Kitgawa, 1978).
Regions in the central nervous system which contain high concentrations
(>1.5 p mole/10 mg wet weight) are the hypothalamus, preoptic area and
mesencephalon.

The spinal cord contains somewhat less substance P.

However, there is about twice as much substance P in the dorsal horn as
in the ventral horn of the spinal cord.

Using substance P labeled with

tritium, a binding site for substance P has been deno::1strated in membrane fragments from rabbit brain.

This binding site has a dissocia-

tion constant (Kd) o= 2.7 nM and the order of binding affinities of a
27
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series of analogs correlates well with their biological potencies (Nakata

et al., 1978).

--

The distribution of the substance P binding site also

correlates well with the distribution of substance P in the central nervous system of rabbit (Nakata et al., 1978).

Immunohistochemical studies also became possible with the availability of pure substance P (Hokfelt, Kellerth, Nilsson and Pernow,
1975) .

Substance P-like immunoreactivity was found in the neuronal cell

bodies and processes.

The distribution of immunohistochemically identi-

fied substance p correlates well with the distribution determined by the
extraction procedures described above.

Although

iwmw~ohistochemistry

cannot be used quantitatively, the cellular and subcellular localization is important in determining the physiological role of this peptide.
Substance P was generally found in small unmyelinated fibers, often associated with afferent nerve pathways (Hokfelt et al., 1975; Otsuka, Konishi and Takahashi, 1975; Takahashi and Otsuka, 1975; Hokfelt, Elde,
Johansson, Luft, Nilsson and Arimura, 1976; Chan-Pala'l and Palay, 1977;
Hokfelt, Ljungdahl, Terenius, Elde and Nilsson, 1977).

Substance P-like

immunoreactivity has also been found in nerve terminals and varicosities
of peripheral ganglia, including sympathetic ganglia, (Hokfelt, Elfvin,
Schultzberg, Goldstein and Nilsson, 1977) and in the myenteric plexus
(Nilsson, Larsson, Hakanson, Brodin, Pernow and Sundler, 1975; Hokfelt,
Johansson, Kellerth, Ljungdahl, Nilsson, Nygards and Pernow, 1977).

Ligation studies of the dorsal roots indicate that substance P is
transported towards the spinal cord in nerve axons and may be involved
in primary afferent transmission (Otsuka, Konishi, Takahashi and Sato,
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1976; Otsuka and Konishi, 1976; Chan-Palay and Palay, 1977).

Lesion stud-

ies using immunohistochemistry and extraction procedtues suggest that substance P is also involved in at least three other neuronal path·,.;ays:

two

are the projections to the substantia nigra from the globus pallidus and
corpus striatum, and a third is the pathway from the hab€nula to the interpeduncular nuclei (Brownstein, Mroz, Tappaz and Leeman, 1977; Jessell,
1978; Jessell, Emson, Paxinos and Cuello, 1978).

Another short projection

within the amygdala has also been described (Emson, Jessell, Paxinos and
CUello, 1978).

The subcellular localization of substance P has been studied in
two ways.

Cell fractionation of rat brain has shm·m

t~1at

substance P is

located primarily in the synaptosomal fraction (Cuello, Jessell, Kanazm'la
and Iversen, 1977).

Electron microscopic immunohistochemistry of sub-

stance P in the amygdala and substantia gelatinosa demonstrated dense
core vesicles which contained substance P-like immunoreactivity

(~uello

et al., 1977; Pelletier, LeClerc and Dupont, 1977).

Substance P has been shown to be released fron synaptosomal preparations (Schenker, Mroz and Leeman, 1976), slices of hypothalamus (Iversen,
Jessell and Kanazawa, 1976), trigeminal nucleus (Jessell
and substantia nigra of the rat

a~d

Iversen, 1977)

(Jessell, 1978) and isolated spinal cord of

the rat (Otsuka and Konishi, 1976).

These experiments all used high potas-

sium containing solutions to evoke the release; the release 'l·:as calcimndependent.

In addition, Otsuka and Konishi (1976) a~d Jessell (1978) ob-

served release of substance P with electrical stimulation and veratridine,
respectively,

Release of substance P in these preparations therefore
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appears to be specifically from nerves.

Little is known of the synthesis of substance P.

Likewise, no

mechanism of inactivation of substance P has been described.
p was not found to be actively accumulated in rat

b~ain

Substance

slices from

which it was released (Iversen, Jessell and Kanazawa, 1976).

Substance

p has been shown to be stable in the postmortem brain (Kanaza...ra and
Jessell, 1976) and in whole blood or plasma (Bury and
If substance P is to satisfy all

criteria

for a

~·!ashford,

1977).

neu~otransmi tter,

dif-

fusion away from the receptor site may play an important role for the
inactivation process.

1.2.1.2.

Actions on Single Neurons.

Since t:-te synthesis of

substance P,studies of the action on single neurons have proceeded relatively quickly.

Prior to this time, the effects of substance P (obtained

from an extract of cattle intestine) on single neurons were inconsistent
(Galindo, Krnjevic and Schwartz, 1967).
ities contained in the extract.
a

weak

This may be attributed to impur-

Recent work has found substance P to be

depolarizing or excitatory agent on cells in several locations

(Table 3).

With the exception of Otsuka and Konishi's work on isolated

spinal cord, all studies have been done in vivo using iontophoretic
application of substance P.

The most striking aspect of the effects

produced by substance P was the extended time course of its action compared to other excitatory agents such as glutamate.

The onset and off-

set of the excitatory effect of substance P often occurred over a period
of several minutes.

The effects were variable and tended to decrease

with repeated applications (Krnjevic and Morris, 1974; Henry, Krnjevic

Table 3.
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The action of substance P studied in various areas of the central nervous system.

Area

SEJecies

Ion

Spinal Cord
Lamina IV and v

cat, rat

t

Perfusion

References

Henry, Krnjevic and Morris
1975.
t
t

frog
rat
cat

t

Konishi and Otsuka, 1974a.
Konishi and Otsuka, l974b.
Krnjevic, 1977.

Renshaw cell

cat, rat
cat
cat
cat
cat

t
t
t
t
t

Henry et al. , 1975.
Davies a..'1d Dray, 1977.
Belcher a..'1d Ryall, 1977.
Krnjevic and Lekic, 1977.
Ryall and Belcher, 1977.

Cuneate

cat

t

Krnjevic a'1d !•!orris, 1974.

Locus coeruleus

rat

t

Guyenet and Aghaj ani an,
1977.

Interpeduncular
nucleus

: ra::.

t

Sastry, 1978ai 1978b.

Amygdala and
Putamen

I
I rat

t

Le Gal La Salle and Ben-Ari
1977.

Substantia Nigra

rat

t

Davies and Dray, 1978.

Cortex

rat, cat
rat

""'
t

Henry et al., 1975.
Sastry, 1978b.

Motor neurons

abbreviations:

I

Ion
- iontophoretic application
Perfusion - superfusion of a known concentration
on to an isolated preparation
t
- indicates that the predominate of
substance P was excitatory

-
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and Morris, 1975; Davies and Dray, 1976; Le Gal La Salle and Ben-Ari,
1977; Sastry, 1978).

Interpretation of in vivo studies on substance P

is difficult for five reasons.

First, in only two studies was the re-

lease of substance P from the iontophoresis electrode measured (Krnjevic
and Morris, 1974; Belcher and Ryall, 1978).
for substance P are not available.

Second, specific antagonists

Third, the effects of general anes-

thetics decrease the response of some cells to substance P (Sastry,
1978b).

Fourth, none of these studies included the iontophoresis of

analogs of substance P.

Fifth, stilistance P in iontophoretic electrodes

has been reported to break down over a period of days (Gozlan, Le Gal
La Salle, Michelot and Ben-Ari, 1977), even though the amount measured
by radioimmunoassay decreased only slightly over extended periods of
time (Krnjevic and Harris, 1974).

This implies that breakdown in the

iontophoresis electrode results in fragments which may be biologically
less active but which are still immunologically reactive.

Some of the above difficulties are removed in in vitro experiments.

In the isolated frog spinal cord preparation, bath application

of known amounts of substance P caused a marked depolarization associated with an increase in conductance of spinal motor neurons (Konishi
and Otsuka,

1974~).

This depolarization was determined to be a direct

action on the spinal motor neurons since it was still present in solutions which contained low calcium and high

magnesiQ~

ion concentrations;

such solutions blocked the reflex activity induced in the dorsal root
and recorded in the ventral root.

The specificity of the depolarization

produced by substance P was tested using a series of analogs.

The po-

tency of the analogs was markedly decreased if any change was made at
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the amino terminus of the molecule.

Also, if more than five amino acid

residues were removed from the carboxy terminal the potency was decreased
(Otsuka and Konishi, 1977).

The relative order of potency of these ana-

logs on spinal motor neurons corresponds reasonably well with the gutcontracting and hypotensive activity (Otsuka and Konishi, 1977), as well
as with their binding affinities (Nakata et al., 1978).

The use of a

series of structurally related analogs is important to demonstrate passible receptor interactions, since there are as yet no known substance
P antagonists.

If the relative order of potency of a series of analogs

is the same for a number of biological responses and binding studies,
then a receptor mediated effect is supported.

A major difficulty in the

interpretation of Otsuka's work is that the effective concentrations of
substance P were 100-1,000 times higher than those effective in contracting smooth muscle or reducing blood pressure.

Indeed, a similar point

may be raised with all the experiments using iontophoretic application,
since the concentration around the cell is not known.

Baclofen (8-(4-chlorophenyl)o-aminobutyric acid)

(Lioresal) was

found to antagonize the depolarization of spinal motor neurons produced
by substance P (Saito, Konishi and Otsuka, 1975).
also decreased the glutamate depolarization.

However, baclofen

At other synapses, antago-

nism of the substance P response by baclofen appears to be at least partially non-specific (cat spinal motor neurons - Krnjevic, 1977; rat interpeduncular neurons - Sastry, l978a).

Systemic administration of bac-

lofen results in a decrease in synaptic transmission to spinal motor
neurons and the cuneate nucleus, but the site of action of systemicallyapplied baclofen seems to be both pre- and postsynaptic (Krnjevic, 1977).
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A second discrepancy between the wo:tk vf Otsuka a..11d that of
Krnjevic is the proposed mechanisms underlying the depolarization produced by substance P.

Krnjevic reported a decrease in conductance in

cat spinal motor neurons; the reversal potential for this action of substance P was more negative than the resting potential.

Otsuka, on the

other hand, found an increase in conductance with a reversal potential
near zero.

Krnjevic's results must be interpreted with caution because

of the possible activation by substance P of cells \vhich have excitatory
or inhibitory synapses on to the spinal motor neuron.

Substance P may

depolarize an interneuron which releases an excitatory tra11smitter on to
the spinal motor neuron.

In this case, substance P ana the excitatory

transmitter may both depolarize the spinal motor neuron, but do so through
different ionic mechanisms.
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1.2.2.

1.2.2.1.

Neurotensin

General Background.

Neurotensin was isolated from

bovine hypothalamus; it is a tridecapeptide (Table 1)
man, 1973; 1975

~,b).

(Carraway and Lee-

When administered intravenously to rats neuroten-

sin has numerous actions including hypotension, increased vascular permeability, hyperglycemia and hyperg1ucagonemia.

In mice and rats, an

intracisternal injection of neurotensin decreases cold tolerance, induces· hypothermia, and enhances the depressant effect of phenobarbital
(Nemeroff, Bissette, Prange, Loosen, Barlow and Lipton, 1977).

These

actions are not seen \·lith systemic administration, which probably indicates either an inability of this peptide to cross the blood brain barrier or a relatively fast metabolism in the blood.

The distribution of neurotensin in the central nervous system
has been studied using radioimmunoassay and immunohistochemical methods
(Uh1 and Snyder, 1976; Kobayashi, Brown and Vale, 1977; uTil, Kuhar and
Snyder, 1977).

Using immunohistochemistry, neuronal cell bodies and

processes containing neurotensin were found in high density in the substantia gelatinosa, trigeminal nucleus, amygdala, anterior pituitary and
hypothalamic nuclei.

Subcellular fractionation studies indicated that

the majority of the neurotensin was associated with a synaptosomal fraction (Uhl and Snyder, 1976).

Release of neurotensin from slices of hypo-

thalamus has been demonstrated; the release was evoked by a high potassium solution and required the presence of extracellular calcium ions
(Iversen, Ivsrs.=:n, Bloom, Douglas, Brown and Vale, 1978).
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Il25_labeled neurotensin binds to membrane frag;c.ents from brain
homogenates with a high affinity (Kd= 3-8 nM) and the density of binding
sites is highest in regions containing large amounts of neurotensin
(Lazarus, Bro>m and Perrin, 1977; Uhl, Bennett and Snyder, 1977).

The

binding affinity of a series of neurotensin analogs also correlates well
with their rank order of potency tested on the hyperglycenic and hyperglucagonemic responses in rats (Uhl et al., 1977).

The neurotensin bind-

ing sites may be taken to indicate that neurotensin acts on a specific
receptor.

The mechanisms by which neurotensin is synthesized, degraded, or
removed from the extracellular space have not yet

bee~

described.

How-

ever, enzymic degradation of neurotensin was suggested by studies on extracts of brain and hypothalamus (Dupont and 1-!erand, 1978).

1.2.2.2.

Actions on Single Neurons.

Some preliminary studies

of the action of neurotensin on neurons in the
have been made.

cent?~al

nervous system

Neurons in several areaswhich have a relatively high density

of binding sites and high levels of neurotensin were studied.

These in-

elude frontal cortex, hippocampus, striatum and lateral thalamus (Zieglgansberger, Siggins, Brown, Vale and Bloom, 1978) and laninas I-III of
the spinal cord (Miletic and Randic, 1978).

The predoninant effect pro-

duced by iontophoretic application in these areas 'das excitation which
was slow in onset.
cation.

This excitation long outlasted the period of appli-

The locus coeruleus also contains neurotensin within cell bod-

ies and nerve terminals but iontophoresis of neurotensin on to these
cells inhibits neuronal firing (Scott-Young, Uhl and

~uhar,

1978).

The
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results from this study differ also in the time course of the effects.
The inhibition in firing rate and the return to control occurred rapidly
after the onset and offset of iontophoretic current.

Neurotensin causes a contraction of the guinea pig ileum which
is blocked by tetrodotoxin, implying an excitatory action on myenteric
neurons (Kitabgi and Freychet, 1978).

A relaxation of other smooth

muscle preparations has been found which was not affected by tetrodotoxin (Andersson, Rosell, Hjelmquist, Chang and Folkers, 1977).
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1.2.3.

1.2.3.1.

Vasoactive Intestinal Polypeptide

General Background.

A second polypeptide first iso-

lated from the gut which has properties similar to those of substance P
is vasoactive intestinal polypeptide (VIP)

(Said and Mutt, 1970a).

Ori-

ginally, the actions of VIP were thought to be confined to the gut since
a single pass through the liver almost completely inactivates this peptide (Said and Mutt, 1970£) .

This 28-amino acid residue peptide (Table

1) causes systemic vasodilation, hypotension, hyperglycemia, stimulates
cardiac output and excites respiratory chemoreceptors (Mutt and Said,
1974a).

Recently, using radioimmunoassay and immunohistochemistry, VIP

has been localized in neurons of peripheral ganglia and central nervous
system (Larsson, Fahrenkrug, Schaffalitzky De Muckadell, Sundler, Hankanson and Rehfeld, 1976).

A dense population of VIP-containing neurons

was found in the gut (Larsson

eta~.,

1976; Larsson,

1977~,£;

Fux, Hok-

felt, Said and Mutt, 1977) and in the mesenteric ganglia complex (Hokfelt, Elfvin, Schulzberg, Fux, Said, Mutt and Goldstein, 1977).

In the

central nervous system, VIP-containing terminals were found in some
hypothalamic nuclei, in parts of the amygdala and in the cortex (Fux et
al., 1977).

VIP has been shown to occur within neuronal granules of 120

nm diameter by immunohistochemistry (Larsson,

1977~)

and in the synapto-

somal fraction by subcellular fractionation studies (Gaichetti, Said,
Reynolds and Koniges, 1977).

Potassium-evoked release of VIP from a

synaptosomal preparation by a calcium-dependent mechanism adds further
evidence to support a neurotransmitter role for this peptide (Gaichetti
et al., 1977).
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1.2.3.2.

Action on Single Neurons.

on the actions of VIP on single neurons.

Little work has been done

Iontophoretic application of

VIP on to cortical neurons results in an increase in firing rate (Phillis,
Kirkpatrick and Said, 1978).

VIP depolarizes the dorsal and ventral

roots of toad spinal cord; however, very high concentrations of VIP
(3-6 X 1o-6M) are required (Phillis et al., 1978).

The high concentra-

tion used in this preparation contrasts with the lower doses required
for other effects; for example, a dose of only 40 ng/kg increased femoral arterial blood flow by 50% (Said and Mutt, 1970a) .
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1.2.4.

1.2.4.1.

Somatostatin

General Background.

The hypothalamic peptide somato-

statin was first isolated, purified and synthesized in 1973 (Brazeau,
Vale, Burgus, Ling, Butsher, Rivier and Guillemin, 1973).

This cyclic

tetradecapeptide has been shown to inhibit the release of growth hormone
in both cultured pituitary cells and pentobarbital-treated rats (Brazeau
et al., 1973).

An inhibition of the release of other hormones by soma-

tosta.tin has also been reported (TSH - Siler, Yen, Vale and Guillemin,
1974; insulin - Curry and Bennett, 1974; Curry and Bennett, 1976; glucagon- Fujimoto and Esinck, 1976).

More recently, somatostatin has been

found by immunohistochemistry and radioimmunoassay at several sites in
the central nervous system which are probably unrelated to hormone regulation (Hokfelt, Efendic, Hellerstrom, Johansson, Luft and Arimura, 1975;
Hokfelt, Elfvin, Elde, Schultzberg, Goldstein and Luft, 1977; Kobayashi,
Brown and Vale, 1977).

Extrahypothalamic areas which have high concen-

trations of somatostatin include the amygdala, nucleus accumbens, medulla,
substantia gelatinosa, thalamus and hippocampus.

Nerve terminals which

contain somatostatin have been observed immunohistochemically in peripheral ganglia including the myenteric plexus (Hokfelt et al., 1975;
1976; Costa, Patel, Furness and Arimura, 1977).

Immunocytochemical tech-

niques have localized this peptide to neuronal fibers and varicosities
(Petrusz, Sar, Grossman and Kizer, 1977) and subcellular fractionation
has indicated that it is concentrated in the synaptosomal fraction
(Epelbaum, Brazeau, Tsang, Brawer and Martin, 1977).

Release of somato-

statin from slices of hypothalamus and amygdala using high potassium
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solutions by a calcium-dependent mechanism may imply tl"lat, in addition
to its neuroendocrine function, somatostatin may act as a neurotransmitter (Iversen, Iversen, Bloom, Douglas, Brown and '/ale, 1978).

There is some evidence, from binding studies aDd behavioral experiments, that the actions of somatostatin may be mediated by opiate
receptors (Rezek, Havicek, Lebin, LaBella and Freisen, 1977; Pugsley
and Lippmann, 1978).

This evidence is weak because 1,000 times more

somatostatin than opiates was needed to displace naloxone from its binding site.

In fact, somatostatin binding compared Hith that of dextror-

phan (Pugsley and Lippmann, 1978).

Large amounts of

istered intracerebroventricularly resulted in slight

so~atostatin

admin-

a~tinociception

which was only partially reversed by naloxone (Rezek et al., 1977).
Somatostatin inhibited the contractile response of the longitudinal muscle-myenteric plexus preparation to nerve stimulation; however, this
effect of somatostatin was not reversed by the opiate antagonist, naloxone (Guillemin, 1976).

In the frog isolated spinal cord, the action of somatostatin on
the membrane potential of the ventral and dorsal roots has been studied
using the sucrose gap technique (Padjen, 1977).

Somatostatin hyperpolar-

ized the dorsal roots and this persisted in solutions ,,;here synaptic
transmission was blocked using a calcium-free solution, and v1here propagated activity was blocked by a local anesthetic.

In this study, the

endocrinologically inactive retro-somatostatin did not produce a hyperpolarization.

The hyperpolarization produced by somatostatin therefore

appears to be a direct action on the dorsal roots; ho·...·ever, the concen-
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tration required \vas l, 000 fold greater than that required to produce
endocrine effects.

1.2.4.2.

Actions on Single Neurons.

Iontophoretic application

of somatostatin inhibits neuronal firing in the cortex,

hy~othalamus

and

cerebellum (Renaud, Martin and Brazeau, 1975) and in l&uina I-III of the
spinal cord {Niletic, Kavacs and Randic, 1977).

On the other hand, in

slices of rat hippocampus, iontophoresis or pressure injection of somatostatin resulted in depolarization and increased excitability of CAl
and CA2 cells (Dodd and Kelly, 1978).

There are no specific antagonists of somatostatin; somatostatin
analogs have not been studied and there is no method b:/ which to correlate the concentrations which produce the endocrine effects with the
amount of somatostatin which is applied iontophoretically.

Moreover, the

differences in responses to somatostatin seen among cells of the hippocampus and those elsewhere in the central nervous system \'lere much like
those seen with morphine and enkephalin (see section 1.1.4.).

The exci-

tation of pyramidal cells of the hippocampus by the opiates and opioid
peptides has been shown to be a trans-synaptic action (Zieglgansberger
et al., 1978).

The opiates are thought to excite

hibiting an in'b.ibitory interneuron.

pyr~~idal

cells by in-

The same type of disinhibition could

explain the depolarization seen with iontophoretic application of somatostatin in the hippocampus.

l. 3 .

THE MYENTERIC PLEXUS

l. 3 . l.

Anatomy

The myenteric plexus is a complicated netv;ork of neurons which
may be involved in the transmission of afferent and efferent impulses to
and from the central nervous system as well as being involved in local
reflex mechanisms (Schofield, 1968).

In the guinea pig ileum, the plex-

us is a network of neurons arranged in ganglia which are laid out in a
relatively structured manner.

The ganglia of the plexus are situated in

a roughly rectangular arrangement with interconnecting strands containing nerve processes running between the ganglia.
50-100 ym in width, are up to l

~~

The ganglia range from

in length and are l-3 cells thick.

The entire ganglion is surrounded by a basal lamina which isolated the
neurons from connective tissue and blood vessels (Gabella, 1972).

Each

ganglion contains from 20-200 nerve cells and about 2-3 times as many
glial cells (Gabella, 1972).

The extracellular space within the ganglia

is limited by a dense neuropil of nervous and glial origin.

The size of the ganglion cells vary from less than 10 ym to 35
~in

diameter (Gabella, 1972; Cook and Burnstock, 1976).

Unlike sympa-

thetic and spinal ganglia, there are few nerve cell bodies which are surrounded by satellite cells (Gabella, 1972; Cook and Burnstock, 1976).
Using the electron microscope, up to nine types of ganglion cells were
distinguished by their size, type of endoplasmic reticulu.ll, appearance
and distribution of other cellular organelles and the relationship the
neurons had with satellite cells and neuropil (Cook and Burnstock, 1976).
43
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Extraganglionic neurons were present in the interconnecting strands between the ganglia.

These cells were seen only occasionally, were unlike

other nerve cell types seen in the ganglia and exhibited very few typical
synaptic specializations (Cook and Burnstock, 1976).

Several types of axons have also been described using the electron microscope (Gabella, 1972; Cook and Burnstock, 1976).

Different

types of axons were distinguished by the type of vesicles found near
synaptic membrane specializations and included:

small granular vesicles

(40-60 nm), round agranular vesicles (40-60 nm), flattened agranular vesicles (20-40 nm), elongate structures (up to 350 nm long and 18-30 nm in
diameter) and three types of large vesicles with granular cores (Gabella,
1972; Cook and Burnstock, 1976).

It was assumed that the small granula-

ted vesicles in nerve terminals contained noradrenaline, and the agranular vesicles which Here most frequently seen contained acetylcholine
(Gabella, 1972).

The presence of cholinergic and noradrenergic terminals

in the myenteric plexus is well accepted.

Electrophysiological evidence

strongly supports the neurotransmitter role of acetylcholine and noradrenaline (see section 1.3.2.2.).

The significance of the remaining types of axon profiles based on
the type of vesicles found in the varicosities remains to be determined.
Several endogenous agents have been proposed to function as neurotransmitters in the myenteric plexus on the basis of their histochemical and
cytochemical locations.

The presence of nerve terminals and cell bodies

in the myenteric plexus which can take up m1d synthesize 5-hydroxytryptamine (5-HT) suggests that 5-HT may be another transmitter in the myenteric

plexus

(Dreyfus, Bornstein and Gershon, 1977; Dreyfus,

s.hon, 1977).

Sher~an
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and Ger-

Electrophysiological evidence on the action and role of

5-HT in the myenteric plexus is inconclusive (see sections 1.3.2.1. and
1.3.2.2.).

The myenteric plexus is also thought to have neurons which

contain and release purine nucleotides (Burnstock, 1972).

Hare recently,

immunohistochemical studies have demonstrated the presence of the following neuropeptides within nerve terminals of the myenteric plexus:

enke-

phalin (leu and met), substance P, somatostatin and VIP (see appropriate
sections for references).

The location of the cell bodies of origin is

not known with certainty.

VIP-like and somatostatin-like irronunoreactiv-

ity have been observed in cell soma within the myenteric plexus such that
at least a part of the VIP and somatostatin is

intrL~sic

to the gut.

An

extrinsic source of enkephalin, substance P and sonatostatin has been
proposed, but experiments using agents to block axonal transport

(colchi~

cine) to increase the content of immunoreactive substru>ces in the cell
bodies have not been performed.

The distribution of the neuropeptides within the gastrointestinal
tract has not been studied, with the exception of enkephalin.

A higher

content of met- and leu-enkephalin was found in the duodenum than in
other parts of the gastrointestinal tract (Hughes et al., 1977).
significance of this observation remains to be detemined.

The

However, it

is possible that regional variations in the content of one or more of
the neuropeptides may account in part for some functional differences
along the gastrointestinal tract.

Histologically, the occurrence of a dense neuropil, the isolation
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from blood vessels and connective tissu8, and the absence of extracellular space make the cells of the myenteric plexus more like those of the
central nervous system than other autonomic ganglia (Gabella, 1972).
Functionally, the myenteric plexus also appears to be somwhat different
from other autonomic ganglia.

The arrangement of neurons within the

plexus confers preferential pathways of conduction in the aboral direction (Bayliss and Starling, 1899; Kosterlitz and

~ydon,

McKirdy, 1975; Yokoyama, Ozaki and Kajitsuka, 1977).

1971; Hirst and

The plexus also

contains a neuronal type which is functionally distinct from those in
autonomic ganglia (see below).

1.3.2.

Electrophysiology

The development of techniques to study single myenteric neurons
has been made by several groups.

The early work utilized extracellular

electrodes made of metal or glass (Yokoyama, 1966; Wood, 1970).

More

recently, intracellular recordings have been performed (Nishi and North,
1973~;

Hirst, Holman and Spence, 1974).

There are marked differences in

the results obtained by these two techniques.
ence

~s

The most notable differ-

that few spontaneously active cells were found with intracellu-

lar techniques, whereas ongoing spike activity was recorded using extracellular electrodes.

A description of the methods and results obtained

with extracellular and intracellular electrodes is necessary before an
understanding of these differences is possible.

1.3.2.1.

Extracellular Recording.

The first recordings from

single myenteric neurons were made by Yokoyama (1966) using extracellular electrodes.

Subsequently, Wood (1970) and Ohkawa and Prosser (1972)

described a series of different
their discharge patterns.

types of neuronal units in terms of

The experimental methods used by

Ohkawa and Prosser were similar.

~vood,

and

Both used the isolated jejunum from

cat and metal or metal-filled electrodes having tip diameters of 1-25

~

The myenteric ganglia were stained with methylene blue for visualization.

They described similar types of activity.

of neuronal discharge patterns:
(3) burst.

There were three types

(1) mechanosensitive;

(2) single spike;

Mechanosensitive neurons were stimulated by distortion of

the ganglion produced by a glass probe or an electrode having a large
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tip diameter.
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Single spike neurons fired at lov; frec;:uencies (0 .1-2 Hz)

with no consistent firing pattern.

Burst type

neuro~s

periodically dis-

charged a flurry of action potentials followed by periods of silence.
Attempts to record activity which was evoked by electrical stimulation
were not successful (Ohkawa and Prosser,

1972~,£).

The same types of

discharge patterns were found in the guinea pig ileun using a similar
experimental design (Wood, 1973).

When a glass suction electrode (30-100

~)

was used to record

activity, only the single spike and burst units were found (Sate, Takayanagi and Takagi, 1973).

This type of electrode enabled evoked acti-

vity to be recorded (Dingledine and Goldstein, 1976; Yokoyama, Ozaki
and Kajitsuka, 1977).

There was also a large difference in the ratio of

burst units to single spike units encountered when using the different
types of electrodes.

vlith metal electrodes, burst U..Dits were found five

times more frequently than single spike units (l·lood, 1970); with glass
suction electrodes, burst units were found only occasionally (Sate et
al., 1973; Dingledine and Goldstein, 1976).

Dingledine, Goldstein and Kendig (1974) were the first workers
to ensure that the unit firing was not secondary to local muscle movement.

They isolated 1-3 ganglia using small pins.

All previous studies

had used methylene blue to visualize the ganglia whereas Dingledine et
al. (1974) transilluminated the ganglia and eliminated the need for
staining.

Methylene blue has been shown to block synaptic transmission

in sympathetic ganglia at the concentrations used for staining and, at
somewhat higher concentrations, it causes irreversible changes in the
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firing patterns in the cat myenteric plexus (Nozdrachev, Gnetov, Kachalov and Fedorova, 1977).

It is likely that methylene blue, at the con-

centrations used for extracellular recording in the myenteric plexus,
raay have changed the sensitivity of the neurons to some agents.

Neuronal spikes have been reported to be 3-5 ms in duration.
The waveform was usually biphasic and sometimes triphasic (Wood, 1975).
Biphasic spikes were considered to originate at or near the soma and triphasic spikes to be from a propagated potential coming toward, passing
under. and moving away from the electrode.

However, extracellular poten-

tials recorded with point microelectrodes may vary considerably in waveform.
system.

One important consideration is the time constant of the recording
As the coupling time constant decreases, the waveform tends to

change to a differentiated type of waveform (DeValois and Pease, 1973).
It is common to use amplifiers capable of increasing or decreasing the
coupling time constant in order to attenuate extraneous slow potentials
and line noise which would interfere with spike discrimination.

Evalu-

ation of extracellular potential waveform under these conditions is difficult.

The waveform of extracellular spikes may also vary with the

position of the electrode.

As an extracellular electrode is advanced

towards a cell in the central nervous system, it is common for the waveform to change (Towe, 1973).

Simultaneous recording of intracellular

and extracellular spikes has shown marked differences in extracellular
waveform when recording from axons, initial segment and soma-dendritic
spikes in a given cell (Svaetichin, 1958).

Similar considerations must

be given to the proximity of the cell being recorded to the electrode in
the myenteric plexus.

The precise site of recording in the myenteric
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plexus has not previously been described.

No

mentio~

spontaneous activity recorded in the interconnecting

has been made of
stra~ds

between

ganglia, although evoked activity from electrical stimulation has been
demonstrated (Dingledine and Goldstein, 1976;

Yokoy&~a

et al., 1977).

The sensitivity of the three types of units to various transmitters and to drugs is different.

Mechanoreceptive and burst type

units were relatively insensitive to most drugs, whereas single spike
units exhibited marked sensitivity to many agents.

All neuronal acti-

vity was abolished by tetrodotoxin or local anesthetics, but not by
manganese (Sato et al., 1973; Sato, Takayanagi and Takagi, 1974).
gle spike units were excited by 5-hydroxytryptamine (5-HT),
crate, caerulein, acetylcholine, nicotine and

pentagas~rin.

tations were blocked by morphine as well as by the
fic antagonist (Sato et al., 1973).

relev~t,

sodi~~

Sinpi-

These excimore speci-

The firing rate of single spike

units was decreased by a-adrenergic agonists and morphine.

A detailed

study on the action of morphine on single unit firing in the myenteric
plexus was reported by Dingledine and Goldstein (1975, 1976)

(see sec-

tion 1. 3. 3 • ) •

1.3.2.2.

Intracellular Recording Studies.

Intracellular re-

cording from myenteric neurons has been accomplished by two groups (Nishi
and North,
group.

1973~;

Hirst et al., 1974).

Similar methods ;.;ere used by each

Direct visualization of individual neurons was necessary to allaH

careful placement of the electrode because the myenteric neurons were
highly sensitive to mechanical damage.
60

Mm

The use of high

resist~ce

electrodes was also required for stable recordings.

(>

The use of
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electrodes of lower resistance led to slow depolarization of the cells
which was attributed to severe mechanical damage.

The results obtained by Nishi and North (l973a) and Hirst et al.,
(1974) were essentially the same.

Two types of myenteric neurons were

distinguished with intracellular recordings.
Nishi and North,

1973~;

The first type (Type I,

S cell, Hirst, et al., 1974) gave multiple spikes

with a depolarizing current, received synaptic input which was blocked by
nicotinic antagonists and had properties similar to other peripheral
gangl;i.on cells.

The second type (Type II, Nishi and North,

1973~;

AH

cell, Hirst et al., 1974) was less excitable, received no synaptic input
and had a slow after-hyperpolarization follmving the action potential
evoked by direct or antidromic stimulation.

A third type of cell was

also impaled which was inexcitable, had a high resting membrane potential and a low input impedance.
a glial cell.

This type of cell was considered to be

Occasional spontaneous neuronal activity was observed;

however, spontaneously active cells were probably damaged by the isolation of the ganglia.

No evidence of any pacemaker activity was described

in any neurons of the myenteric plexus.

The sensitivity of the bvo types of neurons to pharmacological
stimuli (acetylcholine, 5-HT, morphine) appear to be quite different.
Iontophoretic application of acetylcholine to type I cells produce a
rapid depolarization \•7hich was blocked by nicotinic antagonists (North
and Nishi,

1973~).

Application of acetylcholine to type II cells pro-

duced either no effect or a slow depolarization whic:C, Has blocked by
muscarinic antagonists (North, unpublished results).

TI1e results obtained when studying the
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of 5-HT and nora-

actio~

drenaline with intracellular electrodes are different
using extracellular electrodes.

Noradrenaline

th~~

L~hibited

when studied

firing of my-

enteric neurons recorded extracellularly (Sato et al., 1973).

The pre-

dominant action of 5-HT on the firing rate of myenteric neurons recorded
with extracellular electrodes \'las an increase in firing rate (Dingledine
and Goldstein, 1975).

5-hydroxytryptamine produced variable results on

the membrane properties of type

cells, but had a prominent action re-

I

ducing the size of the e.p.s.p.

This is due to a presynaptic effect,

decreasing acetylcholine release (North and Henderson, 1975).

Similar

presynaptic effects of noradrenaline have been found (Nishi and North,
1973b) .

Stimulation of sympathetic nerves to the gut also decreases ace-

tylcholine release without altering membrane properties of the myenteric
neurons (Hirst and I·lcKirdy, 1974).
on the type

II

The predominant effect that 5-HT has

cell is a slow hyperpolarization with a fall in input re-

sistance (North and Henderson, 1975}.

One of the primary differences between results obtained with
intracellular and extracellular recording

tec~niques

in the guinea pig

myenteric plexus was the lack of spontaneous activity recorded using intracellular electrodes, whereas spontaneous neuronal firing was recorded
with extracellular electrodes.

The high sensitivity of myenteric neurons

to mechanical damage seems inconsistent with the use of very large suetion electrodes for extracellular recordings.

h1ere are similarities,

however, for the single spike unit and the burst units in some ways correspond to the intracellular type
First, the type

I

I

and type

II

cells, respectively.

cell is more excitable and, if it corresponds to a
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single spike unit, this may account for the high frequency of single
spike units encountered with a suction electrode.

Second, the type I

cell is sensitive to acetylcholine through a nicotinic receptor and
single spike units are also excited by nicotine.

Third, type II cells

were insensitive to many pharmacological stimulants as ;·;ere the burst
units encountered with extracellular electrodes (Sato et al., 1974;
Dingledine and Goldstein, 1976; Nishi and North,

1973~;

North, 1973).

1.3.3.

Actions of Opiates, Opioids and Neuropeptides
in the Guinea Pig Hyenteric Plexus

l. 3. 3 .l.

ation.

Using the Longitudinal Huscle-I-!yenteric Plexus Prepar-

Electrical stimulation of the nerves in the longitudinal muscle-

myenteric plexus preparation induces release of acet:?lcholine ;...;hich acts
on the longitudinal muscle to cause a contraction.

Tne nerve-mediated

contraction of the longitudinal muscle is depressed by narcotic analgesics ·due to their inhibition of release of acetylcholine from the myenteric plexus neurons (Schaumann, 1957; Paton, 1957).

Tnis decrease in

acetylcholine output produced by narcotics is blocked by narcotic antagonis·ts in a competitive manner (Kosterlitz and 1\'att, 1968).

The rank

order of potency of a series of narcotic agonists in depressing

L~e

nerve-mediated contraction of the guinea pig ileum correlates well with
the analgesic potency of these agonists in man (Kosterlitz and Waterfield, 1975).

There is also a good correlation between the affinity of

opiate binding sites in the myenteric plexus and in the rat brain to a
series of agonists and antagonists (Creese and Snyder, 1975).

The de-

pression of acetylcholine output and the binding of narcotics to opiate
receptors in the myenteric plexus are stereospecific as are the analgesic effects of these compounds (Kosterlitz and Haterfield, 1975).

Fin-

ally, as with the central effects of opiates, cross-tolerance develops
between different narcotic agonists (Goldstein and Schultz, 1973) and
enkephalin, in the myenteric plexus (Waterfield,
1976).

Hug~es

and Kosterlitz,

The neurons of the myenteric plexus therefore appear to have

opiate receptors which are much like those in the central nervous system
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which mediate analgesia.

Tne nerve-mediated contraction of the longitudinal muscle is also
depressed by somatostatin and this is not through an interaction with an
opiate receptor (see section 1.2.4.).

The action of substance P on the

nerve-mediated contractile response of the longitudinal muscle is difficult to assess because substance P contracts the longitudinal muscle
by a direct action of the smooth muscle.

Neurotensin, on the other hand,

causes a contraction of the longitudinal muscle which is blocked by
tetrodotoxin, suggesting an excitatory effect on myenteric neurons.
Since many of the neuropeptides are present in the myenteric plexus and
have been found indirectly to change the excitability of myenteric neurons, this preparation may be useful to study the action of the neuropeptides at a single neuron level.
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1.~.3.2.

Using Extracellular Recording.

There have been several

electrophysiological studies on the actions of opiates on neurons contained in the myenteric plexus.

The first demonstration of an effect of

morphine on single myenteric neurons was made by Sato and colleagues
(Sato et al., 1973).
this was very high (10

In this study, only one concentration was used and
~\:1)

compared to the concentration \vhich is effec-

tive in inhibiting the contractile response of the longitudinal muscle
(ED

50 ~100

nM).

Subsequently, studies by Dingledine and Goldstein demon-

strated that the inhibition of unit firing produced by morphine was dose-·
dependent in the same concentration range as that \vhich is effective in
inhibiting the release of acetylcholine (Dingledine, Goldstein and Kendig, 1974; Dingledine and Goldstein, 1975; 1976).

The inhibition of

firing was stereospecific; that is, dextrorphan was without effect (in
the concentrations tested), whereas the active isomer, levorphanol, was
effective.

Naloxone reversed or prevented the action of opiate agonists.

Morphine also blocked the effects of a number of excitatory agents such
as 5-HT, sodium picrate, caerulein, pentagastrin and acetylcholine (Sato,
Takayanagi and Takagi, 1974), which suggests that it is acting directly
on the neuron whose activity is being recorded.

In fact, strong evidence

for such a direct action on the neuron under study was provided by the
experiments of Dingledine and Goldstein (1976) in which morphine was
shown to be equally effective when synaptic transmission had been completely blocked by omission of calcium ions from the bathing solution.
These studies asstL.lled that the neuronal spikes which '.·Jere being recorded
were made from the cell soma; however, there \vas no clear evidence for
this assumption.

The effects of pentagastrin and caerulein on myenteric

neurons has previously been studied.

Both these peptides caused an in-
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crease in neuronal firing (Sato et al., 1973).
was

Neither of these peptides

studied in detail and there are no other studies on the action of

various peptides on single neurons in the myenteric plexus.

1.3.3.3.

Using Intracellular Recording.

Using intracellular

recordings from myenteric neurons, it has been found that morphine produced a hyperpolarization of the cell soma which \·las sometimes associated
with an increase in conductance (North, 1976; North and Tonini, 1977).
This hyperpolarization was stereospecific and blocked by naloxone.
ever,. the ionic mechanism involved has not been determined.

How-

Both type I

and type II cells appear to be sensitive to morphine; however, the proportion of type I cells which were affected was r:mch greater than that
of type II cells.

l'li th type II cells, it was com.llon for the effect of

morphine to become smaller during the application or

',.;i th

repeated ex-

posures, whereas type I cells more often gave reproducible responses
(North and Tonini, 1977).

The population of cells in 'tlhich a hyperpolar-

ization was found was much smaller than the proportion of cells \vhich
were found to be sensitive with extracellular recordings.

Studies using intracellular recording to test the action of opioid peptides and other neuropeptides have not yet been done.

1.6.

SPECIFIC AIMS

The first aim of the present study was to define the origin and
nature of the neuronal activity recorded with extracellular electrodes
in order to explain better the differences between results obtained with
extracellular and intracellular techniques in the myenteric plexus.
part of the study included:

This

(a) a study of spike waveforms of spontan-

eous and evoked activity; (b) determination of the locations from which
spontaneous activity can be recorded (on the ganglia, on the strands of
nerve processes which connect the ganglia and on the smooth nuscle); (c)
the study of the sensitivity of spontaneous and evoked activity to tetro(d) a general survey

a=

t~e

firing patterns; (e) an investigation of the changes

i~

firing induced

dotoxin

and local anesthetics;

types of

by solutions of varying ionic composition.

The second aim of this study was to investigate t:-te action of
opiates on single myenteric neurons.

This included:

(a) testing the

sensitivity to opiates of units displaying different types of discharge
patterns; (b) confirming that the inhibition of firing is mediated via
opiate receptors by antagonizing the effect of opiates

\•li

th naloxone;

(c) examining the action of morphine in solutions with high

~~d

low po-

tassium ion concentration and low chloride ion concentration to determine the ionic mechanism of action.

The third aim of the present work was to study
several endogenous neuropeptides including leu- and
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t~e

action of

net-e~ke:;:;halin,

s-
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endorphin, somatostatin, substance P, neurotensin
rate of myenteric neurons.

a~~

VIP on the firing

These peptides, \-lith t::,e exception of neuro-

tens in, have all been shown to be contained

\·li

thin neurons of the plexus.

The effect that each of these peptides has on the firing rate of myenteric neurons, the time course of effects and the concentration range in
which they are effective were studied.

In addition, \·lhere applicable,

antagonists of each peptide \.;ere studied to determine the specificity of
the action of the peptide.

For peptides for which there are no avail-

able specific antagonists, the effect of several peptides or peptide analogs·were studied on a single unit in order to
of the effect.

dete~ne

the specificity

Finally, the action of each peptide '.vas studied in a

solution which contained no calcium ions in order to eliminate possible
trans-synaptic influences.

The purpose of these experiments is to help

substantiate or refute the hypothesis that the presence of the neuropeptides in the myenteric plexus may indicate that they act as neurotransmitters or neuromodulators at this site.

2.

2.1.

METHODS

PREPARATION OF TISSue

Hale guinea pigs (300-500 g) were stunned and bled from the neck.
A portion of ileum 10-15 em long excluding the section 5 em in the oral
direction from the ileocecal junction was removed and the luminal contents were gently washed out with Krebs solution.
placed in Krebs solution at room temperature.

The ileum was then

The longitudinal muscle

myenteric plexus preparation was prepared as originally described by
Ambache (1954) and modified for electrophysiological recording by Nishi
and North (1973a) .

A short piece of ileum (1-2 en) was slipped on to a

glass rod such that the longitudinal muscle myenteric plexus preparation
could be separated from the ileum.

Small pieces of cotton soaked with

Krebs solution were used to gently stroke the

ileQ~

longitudinal muscle away from the circular muscle.

in order to tease the
The longitudinal mus-

cle with the myenteric plexus adherent was first separated from the circular muscle along each side of the mesenteric border and then peeled
around to the anti-mesenteric side of the ileum.

The longitudinal muscle

myenteric plexus preparation was then removed from the anti-mesenteric
side of the ileum and placed in a shallow tissue bath.

The longitudinal

muscle was pinned out as a flat sheet with the myenteric ganglia uppermost.

Ganglia were visualized with a dissecting microscope (10-60 x)

using transmitted light.

Ganglia were considered suitable for electro-

physiological experiments if they were free of large amounts of circular
muscle and if they contained few or no large cells which stood out clearly
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within the ganglion.

Attempts to record from ganglia ·.-ihich did not meet

the above requirements were usually futile.

The area surrounding 10-15

suitable ganglia was immobilized with several pins

(tQ~gsten

wire 25

~

in diameter cut into l mm lengths) and the remaining portion.of the tissue was cut and removed from the bath.

When agents which had a direct

excitatory effect on the smooth muscle were to be used, single ganglia
were surrounded by several pins and thus rendered immobile.

The tissue bath used was similar to that described by Nishi and
North-(1973a).

A rectangular hole the size of a coverslip (24 X 40 mm)

was cut from a piece of plexiglass (40 X 80 X 1 mm) .

A coverslip was

then glued to the bottom of the bath and the trough was filled with Sylgard 184 Encapsulating resin (Dow Corning) .

This clear resin can be

transilluminated and is soft enough to allow the use of fine pins to fix
the preparation.
(2 mm high) .

The Sylgard was then surrounded by a layer of caulk

The caulk enclosed the bath and enabled the indifferent

electrodes and perfusion tubes to be fixed to the bath.
was always less than 1 ml.

The bath volume

2. 2.

EXTRACELLULAR RECORDING

A glass suction electrode having a tip diameter of 30-90
used for extracellular recording.

~

was

The suction electrode was prepared by

breaking back a longer electrode having a small tip diameter, andviewing
the broken tip microscopically.

Only electrodes with tips >vhich were

flat, smooth and of proper size were selected for recording.

Attemptsto

use smaller glass electrodes or tungsten electrodes (tip diameter 5-10
~)

for recording were not successful.

The recording electrodes were

filled with Krebs solution and had a resistance of 500-1,000 kJ.

The

electrode was tightly connected by a piece of tubing to a syringe (5 or
10 ml) .

The electrode was placed on the tissue and suction >·las applied

by manually wi thdra>ving the syringe plunger.

Tne amount of suction re-

quired for successful recording varied from cell to cell; usually it was
sufficient to allow the electrode to be raised 5-10 l.tTl •.vi thout dislodging
it from the tissue.

When the electrode had been placed on the tissueand

suction applied, the resistance of the electrode typically increased by
200-500

k~.

This sealing resistance presumably reduced the extracellular

shunting of current through the
the recorded signal.

Y~ebs

solution and increased the size of

Attempts to record neuronal activity vli thout sue-

tion were not successful.

A chlorided silver wire ,,.,as inserted into the

recording electrode, reaching almost to its tip.

This wire led directly

to the input of a differential AC coupled preamplifier
The indifferent electrode had a tip diameter of 70-150
was placed in the bath close to the site of recording.

(DC R.. ,
l.n
~·

10 Wl) .

and its tip

A chlorided sil-

ver wire, at a distant part of the bath, was used to ground thepreparation.
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Potentials were amplified (1,000 X) and dis?layed on an oscilloscope (Tetronix 502A).

Spike waveform of spontaneous and evoked paten-

tials were studied from photographs of oscilloscope traces.

The coupling

time constant was l s in those experiments in which spike \'laveform was
studied, but in other experiments the coupling tiine constant was decreased
to 2 ms.

With a time constant of 2 ms, the spike amplitude was attenuated

and somewhat differentiated.

However, this was necessary to obtain a suf-

ficiently stable base line to use a window discriminator (Nentor Spike
Analyzer).

The output of the window discriminator was recorded either on

chart· paper or counted with a rate analyzer (Frederick-Haer).

Histograms

were constructed of the number of action potentials in a given time
interval (usually 10 s

and up to l min) either by ha.'1d from the chart

record or directly from the output of the rate analyzer.

In some experiments, a third glass electrode ,,,i th a t.ip diameter
of 20-40

~

was used for electrical stimulation.

pulses of 100-500

~s

duration.

The stimuli used were

Single pulses or short trains of pulses

at frequencies up to 10 Hz were used.

The tip of this stimulating elec-

trode was placed so that it just made contact with the preparation, either
on the ganglion surface or on the interconnecting strands.

2.3.

PERFUSION OF THE TISSUE

k~D APPLICATIO~

OF DRUGS

Krebs solution continuously perfused the tissue at a rate of
2-4 ml/min, maintained by a peristaltic pump.
Krebs solution is given in Table 4.

The conposition of the

The solution vras warmed in a heat-

ing jacket before i t entered the bath such that the bath temperaturewas
maintained at 35-37°C.

Drugs were added to the bath by changing the per-

fusing solution to one which differed only in the content of the drug.
There· was a delay time of about l min between the time '.vhen the drug
solution was changed and when the drug entered the bath.

All figures

are drawn such that the periodsof drug applications correspond to the
times when solutions were changed, without

subtracting

the delay time.

All glassware that came in contact with peptide solutions \·ras pretreated
with a siliconizing compound called sigma-coat

(Si~a)

ing of the peptides to the surface of the glass.

to limit the bind-

Solutions of different

ion concentrations were always kept isosmotic by changing the concentration of NaCl in the Krebs.

The content of ions in these solutions is

given in Table 4.

Drug and p.:!ptide solutions were prepared fresh daily from stock
solutions.

Stock solutions were kept frozen for later use.

Peptides

were checked for stability by comparing the response of a single cell to
the same concentration of two peptide solutions.

One solution was fresh-

ly prepared from solid and the other had been made from a stock solution
which had been used for periods up to several weeks.

All the peptide

solutions appeared to be stable for periods up to several weeks if the
t
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stock solution was kept cool or frozen.
this study are listed in Table 5.
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The peptides and drugs used in
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Table 4.

The content of salts (mM) in the various Krebs solutions
used.
Krebs Solutions
Normal

Salt

Na isethionate

Low C1
(10 mM)

+

+

High K
(12 mM)

Low K
(1 mH)

110.7

121.7

Ca

++

Free

High Ca

( 0 rnH)

118

NaCl

118

KCl

4.7

4.7

12

1

4.7

4.7

2.5

2.5

2.5

2.5

0

10

1.2

1.2

1.2

1.2

1.2

1.2

NaH Po
2 4

1.2

1.2

1.2

1.2

1.2

1.2

Glucose

11

11

11

11

11

11

NaHC0

25

25

25

25

25

25

CaC1
MgS0

2
4

3

EGTA *

*

ethylene-bis-(oxyethylene nitrilo)

120.75

1.0

tetraacetic acid

106.75

++
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Table 5.

The peptides and drugs used in the present study ·.·rith the
source(s) of each.

Drug

Source

normorphine
sulfamate or HCl

Dr. E.L. :t-1ay

mor hine sulnhate

Mallinckrodt

enkephalin, base
or HCl
metleu-

Penninsula, Miles, Dr. B.A. :1organ

S-endorphin

Penninsula

substance P (1-11)

Penninsula, Beckman

substance P (7-11)

Penninsula

substance P free acid

Penninsula

neurotensin

Penninsula, Sigma

somatost:atin

Penninsula, Sigrr,a, Beckman

VIP

Calbiochem

naloxone HCl

Endo Laboratories

hyocine HCl

Sigma

hexru~ethonium

HBr

Sigma

baclofen (acid)

Dr. H.K. Proudfit

lidocaine

ICN·K&K Laboratories

tetrodotoxin

Sank yo

:ropranalol HCl

Sigma

phenoxy benz amine

Smith, Kline and French

Mr-2266, Mr-2267

Dr. H. Merz, Boehringer Ingelheim

3.

3 .1.

3.1.1.

RESULTS

EXTRACELLULAR RECORDING

Spontaneous Activity

Recordings were made from more than 500 units in tissues removed
from 190 guinea pigs.

A unit was considered to represent the activity of

a single cell on the basis of the uniformity of the spike
form and duration.

a~plitude,

wave-

Neuronal action potentials were clearly distinguish-

able from smooth muscle action potentials by their different
and durations (Fig. 1).

a~plitudes

Smooth muscle action potentials were readily

recorded when the recording electrode was placed on the muscle away from
a myenteric ganglion.

Neuronal activity was only recorded when the elec-

trode was placed on the surface of a ganglion.

Neuronal action potentials

were blocked by tetrodotoxin (1 lJM, n=6) or lidocaine (1

m:·l,

n=2, Fig. 2) ,

whereas smooth muscle action potentials were unaffected by either drug.

The waveform of spontaneous neuronal activity was usually monophasic, spike duration being 2-5 ms.

If the coupling time constant of

the recording system was decreased, the spike amplitude was reduced and
the waveform became biphasic (Fig. 3}.

During the action potential, the

recording electrode usually became negative with respect to the indifferent electrode, although spikes of opposite polarity were occasionally observed.

No sponteneous neuronal activity could be recorded from the

strands of nerve processes connecting the ganglia within the plexus, although electrically evoked activity was readily recorded from these sites
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Figure 1.

Comparison of neuronal and smooth muscle action potentials
recorded with extracellular suction electrodes.
ent traces from the smooth muscle.
20 ms; Vertical, 1 and 2, 100
spik~s

~V;

at the same sweep speed.

20 ms; Vertical, 50
, (b) was' 1 s.

~V.

(a) Differ-

Calibration:
3, 200

~V.

Calibration:

Horizontal,

(b) Neuronal
Horizontal,

Coupling time constant in (a) and
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B

Figure 2.

Inhibition of firing of a myenteric neuron by
Ordinate:
time.

spike frequency (bin width - 10 s).

lid~caine.

Abscissa:

The solid bar indicates the period during which the

bathing solution was changed to one containing lidocaine
(1

~)

.

Lidocaine (1 mM) depressed neuronal firing in a

reversible manner.
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Figure 3.

Spike waveform recorded with extracellular electrodes from
(a) Coupling time constant 2 ms.

myenteric neurons.

1-3,

typical spikes recorded from three myenteric neurons with
different electrodes.
corded with

~single

4, three different waveforms were reelectrode in the same position.

5, the

same as 4 but spikes were recorded at a slow sweep speed.
,Calibration:
(5) 2 s.

HQrizontal (1) 2 ms;

Vertical (1) 100 f.JV;

time constant 1 s.

(2,3) 10 ms;

(2-5) 200 ]JV.

(b) Coupling

Typical monophasic spike waveforms re-

corded from three different myenteric neurons.
Horizontal 5 ms.

(4) 20 ms;

Vertical (1,2) 100 lJV;

Calibration:

(3) 50 1JV.
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(see section 3.1.2.).
1972).

The strands contain few cell bodies (Gabella,

No neuronal activity was recorded with metal electrodes, glass

suction electrodes with a tip

difu~eter

less than 30

~~

or with electrodes

without suction.

In agreement \'lith previous studies, two basic types of firing
patterns were found.

The first, and most common type

(90%), had a dis-

charge pattern that was irregular with a mean rate of l-3 Hz.

The wave-

form was monophasic (depending on the time constant .of the recording system)

~nd

had a spike amplitude which ranged from 50-300

~V

(Fig. 3).

This type of unit \·las the most likely to continue firing and often lasted
for periods of up to 4-5 hr.

The firing rate of this type of unit was

5-10 Hz soon after placement of the suction electrode on to the ganglion,
but declined to l-3 Hz within a few minutes.

The firing rate usually

declined steadily throughout the period of recording, although some units
maintained the same firing rate for periods of 4-5 hr.

Neurons which

stopped firing within the first few minutes of recording exhibited one of
two distinct patterns of firing.

The first pattern was marked by a de-

clining frequency associated with a steady increase in spike amplitude.
When more suction was applied to the electrode, or if the electrode was
removed and reapplied to the same point, the unit began to fire again.
Units which ceased firing in this manner could usually be reexcited by
changing the perfusing solution to one which contained no calcium ions
or addition of an excitatory substance (see sections 3.1.3. and 3.4.2.).
The second pattern began with a sudden flurry of action potentials associated with decreasing spike amplitude and increasing spike duration.

The

neuron would continue to fire at high frequency until the spikeamplitude

decreased into the background noise.

73
pattern was

disc~arge

This second

probably due to mechanical cell damage leading to depolarization.

Such

cells sometimes appeared to recover; that is to say, after a period of
l0-15 min a unit would begin to fire again.

However, this unit would

also begin to fire at a high frequency with the same result as described
previously.

On rare occasions,

such a pattern of firing would continue
a~d

for periods of up to 1 hr, with a decreasing frequency
spikes in each burst.

This may correspond to the burst

number of

Q~it

described

in the experiments of Wood (1973).

A second distinct type of unit made up a
of the recordings.

sw~ll

proportion (10%)

These units were of large amplitude

had a very regular low frequency discharge

(0 .1-1 Hz) .

(150-400

~V}

and

This type of unit

was less likely to continue firing for extended periods of time and usually the onset and offset of firing was very abrupt

wit~

little change in

the firing frequency during the periods which it was active.

Units of

this type were generally less sensitive to most agents and i t seems likely that they correspond to the small population of

morp~ine-insensitive,

larger amplitude units described by Dingledine and Goldstein (1976).
These units may correspond to the type II cell found with intracellular
electrodes and further evidence for this is presented :below.

A series of experiments was done to test whether polarizing currents could alter the firing rate of spontaneously active myenteric neurons.

While recording from a spontaneously active unit, a stimulating

electrode was placed very close to the recording electrode a~d continuous current (anodal or cathodal) was passed through this electrode.
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When an anodal current was passed through the stimulating electrode, the
firing rate of the neuron being recorded was decreased markedly.

When a

cathodal current was being passed through the stimulating electrode, an
increase in the firing rate was observed.

The changes in firing rate

produced by anodal and cathodal currents usually lasted throughout the
period during which current was passed, although there was some accomodation observed during the passage of cathodal current.

These results

indicate that the firing rate of the neurons under study was sensitive
to the effects of polarizing currents.

3.1.2.

Evoked Activity

A series of experiments was done in which the nerve processes
and cell bodies were stimulated, while recordings \vere made from the
ganglia or along the strands of nerve processes \'lhich connect the ganglia.

When an electrical stimulus was applied to the surface of theplexus

at a distance of 100-1,000

~

from the site of recording, two different

types of responses were observed.

The first type \vas a potential change

which·was of short latency, sometimes coming directly (1-3 ms) after the
stimulus artifact (Figs. 4, 5, 6).

This potential \vas observed whether

recording from the ganglia or from the nerve processes in the connecting
strands between the ganglia.

The amplitude of this potential was graded

with the intensity of the stimulus, and follmved the stimulation at frequencies of 10 Hz (Fig. 5).

This potential was not blocked by hexameth-

onium (100 ]..lH) but was blocked reversibly by lidocaine (300 ]..lN and l mM,
Fig. 6).

The second type of electrically evoked potential closely resembled, in waveform, the spontaneous neuronal spike recorded at the same
site.

This second type of evoked potential was observed only when re-

cordings were made from the surface of ganglia, not from the interconnecting strands.

These potentials (from l-3 following a single stimulus)

were all or nothing spikes which occurred with a latency that was relatively constant for an individual experiment but which varied (from 1030 ms) among cells (Fig. 4).

It is thought that these spikes arise from

direct electrical stimulation of the cell or one of its processes or from
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Figure 4.

Response of myenteric neurons to focal stimulation of the
ganglion with single pulses, and the effect of hexa.,.·nethonium.
Each illustration is a single sweep.
was 0.1 Hz.

Stimulation frequency

(a) A single pulse was follmved by a small, short

.

latencq response and a longer latency response conprising two
spikes which were all or nothing and the individual spikes had
a'waveform similar to the spontaneous potential.

(b) 2 min

after beginning perfusion with hexamethonium (100

~~).

short latency response was still present.

However, the long

ratency all or nothing potential was blocked.

(c) 4 min after

the hexamethonium had been washed from the bath.
Horizontal 10 ms.

Vertical 200

~V.

The

Calibration:
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b-~

-

Figure 5.

Electrically evoked activity recorded from a myenteric ganglion.

Each recording is the last sweep of an oscilloscopy

trace following a 10 s train of pulses at the indicated frequency.

The evoked activity was of short latency (l-2 ms) and

foll?wed a stimulation frequency of at least 10 Hz.

At high

stimulus frequencies, the activity tended to fractionate,
·indicating the activity was a compound response.
tion:

Horizontal 1 ms.

Vertical 100

~V.

calibra-
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101-iz...,..V~~
,y
.

~I

_1100)JV
1mS

Figure 6a.

Electrically evoked activity recorded from a myenteric ganglion.

Calibrat.ion:

Horizontal l ms.

Each recording is a single sweep.
Hz.
whi~h

(l) control.

Vertical 100 f..!V.

Stimulation frequency 0.1

(2) 2 min after changing to a solution

contained lidocaine (l nM) .

after washing out the lidocaine.

(3 and 4) l and 5 min
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Ganglion

a

l

Control

2

1mM Licl.

~

3

Wash 1 mir~

4

5min~

-

I 100 JJV

1 mS

Figure 6b.

Electrically evoked activity recorded from the strailds of
nerve processes connecting the ganglia.
zontal l ms.

Vertical 100

~V.

Calibration:

The stimulation frequency

was 0.1 Hz and each recording is a single S'tleep.
trol.

A

typ~cal

Hori-

waveform of activity recorded

(l) con-

fro~

the

interconnecting strands consisting of a short latency com.pound

response~

(2-4) 1, 2 and 2.5 min after changing to a

solution which contained lidocaine (300 mM).

(5) 4 min after

the solution containing lidocaine had been replaced with a
normal Krebs solution.

Strands

b

lControl0~
2

300nM

Lid •.

1m1n'\i~

3

4

2..5mln

~

1mS
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synaptic excitation of the cell.

It was possible to distinguish synap-

tically evoked potentials from directly evoked potentials as follmvs:
(l) some of the evoked spikes followed at high frequencies ofstimulation
(up to 10 Hz) with only a small increase in latency.

These were not

affected by hexamethonium (100 UM) and were considered to be directly
evoked spikes.

(2) Other potentials were reversibly blocked by perfus-

ing the tissues with hexamethonium (100 UM, Fig. 4).

These spikes dis-

appeared when the frequency of stimulation was increased above 1 Hz:
this observation supports the interpretation that th.ese are synaptically
drive~

spikes, because the e.p.s.p.'s recorded intracellularly from myen-

teric neurons decline in amplitude when they are evoked at frequencies
above 1 Hz (Nishi and North, l973a).

The effect of repetitive electrical stimulation on the rate of
spontaneously firing cells was studied (n=l5).
was placed close (< 20

~)

A stimulating electrode

to the recording electrode and a train of pul-

ses at 10 Hz for 10-60 s was applied.

In a Krebs solution which did not

contain acetylcholine receptor antagonists, this stimulation often resulted in movement of the muscle which dislodged the electrode from the
ganglion and an increase in firing rate was always observed.
methonium (100

~M)

and hyoscine (1

~M)

~~en

hexa-

were added to the perfusing solu-

tion, muscle movement was eliminated; however, an increase in firing
rate usually followed the period of stimulation.

The firing rate in-

creased to about 10 Hz and lasted from 30 to 90 s following termination
of the stimulation.

An electrically evoked inhibition in firing was

rarely observed (2 of 15 trials) .
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3.1.3.

Effects of Solutions of Varying Ionic Composition

3.1.3.1.

Lm.; Potassium.

The effects of a solution containing

a low concentration of potassium (l mM) was tested on 8 units.

This

solution reversibly decreased the spontaneous firing of only l unit and
reversibly increased the firing rate in 5 units.

The increase in firing

frequency was preceded by a transient slowing (30-60 s) in 4 of these
units (Fig. 7).

The increase in firing rate was usually not maintained

throughout the period during which the low
fusing the tissue.

potassiQ~

solution was per-

This increase in firing rate produced by a low potas-

sium solution, although unexpected, may be explained in terms of the effect that such a solution has on the sodium-potassium pump (Na-K pwnp).
Under these conditions, when the cell is actively firing, the Na-K pump
may be important in maintaining the membrane potential.

By decreasiLg

extracellular potassium, the pump is inhibited, which may lead to a depolarization and an increase in firing rate.

This possibility is sup-

ported by experiments with the Na-K, ATPase inhibitor, ouabain.
tion of ouabain (1

~.!H)

The ac-

on the firing rate was tested on 7 units and at

least a twofold increase in firing rate was found in 3 units.

3.1.3.2.

High Potassium Solution.

The effects of a solution

containing high potassium ion concentration (12 m:1) ,,·as tested on 7 units.
The firing rate of 3 of these was increased and the firing rate of 3
others was decreased.

The increase in firing rate induced by the high

Figure 7.

The effect of a low potassiQm (1
of a typical myenteric neuron.
width - 30 s).

Abscissa:

time.

~1)

solution on firing rate

Ordinate:

firing rate (bin

During the periods indi-

cated by the filled and open bars, the bathing solution containe~

normorphine (300 nM, NM) and 1

tively.

potassium, respec-

The unit showed a typical decline in firing rate

with time.
ing rate.

~~

NormGrphine (300 nM) caused an inhibition in firThe solution containing low potassium increased

the firing rate and normorphine prevented the increase in
firing rate produced by the low potassium solution.

Subseq-

~

uent application of low potassium solution increased the fir-

l

ing rate even though spontaneous firing had decreased to a

J

1

very low level.
ij

·.·.:l··1

~

f

•
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potassium solution was not maintained throughout the period during which
it perfused the tissue and in 2 units vms biphasic; that is to say, a
transient increase in firing rate was followed by a decrease in firing.
The firing rate remained depressed for several minutes after the perfusing solution had been replaced with Krebs solution containing normal potassium (4.7 mM) ion concentration (Fig. 8).
be expected to depolarize the neurons.
crease in firing might be expected.

A high potassium solution would

With this depolarization, an in-

The decrease in spike frequency ob-

served in some units and the biphasic response of the
and

th~n

firL~g

rate (increase

decrease) observed in others may be a result of a depolarization

beyond the threshold level.

3.1.3.3.

Low Chloride.

chloride ion concentration (10
myenteric neurons.

The effect of a solution containing low
~~)

was tested on the firing rate of 12

In 11 of these, a small increase in firing rate which

was slow in onset and offset was produced (Fig. 9).

It appears that

myenteric neurons are much less sensitive to changes in chloride ion concentrations than potassium ions.

A small (5 mV) depolarization is pro-

duced in myenteric neurons in lov; chloride solutions recorded with intracellular electrodes (North,

unpublishe~

results) .

This small depolari-

zation is consistent with the increase in firing rate observed in the
present study.

3.1.3.4.
(l

roM)

Calcium Free.

Calcium-free solutions containing EGTA

always markedly increased the firing rate of myenteric neurons

(Fig. 10, n=26).

Neurons which had ceased to fire action potentials in

association with an increasing spike amplitude were often induced to fire

Figure 8.

The effect of a high (12 nM) potassium solution on the firing
rate of two myenteric neurons.

Ordinate:

(bin width - 30 s).

time.

Abscissa:

spike frequency

During the periods

marked by the open and closed bars, the bathing solution was
chan~ed

to orre containing a high potassium (12 nM) and nor-

morphine (NM, 300 nM), respectively.

(a) Application of a

'high potassium solution produced a small depression in firing
rate but did not alter the inhibition caused by normorphine.
(b) Application of a high potassium solution produced a large
increase in firing rate followed by a prolonged depression in
firing which returned slowly upon washing the high potassium
solution from the bath.
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c

E I

~
(!)

1-1 i g h I<+ (12 m M )
. ==::=J

'2

T ~~I

-Nv,

Figure 9.

The effect of low chloride (10 nM) solution on the firing
rate of a typical myenteric neuron.
uency (bin width- 30 s).

Ordinate:

Abscissa: time.

spike freq-

During the per-

iods denoted by the open and closed bars, a low chloride solution.(lO nM,

~sethionate

substitution) and normorphine (NM,

300 nM) perfused the tissue, respectively.
~aining

A solution con-

low chloride caused a modest increase in firing rate.

The inhibition in firing rate produced by normorphine (300
nM) appeared to be somewhat smaller in a low chloride solution on this neuron.
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by changing to a solution which was calcium-free (?i;. 13).

Similarly,

when recording the firing rate of a single unit, cells ·.·::-1ich had been
silent (not firing) prior to changing to the

calci~-free

solution, be-

gan to fire and interfered with the unit under study.

It was also noted that if the preparation Has first perfused
with calcium-free solution and then recordings were made, it was much
easier to record neuronal activity.

This contrasted ·..;i th the inability

to record smooth muscle action potentials in calciuu-free solutions.

3.1.3.5.

High calcium.

A solution contair.ing high calcium ion

concentration (10 ml-1) was tested on 10 myenteric neuro:-:cs.

In every case,

this solution markedly depressed the firing rate (?igs. 10, 22), with a
time course Hhich was abrupt upon entry of the

solu~io"

into the bath

and which returned upon changing the perfusing

solutio~

back to a Krebs

solution containing normal calcium (2.5 ml-1).

Figure 10.

The effect of high calcium (10 mM) and

calci~~-free

on the firing rate of a myenteric neuron.
frequency (bin width - 15 s).

Abscissa:

solutions

Ordinate:
time.

spike

7!e solid

bar indicates the period of time during which the bathing
solution contained 10 mM calcium solution and the open bar
indicates the periods when a calcium-free solution \>7as present.

The hign calcium solution caused a marked inhibition

of cell firing.

The calcium-free solution caused a marked

excitation which became larger with longer periods of exposure to the solution.

This graded increase in firing rate

probably indicates incomplete removal of
bath.

calci~~

fro~

the

87

- I

IOOr

I

aol

0

D

-

3.2.

THE ACTION OF OPIATES

Normorphine was used in the majority of the exoeriments because
its onset and offset of action is more rapid than that of morphine
(Kosterlitz, Lord and Watt, 1972).

The results are taken from 58 units

recorded from tissues taken from 33 animals.

Normorphine (100-1,000

reduced the firing rate of 90% of the units tested.

~1e

ru~)

onset of the

inhibition produced by normorphine was relatively fast (within 10-20 s
after·the entry of the normorphine into the bath).

T.1e inhibition in fir-

ing was rapidly reversed by washing the tissue with drug-free Krebs.
Occasionally, a short lasting rebound increase in
served upon washing out the normorphine.

rate was ob-

firi~g

The inhibition in firing pro-

duced by morphine, however, was slower in onset and re:::;uired a longer
period of time for the firing rate to return to co:1 trol ivhen 'dashing out
the drug (Fig. 17) .

In cells which were sensitive, r.or:::1orphine

(l

J.ll'1)

completely inhibited firing (n=lO) and, in 31 of 37 experiments, normorphine (300 nM) reduced the firing rate to less than 75% of its control
(Fig. 11) .

The inhibition in firing rate produced by noE1.orphine was antagonized by a 3-10 fold lower concentration of naloxone.

The inhibition

was reversed by addition of naloxone during the period ·..;hen normorphine
was in the bath and prior treatment of the tissue wi tn naloxone prevented
the normorphine-induced inhibition (Fig. ll).

Tnese findings are essen-

tially the same as those reported in detail by Dingledine
(1975, 1976).
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a~d

Goldstein

Figure 11.

Effect of normorphine on firing of two myenteric neurons and
the reversal of this inhibition by naloxone.
spike frequency (bin width-60s).

Abscissa:

Ordinate:
ti::1e.

Dur-

ing the periods indicated by the closed and diagonal hatched
bars, the bathing solution was changed to one which contained
normorphine (NM, 300 nM) and naloxone (Nal, 30 :n.:·:) , respec·tively~

(a) The firing rate of this myenteric

ily declined throughout the experiment.

neuro~

stead-

The de?ression in

firing rate produced by normorphine (300 nM) •;.;as co:-:l;?letely
·reversed by a tenfold lower concentration of naloxone (30
nM) .

This reversal was not due to tachyphylaxis to the ef-

fect of normorphine since the inhibition produced by a subsequent application lasted throughout the perioC: -;,.;hich it
was in the bath.

(b) The firing rate of this U.'1i t ·,:as main-

tained throughout the experiment.

Figure 11.

Effect of normorphine on firing of two myenteric neurons and
the reversal of this inhibition by naloxone.
spike frequency (bin width-60s).

Ordinate:

Abscissa:

ti~.

Dur-

ing the periods indicated by the closed and diagonal hatched
bars,. the bat-hing solution was changed to one which contained
normorphine (NM, 300 nM) and naloxone (Nal, 30 p_:.n, respec'tively.

(a)

Th~

firing rate of this myenteric neuron stead-

ily declined throughout the experiment.

The de?ression in

firing rate produced by normorphine (300 n!-1) was

co:::~pletely

·reversed by a tenfold lower concentration of naloxone (30
nM) .

This reversal was not due to tachyphylaxis to the ef-

fect of normorphine since the inhibition produced by a subsequent application lasted throughout the period >·ihich i t
was in the bath.

(b) The firing rate of this U.'1it '..:as main-

tained throughout the experiment.
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90
(1 J-!2·1), the firing

rate of these neurons was increased by passing a steady cathodal current
through a stimulating electrode close to the recording site.

Tnis obser-

vation is compatible with a hyperpolarizing action of normorphine on the
cell membrane which has subsequently been demonstrated by intracellular
recording (North and Tonini, 1977).

The inhibition in firing rate produced by normorphine (300 nM)
was not altered when the tissue was perfused
1

~~

(n=4) or 12 mM (n=S)

potassiTh~

\~ith

solutions containing

ion concentrations (Figs. 7, 8).

The action of normorphine (300 nr-1) was tested on 5 units in the presence
of a solution containing 10

mM

chloride ion concentration.

units, the inhibition of firing produced by nor:norp'hine

\~as

In 3 of these
unchanged

from control and, in 2 others, the inhibition in firing appeared to be
reduced (Fig. 9).

3.3.

THE ACTION OF OPIOID PEPTIDES

These results are based on 192 neurons recorded from tissues
taken from 67 animals.

3.3.1.

Met-Enkephalin

Application of met-enkepha1in (1-300 nM) inhibited the firing of
77 of 96 neurons (Table 6).

For a given neuron, the degree of inhibition

of firing was dependent on the concentration of
(Fig. 12).

enkep~alin

in the bath

Met-enkepha1in at a concentration of 100 n2·! \'las sufficient

to reduce the firing rate to 10% or less of the control rate in 90% of
sensitive neurons.

Lo~tier

concentrations of met-enkep::alin caused marked

inhibitions in many cells (Fig. 12).

The onset of inhibition of firing and the return to control was
within 10-15 s of the arrival and washout of met-enkephalin.

There was

a rebound increase in firing rate following the washout of enkephalin in
40% of cells tested (Figs. 17a, 14).

The inhibition in firing was usu-

ally maintained throughout the period that met-enkephalin was in thebath.
Likewise, the degree of inhibition was reproducible with repeated applications of the same concentration at intervals of 2 min (Fig. 13).

With

concentrations of met-enkephalin (< 10 nM), the firing rate occasionally
(~

15%) returned to control levels during the presence of enkephalin.

In such cells, the application of a higher concentration (30 or 100 nM)
caused a greater degree of inhibition and this lasted throughout the
period of application.
91

Table 6.

92
The effect of different concentrations of met-enkephalin, leuenkephalin and B-endorphin in inhibiting the firing rate of
myenteric neurons.

Inhibition of firing indicates that the

spike frequency fell to less than 75% of its control value during the period of drug application and recovered to the original control value following washout.

The proportion of neurons

which were inhibited by low concentrations of the peptides is
artificially high, because low concentrations (met-enkephalin
30 nM or less, leu-enkephalin 100 nH or less) were only tested
when the unit was found to be sensitive to a higher concentration.

Drug

I

met-enkephalin

Concentration

Number of Units
Tested

(nM)

1
3
10
30
100
300

1
7

I
II
I
I

20

38
23
7

I
i

B-endorphin

10
30
100
300
1000

I

I

1
3
10
30
100
300
1000

II
I

!

I

t:u.sber of Units
rn::ibited
1
6
13
30
20
7

I

I

1eu-enkepha1in

I

1
12
73
21
1
5
8
3
13
25
7
2

I
I

I
I

I

0
11
54
13
l
0
2
2
8
16
7
0

Figure 12.

Inhibition of spike frequency by met-enkephalin in a concentration-dependent manner.
epochs).

Abscissa:

time.

Ordinate:

spike frequency (10 s

The solid bars indicate the per-

iods during which rnet-enkephalin was included in the bathing
solution at the indicated concentration (n?-1) .
3 nM rnet-enkephalin was without effect and a

In this cell,
te~fold

concentration completely suppressed the firing.

higher
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.. 3

met -enkephal·
10
In

30
Time (min)

Figure 13.

Repeated applications of met-enkephalin on a singlemyenteric
neuron.
Abscissa:

Ordinate:
time.

spike frequency (bin width - 15 s).
Met-enkephalin (lOO nN) decreased the fir-

ing rate in a reproducible manner during each of five applicatiqns with
min) .

~arying

durations of exposure (1, 2, 3 and 10

94

met-E nkephalon

150

1100 nMI
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In comparing the inhibition produced by morp::.ine a..Dd normorphine
with that produced by met-enkephalin, two differences

beca..~e

apparent.

First, met-enkephalin produced the same degree of inhibition at atenfold
lower concentration than that of morphine or normorphine (Fig. 17). Second, the time course of the inhibition produced by enkephalin was usually
much faster than that produced by morphine and it was also slightly faster
than the inhibition produced by normorphine (Fig. 17a).

The frequency

with which a rebound excitation was observed with the washout of enkephalin was also much higher than that observed for normorphine (Fig. 17a).

96

3.3.2.

Leu-Enkephalin

Leu-enkephalin (10-300 nH) inhibited the firing of 79 of 108
neurons tested (Table 6).

The time course of the inribition produced by

leu-enkephalin was similar to that of an equieffective concentration of
met-enkephalin.

In 90% of sensitive neurons, leu-enkef-halin (300 nH)

reduced the firing rate by at least 90%.

On a given neuron, the degree

of inhibition produced by leu-enkephalin was dependent on the concentration in the bath.

A 3-5 times higher concentration of leu-enkephalin

was usually required to produce the same degree of inhibition as a given
concentration of met-enkephalin (Fig. 14, n==l2) .
the washout of leu-enkephalin
increase in the firing rate.

"~i!as

As ·.,·i th met-enkephalin,

after: associated \•rit:-. a marked rebound

Figure 14.

Inhibition of spike frequency by met- and leu-enkephalin.
Ordinate:
time.

spike frequency (bin width - 30 s).

Abscissa:

In this cell, leu-enkephalin (100 nN, leu) had no

effect whereas the same concentration of met-enkephalin
(160 nM, met) caused almost a complete inhibition in firing.
A five fold higher concentration of leu-enkephalin ( 500 n!·l)
produced an inh,ibition in firing; rate which was sirular to
that caused by met-enkephalin (100 nM) .

Note that the inhi-

bition of firing by met-enkephalin remained present throughout a 20 min period of exposure.
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3.3.3.

S-Endorphin

S-endorphin (1-1,000 nM) inhibited the firing of 35 of 54 neurons (Table 6).

The time course of the effects produced by 3-endorphin

was similar to that of the enkephalins.

The rebound increase in firing

rate with the washout of S-endorphin was very small and seen only occasionally.

The effect of S-endorphin was dependent on the concentration

applied (Fig. 15).

The most sensitive units were inhibited at a concen-

tration of 3 nM (Fig. 16).

It was usually necessa0; to use a 3-10 fold

higher concentration of S-endorphin to equal a response to a given concentration of met-enkephalin (Fig. 17c).

In most units, the inhibition

in firing produced by S-endorphin was equal or slightly s:-:caller than that
caused by an equal concentration of leu-enkephalin (Fig. 25a).

Figure 15.

Concentration-related inhibition in firing of a single neuron by S-endorphin.
10 s).

Abscissa:

Ordinate:
time.

spike frequency (bin '.vidth -

Solid bars indicate the periods

during which the bathing solution was changed to one which
contained S-e_ndorphin in the concentration indicated (nN) .
S-endorphin caused an inhibition in firing
~o

the concentrqtion in the bath.

whic~~

\vas related
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Figure 16.

Inhibition in firing rate by B-endorphin and reversal of
this inhibition by naloxone.
'(bin width - 10 s).

Ordinate:

Abscissa:

time.

spike frequency
During

t~e

periods

denoted by the solid bars and diagonal hatched bar, the
bathing solution was changed to one which contained S-endor-

.

phin and naloxone, respectively.

The numbers above and be-

low the.bars indicate the concentration (nM).

S-endorphin

(30 nM) caused a marked decrease in firing rate vmich was
completely reversed by naloxone (10 nM) .

Subsequent appli-

. cation of B-endorphin (3 nM) produced increasing amounts of
inhibition of firing rate.

The loss of effect of the first

application of 3 nM S-endorphin may be due to tachyphylaxis
following the larger concentration, or due to residual effects of naloxone.
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Figure 17.

A comparison of the effects produced by

S-

met-enkep~alin,

endorphin, morphine and normorphine on three myenteric neurons.

(a) Ordinate:

Abscissa:

time.

spike frequency (bin \vidth - 30 s).

During the periods indicated, the perfus-

ing solution was changed to one which contained morphine
(M, 300 nM, vertically hatched bar) met-enkephalin (met-E,
,30 nM, ·open bar{ or normorphine (NM, 300 nH, solid bar) .

The time course of the inhibition produced by morphine \-las
much longer than that caused by enkephalin or

no~orphine

. About the same degree of inhibition in firing rate

\'laS

.

pro-

duced by met-enkephalin at a tenfold lower concentration as
was produced by morphine and normorphine.

A marked rebound

increase in firing was also produced by washout o:=.

enkep~alin.
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Figure 17b.

Ordinate:
time.

spike frequency (bin width- 15 s).

rlbscissa:

The inhibition in firing rate produced by ::-.et-enke-

phalin ( 30 n?-1) was exactly the same as the inhibition by
morphine (300 nM) .
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met-E (30 nMl
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Figure 17c.

Inhibition of spike frequency by met-enkephalin
spike frequency

(10 s epochs).

a~d

3-endor-

phin.

Ordinate:

Abscissa:

time.

The solid and stippled bars indicate the periods dur-

ing which the bathing solution contained met-enkephalin and
B-en.dorphin .at the concentration indicated (n:·!) .

Het-enke-

phalin (30 nM) produced a marked inhibition in firing rate
.whereas the

in~tial

application of the same concentration

of B-endorphin only caused a transient inhibition which was
not repeatable.

A higher concentration of 3-endorphin (100

nM) was required to cause the same amount of inhibition as
met-enkephalin (30 nM).
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3.3.4.

The Effect of Calcium-Free Solutions
on the Action of Opioid Peptides

The action of met-enkephalin (n=l5) and leu-enkephalin (n=6) were
both unchanged in solutions which were

calciQ~-free

(?ig. 18).

Even per-

fusion of the tissue with a calcium-free solution for periods of more
than 1 hr did not change the action of the enkephalins on sensitive units.
If the preparation was perfused with calcium-free solutions before recordings were made, the proportion of neurons which were not sensitive to enkephalin increased to about 50% of those tested.
been reported for the action of morphine in
(DL~gledL~e

and Goldstein, 1976).

Sinilar results have

calci~~-free

solutions

Figure 18.

Extracellular recordings from two myenteric neurons.
nate:

spike frequency (30 s epochs).

Abscissa:

Ordi-

time.

During the periods indicated by the solid bars, the bathing
solution was changed to one which contained met-enkephalin;

.

the numbers

~ndicate

the concentration in nH.

(a)

The hori-

zontally hatched bar indicates the period during which the
,bathing solutiop was changed to a calcium-free solution
which also contained EGTA (1 mM).

The initial firing rate

of this unit was low, but met-enkephalin (10 n11) caused a
. small inhibition in firing.

The firing rate increased mark-

edly when the bathing solution was changed to a calcium-free
solution.

Enkephalin, however, still produced a marked in-

hibition in firing rate.

(b) The open bar indicates that

the bathing solution was calcium-free and included EGTA
(1

~1).

The tissue had been perfused with the calcium-free

solution for 70 min prior to this experiment.

Het-enkepha-

lin caused a marked inhibition in firing rate of this cell.
When the bathing solution was changed to one containing a
normal calcium concentration, the firing rate of this unit
decreased markedly and the effects of enkephalin could not
be reliably assessed.
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3.3.5.

Naloxone (100 nM- 1

~)

Antagonists

usually did not affect neuronal firing,

but caused an excitation in approximately 15% of neurons tested (n;30).
This increase was usually small (< 2 x control) and

s~ort-lived

(30-90 s)
P~

and only rarely persisted throughout the period of application.

in-

crease in firing rate was also evoked by both the active (levorotatory
Mr-2266) and inactive (dextrorotatory Mr-2267) isomers of the
antag~nist

benzomo~han

5,9-diethyl-2-(3-furyl-methyl)-2'-hydroxy-6,7-benzonorphan

hydrochloride (Fig. 19, n=6).

The active and inactive isomers were equal~~erefore,

ly effective in producing an increase in firing rate;
unlikely that this effect is due to antagonism at

t~e

it seems

O:"'iate recer,tor of

an endogenously released opioid.

Naloxone (3-30 nH) reversed or prevented the action of the enkephalins and S-endorphin (Figs. 16, 20, 25).

Antagonis::n v1as considered

to be adequate when the inhibitory action was reversed by at least 90%.
The mean ratio (dose of enkephalin) I (dose of naloxone) at \vhich antagonism was observed for met-enkephalin was approximately 9:1 ('l'able 7).
Antagonism was also observed with Mr-2266 but not wit[-,

~·~r-2267

(Figs. 19,

21, n;4).

The specificity of the action of naloxone to reverse opioid peptides was tested by examining its ability to reverse t:Ce inhibition of
the firing of myenteric neurons produced by high calciu:::: solutions (10
nH)

(Fig. 22) or somatostatin (10-100 nH)

(Fig. 25).

:'::\·en at high con-

Table 7.
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The antagonism of the inhibitory action of endorphins by naloxone.

Antagonism is indicated when concurrent application of

naloxone completely (>90%) prevented or reversed the inhibitory
action of the agonist.

Concentrations of agonists \.;ere:

met-

enkephalin (30- 300 nH), leu-enkephalin (100- 300 nH), Bendorphin (100 - 300 nM) .

Concentrations of naloxone were 1 -

100 times lower than those of the agonists.

In the case of

met-enkephalin, the mean ratio agonist concentration:

antago-

nist concentration \vas 8. 7:1 when antagonisn was observed (n=
15) and 14:1 when antagonism was not observed (n=B).
Drug

Nwnber of units
tested

Number of units
in which antagonism was observed

met-enkephalin

23

15

leu-enkephalin

9

7

B-endorphin

5

4

Figure 19.

Prevention of the effect of met-enkephalin by benzomorphan
antagonist.

Ordinate:

(bin width - 10 s).

P~scissa:

time.

The solid bar indicates the period during >,;hich the perfusing solution contained met-enkephalin (300 nH) .
peri~ds

During the

indioated by the diagonally hatched bars,the solu-

tion contained either the inactive (Mr-2267) or the active
, (Mr-226'6) isomel!' of the benzomorphan antagonist.

Both the

active and inactive isomers caused an increase in the firing
rate of this neuron.

During the period which the inactive

·isomer (Mr-2267, 100 nM) was being perfused, met-enkephalin
(300 nM) caused a complete inhibition of firing.

In the

presence of the active isomer (Mr-2266) met-enkephalin (300
nH) produced only a slight decrease in firing rate.
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Figure 20.

Inhibition in firing produced by met-enkephalin:
and prevention of the inhibition by naloxone.
spike frequency (bin width - 30 s).

Abscissa:

reversal

Ordinate:
+-'
-.J.me.

Dur-

ing. the periods denoted by the solid and diagonally hatched
bars, the pe:t;"fusing solution was changed to one which contained met-enkephalin (100 nM) and naloxone (10 nH), respec.tively.

Met-eQkephalin produced a nearly complete inhibi-

tion in firing rate of this unit.

Reversal and prevention

of the inhibition in firing rate produced by enkephalin was
.obtained with a tenfold lower concentration of naloxone.
The inhibition in firing rate during subsequent application
of enkephalin was not as large as previous

application~

ably because of the continued presence of naloxone.

prob-
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Figure 21.

Inhibition of firing rate by B-endorphin and the reversal of
this inhibition by a benzomorphan antagonist.
spike frequency (bin width- 10 s).

Abscissa:

Ordinate:
+-'
~1me.

The

solid bars indicate the periods during which the bathing
sol~tion

(nM).

contained B-endorphin in the indicated concentration

The inactive (+) isomer of the benzomorphan antago-

nist {Mr-2267,'30 nM) and the active (-) isomer (:-Ir-2266,
30 ni1) of the benzomorphan antagonists
the periods indicated.

'~rere

perfused during

B..,.endorphin ( 300 ni·:) co:-:1pletely

·stopped the firing of this unit.

Pretreatment of the tissue

with the inactive isomer (Mr-2267) failed to alter the inhibition produced by B-endorphin whereas

pretreat:::~ent

with the

active isomer (Mr-2266) completely blocked the inhibition in
firing caused by B-endorphin.
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Figure 22.

Inhibition in spike frequency of a myenteric neuron ·,;i th a
high calciu.rn solution.
·width- 10 s).

Ordinate:

Abscissa:

time.

spike frequer:.c:.: (biYl
During the periods indi-

cated by the solid bars, the bathing solution was

c~an;ed

to

one which contained a high calcium (10 mH), and the diagonal
·hatched bar indicates the period in which the perfusing solution cqntained naloxone (300 nM).

The high

calci~~

solution

produced an inhibition in firing rate which was not affected
by prior treatment with naloxone even at a high concentration.
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centrations (300 nM), naloxone did not alter the

inhibi~ion
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produced by

these agents.

Alpha-receptor antagonists have been shmvn to reverse the inhibition of the firing of myenteric neurons produced by noradrenaline
(Sato et al.

1

1973).

The inhibition in firing rate produced by met-

enkephalin was not effected by phenoxybenzamine (n=4)

1

nor was the effect

of met-enkephalin blocked by the B-receptor antagonist propranolol (10
~"1 1

n=2).

3.4.

NEUROPEPTIDES

3.4.1.

Somatostatin

These results are based on recordings made
animals.

Somatostatin (100 nM - 1

of myenteric neurons tested.

~)

7'J units from 25

inhibited the firing of up to 80%

This effect was

tion of somatostatin applied (Fig. 23).

fro::~

depend~<t

on the concentra-

The firing of the

~ost

sensitive

units was inhibited by a concentration of 300 pM and 50% of the units
'"ere inhibited by somatostatin (30 nM)

(Table 8).

The inilibition of fir-

ing caused by somatostatin occurred within 15 s of the arrival of the somatostatin, reversed equally quickly and usually persisted throughout the
perio::'l of application (::''iss. 23, 25).

Higher

co:~cer:tr.c:.·~io!1s

of somatosta-

tin sometimes caused a depression of firing which passed off during the
continued presence of the peptide.

The loss of effect during the applica-

tion was observed in 42% of units tested with a concentrc.tion of 300 nM,
23% of units with 100 nH, 8% of units with 30 nH and in 19% of units with
10 nM.

In cells in which the inhibition in firing rate passed off during

the presence of somatostatin, the response to somatostatin, even at higher
concentrations, disappeared if the interval between applications was less
than 9 min.

However, repeated applications of the same concentration of

somatostatin at intervals of at least 9 min produced

sL~ilar

inhibitions

(Fig. 24).

Somatostatin also produced an inhibition in the firing rate in calcium-free solutions.

The inhibition in firing produced by somatostatin was

not altered by phenoxybenzar:1ine (l

~'

113

Fig. 24, n=2) or by naloxone (100 n!-1,
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Table 8.

The number of neurons in which firing \·:as in'r.ibi ted b:l various
concentrations of somatostatin.

Inhibitio:1 indicates that the

firing rate fell to 75% of the control rate.
Concentration
nM

0.3
1
3
10
30
100
300
1000

~ested

Ntunber of Units
inhibited
I
I

1
1

9

10
10
16
52

30
12
3

I

2

4
26
24
11
2

excited

0
0
0
1
2
0
0
0
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Fig. 25, n=l2).

Propranolol (10

~1)

did block the inhibitio:1 produced by

somatostatin in l of 5 experiments.

The effects of enkephalin and somatostatin were compared on 51
units.

Six were unaffected by either peptide (enkephalin in concentra-

tions up to 300 nH, somatostatin in concentrations up to 100 n..:.l) •

Ten

units were inhibited by enkephalin but not by somatostatin (up to 100
n:t-1).

Nine units were inhibited by somatostatin but not enkephalin (up

to 300 nM).

The other 26 units were inhibited by both somatostatin and

enkepbalin.

In those units where a sufficient number of different con-

centrations of each peptide were applied, an equal

in~ibition

of firing

was produced by somatostatin and enkephalin at about equimolar concentrations.

The existence of cells which respond to somatostatin and not to

enkephalin (Fig. 23) is strong evidence to support the hypothesis
somatostatin and enkephalin do not act via a corruno:1 receptor.

t.hat~

Figure 23.

Inhibition of spike firing by somatostatin.
frequency (10 s epochs).

Abscissa:

time.

Ordinate:

spike

Tne entire ex-

periment was carried out in a solution which was calciumfree and contained EGTA (1 mM) .
by

t~e

stipp~ed

During the period indicated

bars, the bathing solution contained somato-

statin in the indicated concentrations (nH) .

Tne horizon-

.tally hatched bar indicates the period during which leuenkephalin (300 nH) was included in the bathing solution.
Somatostatin produced a concentration-dependent inhibition
. in spike frequency.

The lowest concentration of somatosta-

tin (0. 3 nM) appeared to increase the firing rate.
this was not repeatable (not shown).
nM) was without effect on this cell.

Hm.;ever,

Leu-enkephalin (300
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Figure 24.

Inhibition by sonatostatin of the firin(] of bvo r:-::,•enteric neuOrdinate:

time.

(a) During the periods marked by the solid bars, the

bathing solution
tin · (100 nH).

spike frequency (10 s epochs).

~bscissa:

rons.

v1as

changed to one which contained so:aatosta-

The open bar denotes the period during which

the perfusing solution contained phenoxybenzarnine (POB, 1 f.Ji·!).
~omatostatin

(10? nM) caused an inhibition in firing rate

which was not maintained throughout the period during ,,.,hich
somatostatin was in the bath.

The inhibition was reproducible

?n each of six applications and was still present in solutions
which contained phenoxybenzamine (1

~1).

(b) The perfusing

solution throughout this experiment, and for one hour previous to this experiment, was calcium-free and co::1tained EGTA
(l rr,:.;).

During the periods marked by the solid :Oars, leu-

enkephalin (LE, 300 nM) was contained in the bathi::1g solution.
The diagonal hatched bars represent the periods ;·:hen the bathing solution contained somatostatin (S, 100 or 300 n:.:).
tostatin (lOO and 300 nM) and leu-enkephalin (300
ted firing of this myenteric neuron.

n~·l)

Soma-

inhibi-

The inhibition caused

by somatostatin did not last throughout the period of its
application.

The inhibition by leu-enkephalin

throughout the period of application.

~as

maintained
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Figure 25.

Inhibition of spike firing by opioid peptides ae1d so:nat.ostatin, and the sensitivity of these
Ordinate:

inhibitio~s

spike frequency (30 s epochs).

t.o naloxone.

Abscissa:

time.

During the periods indicated by the solid bars, the bathing
solution contained somatostatin (S), leu-enkephalin (LE) and
B-endorphin

(BE) ,

in the concentrations indicated (n:·n .

The

perfusing soluti<;?n contained naloxone (lOO n:·l) during the
period denoted by the diagonally hatched bar.
statin (lOO

n~1),

(a) Somato-

leu-enkephalin (100 nM) and 3-er..dorphin

.(100 nM) all caused a marked inhibition in firing rate of

this unit.

Only somatostatin produced the

hibition in the presence of naloxone.

(b)

sa~e

6egree of in-

~~other ~~it

in

which the inhibition produced by somatostatin at lo-.-;er concentrations (30 nH) was not effected by high
of naloxone.

co~centration

(c) A final unit in which the inhibition pro-

duced by a low concentration of somatostatin (10 n:·:) was not
effected by a tenfold higher concentration of naloxone (100
nM).
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3.4.2.

Substance P

Extracellular recordings were made from 204 units in tissues
from 74 animals.

Substance P was found to cause a marked increase in

the firing rate

in up to 80%

of neurons.

The increase in firing rate

was abrupt upon entry of the peptide into the tissue bath (10-15 s) and
the firing rate returned to control soon ('.vithin 30-60 s) after ;..;ashing
the peptide from the bath.

Substance P ( 1 nl·1) caused a clear excitation,

at least doubling the firing rate, in about 50% of the cells tested
(Table 9).

Higher concentrations resulted in a greater proportion of

cells being excited; up to where 80% of the units tested were foQDd to
be sensitive (Table 9).

Excitation of the smooth muscle by substance P

limited the use of concentrations greater than 30 n;·l, and it is possible
that the increase in firing rate with higher concentrations may have
been secondary to muscle movements near the recording site or it may have
been due to increased synaptic activity secondary to violent muscle movement away from the recording site.

These difficulties ;·:ere minimized by

the use of lov;er concentrations of substance P and the careful pinning
of single ganglia.

The proportion of cells excited by low concentration (300 pl-'1)
was less tha.'l the proportion of cells excited by higher concentrations
(up to 30 nM).

This change in proportion of cells excited by increasing

concentrations implied a dose-related effect.

The response of single

cells to substance P was also dose-related, but. nbsolut:e sensi ti vi ties
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Table 9.

The effect of different

concentratio~s

of substance P 1 sub-

stance P pentapeptide and substance P free acid on the firing
of myenteric neurons.

An increase in firing '.-las determined if

the firing frequency at least doubled in the presence of substance P or either analog.

About 80% of the units tested were
n~1),

sensitive to substance P (10

no effects Viere seen with

substance P free acid below a concentration of 100 n:•r and few
cells were sensitive to substance P pentapeptide below a concentration of 30 nM.
D.rug

substance p
(l-11)

substance p
(7-ll)

substance p
free acid

Concentration
(nM)

0.1
0.3
l
3
10
30
300
l
10
30
100

3
10
30
100
300
600

1000
3000

Number of
Units Tested
l

15
81
134
25

4
2

1
6

6

3
6
4
2
7

5
1
2
1

Number

Excited
l
4
42
80
21
4
2

Number
Inhibited

0
0

1
3
0
0

0

l
l

0
0

5
2

0

0
0
0
4
3
1
l
1

0
0
0
0

0

0
0

0
0
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varied among units (Figs. 26, 27, 31).
peated

The responses obscrvec tore-

applications of the same concentratio!1 of

three types.

su:!Jsta::~.ce

I' '\·.'ere of

First, the amplitude of the excitation decreased \vi th sec-

ond or subsequent applications (Figs. 26a, 27, 31).
tory effect remained the same

(Pigs. 28, 29, 30).

effect became greater (Fig. 36c).

Second, the excitaThirc, the excitatory

The proportion of units shm·;ing these

different types of responses to repeated applications ·..:as 60%, 30% and
10%, respectively.

Prolonged applications (up to 15 min) of substance P also yielded
variable results:

most units maintained an increased firing rate through-

out the period of application, but in other units the firing rate returned
to the control rate b-2fore the peptide was washed fro.:-n ':.he bath.
crease i;-; respo:-,se

·"o.j

~cepresent

The de-

desensitization, bu::. ce_:::olarization block

or other change in the condition of the cell cannot be detected using
extracellular recording.

Substance P produced a dose-dependent increase in firing rate of
myenteric neurons in solutions which contained no calcilL-:t and EGTA (1 m:r-.1)
(Fig. 27).

In cells which were sensitive to substance Pin normal Krebs

solution, an equivalent excitation could be produced by a lo·,.,·er concentration of substance P v;hen the neuron \·Jas in a calch4T•-free solution (Table
10).

This may be due to the depolarizing effect of the

tions (Nishi and North, 1973a).

calciTh~-free

solu-

The proportion of cells which were found

to be sensitive to substance P was decreased to 40% of those tested in calcium-free solutions (Table 10); similar results were obtained
and enkephalin (see above).

~·:ith

:morpLine

Substance P caused an excit;o.':.ion in solutions

which contained cobalt chloride (l mM, n=3).

Figure 26.

Excitation by substance P of tvro myenteric: neurc::-:s.
spike frequency (10 s epochs).

Abscissa:

tL~e.

Ordinate:

7'e solid

bars indicate the period during which substance P (SP, concentrations indicated in nH) was contained within ';:he bathing
solution.

(~)

Increasing concentrations of

subs~ance

P from

1-10 nH produced graded increases in firing rate of thisunit.

,A second application of substance P in the same concentration range resulted in somewhat smaller responses.

(b) The

vertical hatched bar indicates the period during ·.-·hich the
.bathing solution contained substance P free acid (SPFA, 100
nH) .

Substance P caused a concentration-dependent increase

in firing of this unit.

The substance P free acid

about 33 times less potent than substance P on

t~is

a~alogwas

unit.
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Table 10.

The effect of substance P in different

concen~rations

on the

firing rate of myenteric neurons in a solutio:1 which was calcium-free and contained EGTA (1 mH).

An

increase in firing

rate was determined if the firing rate at least doutlled in
the presence of substance P.

About 50% of the cells tested

were sensitive to substance P (300 p:'l) in calciu.rn-free solutions.

At the same concentration of substance P (300 pM) in

calcium-containing Krebs, less than 30% of the units were sensi tive.

At higher concentrations (1-10

n~l)

, the number of sen-

sitive units in calcium-free solutions Has only 40% of those
tested as

c~~pared

to 60% of units tested in

calcilli~-contain-

ing Krebs.

Concentration
(n!-1)

Drug

substance

p

0.1
0.3
1
3
10

Number of
Units Tested
2
13
23
9

5

i\Jl.L:"tbe r

Excited
0
7

lG
4
1

Number
I!ihibited
0
1
0
1
0

Figure 27.

Increase in firing rate produced by substance P on a myenteric neuron in calcium-free solution.
frequency ( 2 s epochs).

Abscissa:

Ordinate:

time.

continuously bathed in a solution which was
cont~ined

EGTA (1 m}1) •

The tissue was
calciQ~-free

and

The open bars indicate the periods

during which the bathing solution contained
,l nM, SP).

spike

subst~~ce

P (0.3-

Substance P (300 pM) caused a marked excitation

of this unit.

Repeated applications of the same concentra-

tion of substance P resulted in decreasing responses.
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Substance P was equally effective in the presence of hexamethonium (100 flM, Fig. 28, n=l2) .

This concentration of hexa.-nethoniurn

blocks the fast e.p.s.p. of myenteric neurons (Nishi a.r;d North,

1973~).

The excitation produced by substance P was not altered by naloxone at a
concentration (300 nl-1, Fig. 30, n=l2) which was su£ficient to block the
action of morphine or enkephalin (:Fig. 29, Table 7).
duced an inhibition in 4 units.

Substance P pro-

This inhibition Has not prevented by

naloxone (300 nH) in the one cell on which it >·las tested.

The increase in firing rate produced by substa.'lce P was not altered by baclofen (5 f.llll, n=S)

(Fig. 30) or baclofen (50 f.L'l, n=9).

In two

other experiments, the excitation produced by substance P was partially
and reversibly blocked by baclofen (50

~~)

.

The actions of two substance P analogs, substance P pentapeptide
(penta-substance P)

(l-100

n~1)

and substance P free acid (3-3 ,000 nN)

(Table 9) were studied on 9 and 17 units, respectively.

Both analogs

markedly increased the firing rate of myenteric neuro:1s ivith a time course
which '\vas similar to that of substance P.

Such excitations were observed

only in units which were also excited by substance P.

The response to

repeated applications of the two analogs was similar to that observed
with repeated applications of substance P.

Penta-substance P (10 nM)

produced an increase in the firing rate in 1 of 6 cells, whereas pentasubstance P (30 nM) increased the firing rate in 5 of 6 cells tested
(Table 9) .

No effects of substance P free acid i·rere observed at a con-

centration below 100 nl'-1, and above this concentratio:1, the proportion of
units which were excited was about the same as for substance P.

Substance

Figure 28.

The effec-t of acetylcholine antagonists on the response to substance P of a myenteric neuron.
(10 s epochs).

Abscissa:

Ordinate:

time.

spike frequency

Both upper and lower rec-

ords are taken from the same neuron, but they are separated
in

t~me

by 30-min.

During the periods indicated by the solid

bars, the perfusing solution was changed to one v1hich contained substance P (SP, 10 nM).

The cholinergic antagonists,

hexemethonium (C-6, 100 }.!M) and hyoscine (Scop. 1 lJl·l) were
included in the bathing solution during the period marked by
·the horizontally hatched bar.

The cholinergic antagonists

did not alter the excitation of this myenteric neuron by substance P, even after continuous exposure to the antagonists
for 30 min (lower record).
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Figure 29.

Increase in spike frequency by substance P and lack of effect
by naloxone.
scissa:

Ordinate:

time.

spike frequency (10 s epochs).

Ab-

The solid bars indicate the periods during

which the perfusing solution was changed to one containing
substance P

~n

the given concentrations (nH).

During the

period denoted by the diagonally hatched bar, naloxone (300
nM) was· includeq in the bathing solution.

Substance Pcaused

a marked increase in firing rate which was not affected by
naloxone.
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Figure 30.

Lack of effect of baclofen on the increase in

firi~g ~ate

produced by substance P on a myenteric neuron.
spike frequency (10 s epochs).

Abscissa:

Ordi::-1at.e:

time.

L~e

bars represent the periods during which the bathing

solid

solutio~

was changed t.o one which contained substance P (SP, 1 n;·!) and
the diagonally hatched bar indicates the period when baclofen
.( 5 1£1) · was inc],uded in the bathing solution.
(l
\'laS

Substance P

nN) produced an increase in firing rate of this unit -,.,rhich
not affected by baclofen.
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P free acid produced a concentration-dependent increase in spike frequency (Fig. 31).

In order to obtain an equal response on a single unit to a. given
concentration of substance P, a 10-30 fold higher concentration of pentasubstance P and a 100-600 fold higher concentration of substance P free
acid was required (Fig. 31) .

The proportions of cells -,.;hich were ex-

cited by these peptides may be taken as an approximation of relative potency.
~,

About 50% of the cells tested with substai1ce P (1 nH) produced

inGrease in firing rate.

In order for 50% of the cells to be affected

by penta-substance P and substance P free acid, concentrations of 10-30
nH and 100 nH were required, respectively.

Thus, the relative potency

of the two substance P analogs to substance P has been tested in two
ways:

first, by testing different concentrations of each peptide on a

single unit. and second, by determining the concentration of each peptide
which causes an increase in firing rate in 50% of the units tested.

Figure 31.

The effects of substance P and

h'lo

myenteric neurons.

spike frequency {10 s epochs).

Abscissa:

time.

Ordinate:

analogs on two different

The solid, horizontally hatched and verti-

cally hatched bars indicate the periods during which the perfusin~

soluti9n was changed to substance P, substance P

pentapeptide (PSP) and substance P free ncid (SPFA) , respe=tively. · (a) Sub$tance P produced a concentration-dependent
increase in firing rate.

On this cell, a concentration of

30 nM substance P pentapeptide produced about ,the same increase in firing rate as did 1 nM substance P.

A 300 fold

greater concentration of substance P free acid was required
to equal the substance P (1 nM) response on this unit.

(b)

Substance P (1 nH) produced a reproducible increase in firing
rate in this neurc.n.

About a 100 fold larger concentration

of substance P free acid and a tenfold larger concentration
of substance P pentapeptide were required to equal the substance P response.

131

a
~

N

SP
3

I

II

---7.5

PSP

SPFA

1 03
a 11

30 3
!!

1 100 300 1 (nM)
II

[)

D

II

>,

u

c

(l)

::J

o-

(!)

Lt
(!)
.:Y..

·Q_
(/)

30
Time (min)

b

SP
1

N

•

~7.5~
c

SPFA
100

m

PSP
10

m

1

•

1
c

1 (nM)
f3

(!)

:J

CT
(!)

L
[_t_

~
Q_

(/) 0

~~~

0

30

60

90

Time (min)

132
3.4.3.

Neurotensin

Neurotensin was tested on 54 units in pre9arations
mals.

fro~

37 ani-

Neurotensin (1-300 nM) increased the firing rate in about 50% of

those cells tested.

For a given unit, the increase in firing was concen-

tration-dependent (Fig. 32); however, the sensitivity among units varied
considerably.

Even at higher concentrations (> 10

~~)

only about half

of the cells tested were sensitive to neurotensin (Table 11).

Little or

no smooth muscle movement was observed by microscopic examination during the application of neurotensin and this permitted the use of higher
concentrations.

The action of neurotensin directly on the snooth muscle

has been reported to be inhibitory (Kitabji and Freychelt, 1978).

'The

excitation of myenteric neuro!l.s produced by neurotensin ha.d a time course
similar to that observed with substance P.

The increase in firing rate

usually lasted throughout the period of application (up to 15 min) and
the effect produced by a given concentration of neurotensin \vas reproducible on the same unit (Fig. 33):

in this respect, the excitations

produced by neurotensin differ somewhat from those produced by substance
P.

The increase in firing rate produced by neurotensin was not altered

by solutions containing hexamethonium (100

l-ll-1)

and hyoscine (l l.ll'l, n=6) .

Neurotensin excited neurons in solutions which were calcilli11-free.
The proportion of cells which were sensitive to neurotensin was the same
in a calcium-free solution as in solutions with normal concentrations of
calcium (Table 11) .

This suggests that neurotensin is affecting a some-

what different population of cells from those which were sensitive to
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substance P or enkephalin.

Further evidence for this was found in stud-

ies on the action of several peptides on the sane cell
3.4.5.).

(see section
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Table 11.

The effect of neurotensin at different concentrations

o~

th8

firing rate of myen 1:eric neurons in normal Krebs, and in sol·utions

whic~

were calcium-free (+EGTA 1 m1·1).

A.T'l

increase in

firing rate indicates that the firing

fre~~ency

bled in the presence of neurotensin.

The proportion of units

at least dou-

sensitive to neurotensin did not change vlhen studied in solutions which were calcium-free.
Drug

Concentration
(nM)

neurotensin
(in normal Krebs)

Number of
Units Tested

NUITLl:>er
Excited

6
1
29
13

3

0

1
17
7

0

0.1
0.3
1
3

Nmnber
Inhibited

0

0

24
_L---~~~~-------r-----2~~-----+~----l~~~ I ~ I 31----~----~~~
1

I

neurotensin
(in Ca-free Krebs)

I

I

I

_L

~
10

-

I'

21

~

~

~-____1.______2____~_____0______

Figure 32.

Effect of neurotensin on the firing rate of a m:,renteric neuron.
time.

Ordinate:

spike frequency (10 s epochs).

Abscissa:

During the periods indicated by the solid bars, the

bathing solution contained neurotensin in the indicated concentration (QM) •

A concentration-dependent increase in fir-

ing rate was produced by neurotensin at concentrations rang,ing from 0.3-lO,nM.

135

- -

Neurotensin (nM)
1
3

0.3

.-...
N
I

10

'-'5
>.
u

c

(!)

::J

u

(!)
L

10

20

30

40

50
Time (min)

Figure 33.

Effect. of long applications of ncurotensin on the firing
rate of a myenteric neuron.
s epochs).

Abscissa:

time.

Ordinate:

spike frequency (10

The solid bars indicate the

periods dl!ring which the perfusing solution contained neurotensin (l nH)..

Neurotensin (l nM) produced an increase in

firing rate which was maintained throughout the period of
application (up,to 16 minutes).
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3.4.4.

VIP

The action of VIP (1 pH - 10 nM) was studied on 78 units in tissues from 24 animals.

An increase in firing rate was found in 35% of

the cells studied (Table 12}.

The time course of action of VIP was sim-

ilar to that of substance P and neurotensin.

The increase in firing fre-

quency was dependent on the concentration (Fig. 34).

Repeated applica-

tions of the same concentration of VIP usually resul.ted in progressively
declining responses (Fig. 35).
very low:

The effective concentrations of VIP were

4 neurons were excited by 1 pM.

It is possible that e. higher

proportion of neurons \·lOuld have been affected by VIP in concentrAticns
greater than 10 ru"1.

The use of concentrations greater than 10 nH was

not attempted for the follm·;ing reason.

One co:TU'Tl.ercially available

source of VIP (Calbiochem} contains VIP in 100 ng quantities lyophiled
from 1 ml of a solution containing 0.2% bovine serum albunin (BSA).
Solutions of VIP exceeding 10 nM therefore contained significant amounts
of BSA.

In control expermients, the tissue was perfused with a Krebs

solution containing BSA (up to 0.2 g/1):

this did not alter neuronal

firing (n=6) •

The action of VIP on myenteric neurons was present when the tissue had been bathed i.n calcium-free solutions (Table 12, Fig. 36) and in
solutions "'hich cc•ntained cobalt chloride (1 m!l).

Table 12.
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The effect of different concentrations c.f VIP on the firing
rate of single myenteric neurons in nor:c:Jal and in calciumfree Krebs.

increase in firing rate v:as determined if the

An

firing frequency increased to at least 50% over control.

The

proportion of units sensitive to VIP '.·Jas about 45% at concentrations up to 1 nM.

Some units were sensitive to concentra-

tions as lm-1 as 1 pH.
VIP

VIP
(in I1orma1 Krebs)

I Concentration

I
I!
I

Number of
Units Tested
15

!

Number
Inhibi ted

1 pM
3 pM
10 pM
30 pM
100 pM
300 pM
1 nH
10 nH

14

3
3

29
5

13
5

1 pM

19

4

3 pM

1

1

0

12

6

0

l

0

0

10

p~·!

100

H

I

4

35
6

I

13

!
VIP
(in Ca-free Krebs)

Nu1nber
Excited

-

4

1

2

10
4

0
I

I

I
I
I

0
0
0

0
0

0
0

--------------------!----~~~~----~------~------~----~--~----~-----

Figure 34.

Effect of VIP on the fix·ing rate of a myenteric neuron.
Ordinate:

spike frequency (10 s epochs).

Abscissa:

time.

During the periods indicated by the solid bars, the bathing
solution contained VIP in the concentration indicated (pH) •
VIP

(~0

pM)

ca~sed

a marked increase in firing rate of this

unit, whereas 3 pM VIP caused only a small increase and l pM
\\•as without effect.
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Figure 35.

Effect of repeated applications of VIP on the firing rate of
a myenteric neuron.
Abscissa:

time.

Ordinate:

spike frequency (lo s epochs).

During the periods indicated by the solid

bars, the bathing solution contained VIP (300

p~!).

Applica-

tion of VIP caused a modest increase in firing rate which
became less apparent with repeated exposure and almost disappeared durir.g

a

longer exposure.
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3.4.5.

Effects of Excitatory Neuropeptides on the Same Cell

Substance P (1-10 n...'vl) , neurotensin (1-100 nM) and \liP (l pM-1 nH)
>-Tere studied on each of 53 units.

The effects of substance P and neuro-

tensin were initially tested at a concentration of 1 nM and the starting
concentration of VIP was usually 10 pM.

If an increase in firing rate

was observed with at least one of the peptides, at the initial concentration, then a higher concentration (up to 100 times the initial ccncentra·tion)·of the other peptide or peptides which did not previously cause an
excitation was applied.

tVhen each of the peptides

v:as tested at t.he

initial concentration, 14 (25%) of the units were not affected by any of
the peptides and 8 (15%) of the units were excited by all three peptices.
The number of cells sensitive to one peptide and not the other two was as
·follows:
11 cells were sensitive only to substance P,
7 cells were sensitive only to neurotensin
and 1 cell was sensitive only to VIP.
The number of cells which were sensitive to two pep tides but· not to t.he
third was as follows:
7 cells were sensitive to substance P and neurotensinbut not VIP,
3 cells were sensitive to neurotensin and VIP but not substanceP
and 2 cells were sensitive to substance P and VIP but not neurotensin.
The existence of cells which respond to one of the three excitatory peptides studied and not the other two strongly suggests that there are populations of cells Hhich are specifically excited by one of these peptides.
There is also considerable overlap in the sensitivity to the three p2p-
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tides between cells of the myenteric plexus.

Figure 36.

Effects of two or more excitatory peptides on each of three
myenteric neurons.
Abscissa:

time.

Ordinate:

spike frequency (10 s epochs).

(a) This experiment was done in calcium-

free Krebs which contained EGTA (l mM) •
indi~ated

During the periods

by·the open, vertically hatched and solid bars,

the perfusing solution was changed to one which contained
·neurotensin (NT, 1 nM), VIP (1-10 pM) and substance P (SP,

1-10 nM) .
frequency.

All three peptides caused an increase in spike
This unit had about a tenfold greater sensitivity

·to neurotensin than to substance P.

VIP had a clear effect

at a concentration 1,000 times less than substm1ce P.

(o)

The solid bars indicate the period during which the bathing
solution contained neurotensin (NT, 1 nM}, VIP (1 nN} or
subtstance P (SP, 1 nM}.

Neurotensin and substance P were

about equally effective in causing an increase in spike frequency while VIP was without effect.

(c) Solutions of sub-

stance P (SP, 1 nM} and neurotensin (NT, 1 nN} were perfused
during the periods indicated by the solid bars.

The spike

frequency of this unit was markedly increased by substance P

(1 nM) and only slightly affected by neurotensin (1 nM} .
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DISCUSSION

EXTRACELLULAR RECORDING FROM THE HYENTEHI C PLEXUS

Extracellular recording in vitro offers many advantages over recording in vivo.

Known concentrations of agonists

a~d

antagonists can be

added to the bath, the effects of changing ion concentrations in the bathing fluid can be studied and the distinction can be made between direct
actions of the drug on t.he cell and those mediated t.ranssynaptically.
However, there are some limi·tations which are common to both extracellu··
lar recording in vitro and in vivo.

First 1 investigation of ionic mech-·

anisms with solutions of altered ionic compositions are difficult to interpret because changes in firing rate are only a rough measure of t.he
action of the agent tmd8r study.

A cha.r>go in firing rate can be as a

result of many possible factors including membrane poc.:en tial, membrane
resistance, a change in the threshold or sodium inactivation or potassiu:n
activation.

h'hen studying the change in firing rat.e produced by a given

dr-u.g, the experiment is limited to changes in firing rate which vary between complete in!-1ibi tion caused by an inhibitory substance and depolarization block caused by an excitatory substance.

To investigate ionic

mechanisms, it must be possible to measure changes in the propert.ios of
the neuron which are not bcu.'1dcd by the limits which determine \vhether
the neuron will or \dll not give an action :9otent.ial.

Properties such as

membrane potential, input resistance 1 threshold and n:.:versal potentials
of drugs in normal Krebs solutions and in solutic-ns cf ult.ered ion concentrations are much more useful in determination of U:e ionic mechanism
by which a drug acts.

Second, us_ing extraceLlular recording, it. is net
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possible to study changes in synaptic potentials.

Third, in the present

study, special attention must be paid to possible changes in firing rate
produced by movement of the underlying smooth muscle when recording from
myenteric neurons.

All movement of the smooth muscle was eliminated in

the present experiments by careful pinning of a single ganglion, or by
using solutions which were calcium-free or contained cobalt {1 mM).

The primary difference between results from intracellular and
extracellular recording of neurons from the guinea pig myenteric plexus
is that spontaneous activity was recorded with extracellular electrodes
and no spontaneous activity was found when intracellular recordings were
made.

The site of origin of the extracellular activity could acco1mt for

this difference between the two techniques.

That is t.o soy, intracellu-

J.ar electrodes record activity in the cell soma, whereas

""xtraceL~ular

electrodes may record activity from other sites, such as the C8ll pro-cesses or terminals.

It is difficult to identify the source of the ex-

tracellular activity definitively; however, all indications suggest it .... "
the cell soma.

(1) The strongest such indication is that spontaneous

action potentials or evoked ali-or-nothing potentials were

record(:~d

only

from the surface of the ganglia and were never recorded from the interconnecting strands.

(2)

The only activity which was recorded from the

interconn2cting stra..1ds was electrically evoked, graded with the intensity of stimulation and had a multiphasic waveform.

Because few cell

bodies are found in these strands, it is likely that the graded, short
latency, evoked

po'L~entials

\-rhich were recorded, v1ere from cell processes.

(3) The waveform and time course of the spontaneous extracellular spikes
recorded from the ganglion surface also suggest that the source of the
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activity is somatic.

The time course of the action

pote~tial

corresponds

to the first time differential of that recorded >vith intracellular electrodes (Nishi and North, l973a).

The monophasic or sligl:tly biphasic

waveform of the potential is usually considered to be somatic (De Valois
and Pease, 1973).

This waveform indicates that there is a good resistive

seal around the electrode.

If the resistive seal was smaller, two changes

in the extracellular spike would result.

First, the amplitude of thespike

would become much smaller due to an increased a..--nount of e:!.ec·trical shlmting between the recording and indifferent electrodes·.

Second, one might

expect to record the field potentials from the cell w--:tich 2-.re set up hy
the membrane currents during the action potential.

The fielJ potePtials

would result in a triphasic waveform which is proportional to the second
differential of the change in cell potential vli th respect to time (Hubbard,
Llinus and Quastel, 1969).

The resistive seal around the electrode is sufficiently go(x1 that
the extracellular potential is coupled to the intracellular potenLi:1l by
the capacitance of the cell mernbra!'1e.

Under these conditions the extra-

cellular spike should be in the opposite polarity to the intracellular
spike and the wavefoxnt would be proportional to t.he first differential of
the change in potential with respect to time (Hubbard et al., 1969).

In

p:r·actice the polarity and waveforra of the extracellular spikes usually
conformed to this prediction; however, spikes of opposite polarity and of
varied waveform (syrt,;r.etrically biphasic rat.her than monophasic) \·mre recorded occasionally.

These spikes were more often seen ,.;hen using large

recording electrodes (> 70 ].!n).

There are at least b·:o explanations which

may accoUl'1t for the variation in spike polarity and \·?a.veform.

(1) The
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resistive seal around the electrode is not perfect.

~·;:Cen

recording extra-

cellularly using ·the sucrose gap method, the resistance betwec:n the recording and indifferent electrodes was reported to be usually nore thm1 5

Mst (Nishi and Koketsu, 1968).

Using this method the extracellular poten-

tials are opposite in polarity but
the intracellular potentials.

s~~ilar

in

wavefo~n

and

amplitud~

to

Because a sucrose gap involves the resis-

tance of a population of cells over a fairly large (1 mm) gap, i t is difficult to compare the resistance seen using sucrose gap .,.,ith the resistance observed with a suction electrode.

However, tl:ere is at least a

tenfold difference between the resistance measured by tl-:e tv.·o methods,
and this may account in part for the differences in spike polarity, atnplitude and waveform seen using the suction electrodes.

(2) An e:1tire cell

body is not always covered by the suction elec:t.roCl.:'.

;;h:;,n a large <:::lee-

trode (> 70 f.Jffi) is used, one might expect that parts e;f. several eel} bodies would be covered.

If a large part of the cell bod.y ,,;ere not co'.'ered.

by the electrode, the membra.-'1e current produced durir:g a:1 action potential
by this part of the cell may result in a large local field potential.
These field potentials, and not others, are recorded
imity of the electrode to the source and the

relativel~·

source (cell body as opposed to cell process).
cell body is outside the

e~ectrode,

b2ca~se

of the prox-·

la.rge size of t:he

If a largs p3rt of the

then the polarity of the E:piJ:e shoulcl

be opposite (posi·tive) to that which is recorded when the cell is mostly
beneath the electrode.

1[

half of the cell '.Yas cover•;;ci b'J the electrode,

then the waveform might be expected to be

symrnetrical~.y

biphasic.

The small size of the clectracellular potentials recorded

r<~ight

i.ndic'J.te that their source is '.:\ smaller st.ructure tha.;1 the cell so:na.
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Ho·..rever, the use of a large, lovr resistance electrode may result in attenuation of extracellular potentials.

In fact, on theoretical grounds, the

size of the potential can be predicted (appendix 1).

Even if the elec-

trade made a perfect resistive seal around a cell 1 such that all the current generated by the cell resulted in a potential difference recorded at
the electrode,-the potential would be only 1-5 mV.
from a cell process, the

maximt~

If the recording was

potential would be only 50-150

~V.

These

considerations therefore suggest that the extracellular electrodes are in
fact recording potentials which are derived from the·

s~~a

spike.

Another possible consideration which may explain the origin of
the spontaneous extracellular act.i vity is that under the conditions of
extrc:tcellular recording, tlw n

~urons

"·ere S:f'11dl'tically d:river:., and tha.t

synaptic activity v1as nbse:nt in the intracellular record::.ng e);.perirc.2nts.
'I'his f'OSSibility \•TaS test.ed in bvO ways:
solutions and (2) by the use of cobalt.

(1)

By the use of c.':llciu:n-·-:':::::ce

Calcium-free solution blocked

synaptic 1:·L"an.s;nissicn (Dingledine and Goldstein, 1976), b11t had a. de::;,olarizing effect on its

O\vn

(Nishi and North, l973a) .

The depolarization

of cells in calcium-free solutions may then substitute for the decline
in any ongoing synaptic influences such that the firing rate was maintained.

Solutions which contc..in cobalt (1 nH) also block the e.p.s.p.

and have no effect or a ver-J sn;o.ll depolarizing
tied

(Kat.ayama and North, nnpulJlishcd results).

effe~t

on membrane paten-

In the present study,

the firing rate, of myent,:-r.ic neurons \·;as not affected by solutions which
contained l

rn~ cobal1~

(n=G).

It appears that U1c

exi~racellular

electrodes are recordin'] from
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t!-le cell soma of myenteric neurons and that the sponta:r,e:ms activity is
not due to ongoing synaptic activity.

The neuronal o.ctivity recorded

with extracellular electrodes is thought to be induced by the large suction electrodes based on the following observations.

First, no spontan-

eous activity was recorded with suction electrodes having a tip diameter
less than 30

~.

but electrically evoked activity could be recorded with

these 5mall suction electrodes.

Second, the firing rate of some units

could be increased or decreased by using greater or lesser amounts of
suction.

Third, sometimes when the electrode was placed on the ganglion

with suction and no activity was recorded, excitatory agents adder'! to the
bath would cause a ur'li t to begin firing.

Likewise, units other than the

one being recorded v10uld sometimes begi:'l to fin" wh'=n ezci t::atcry ag8nt.s
were added to the bat.h.

Although the single spike and burst type firir.g patterns previously described may represent different function::;.l t:,:pes of neurons
within the myenteric plexus, little physiological significance can be
ascribed to this activity since it is thought to be artificially induced
by the suct.ion electrode.

As a model to study the action of various

agents on neuronal firing, it is in some respects analgous to artificial
induction of
mate.

fi.rin~

in many studies by iontophoretically applied gluta-

The use of me.chanical irritation of the cell to in::luce firing may

be, in some respects, <:m improvcnent over the use of excitatory amino
acids because it eliminates possible interact io:1s {or pro::::>osed interact: ions) betw.:,en

t~e

agent being studied and the exci tato:cy agent used

to stimulate the cells.
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Nechanical irritation of the myenteric n""urons

b~· t'!"'.e

su-:::tion

electrode may also be closer to a physiological stimulus ::ha.:-1 cne migh·t
expect since the gut \vall is subjected to chc>..nges in pressure and marked
changes in diameter during the passage of luminal contents through the
gastroi.ntestinal tract.

The ganglia of the myenteric plexus undergo

clear changes in size with the amount of stretch which is put on the
longitudinal muscle when pinning out the tissue.

Similar changes in size

and shape of the ganglia are observed in tissues where the longitudinal
smooth muscle is spontaneously active.

The movements of peristalsis must

also result in mechanical deformations of the ganglia in vivo.
sible that application of a suction electrode simulates
tension which is present during peristalsis a.'1d this

so~e

results

It.

lS

pos--

stage of disin the fir-

ing of myenteric neurons.

The sensitivity to various agents, both exci ta~ory and inhihi tory,
varied among units.

One explanation is that the myenteric pleX'.1E" L, a

heterogeneous population of cells and that certain cells are much more
sensitive to some agents than are other cells (see sections 3.4.1. cmd
3.4.5.).

Another possibility is that the intensity of st.L"":lulatior: p:co-

duced by the suction electrode could alter the response of a cell to any
given agent.
neurons.

The c:.rnount of suction does alter the firing rate of some

It i.s possible that the degree of inhibition or excitation pro-

duced by a giv2n agent could be altered by the amount of suction in the
elect1~ode.

Thr~

sensitivity of units to inhibitory agents also seemed to

vary vrith the size of the suction electrode; units roco.::-ded v:ith large
(70-90 )JTII) electrodes being less sensitive than those recorded vlith smaller
electrodes.

Presumab.l~',

a larger electrode or an increased a.r:tount of sue-
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tion offered a greater source of stimulation such ttat: it took a greater
concentration of inhibitory substctnce to overcome the sti.:im1ation.
explanation may account for the variability in the degree of

This

i~:hibition

or excitation produced by inhibitory or excitatory agents among populations of sensitive units.

4. 2.

THE ACTION OF OPIA'l'ES AND ENDOGENO'JS OPICID P:SPTIDES

Morphine has been shown to inhibit the firing rate in 90% of
myenteric neurons tested (Dingledine, Goldstein and Kendig, 1974; Dingledine and Goldstein, 1975; 1976).

This inhibition was found to be media-

ted via opiate receptors located on the cell being studied and not mediated through a synaptic mechanism (Dingledine and Goldstein, 1975; 1976).
The present results confirm these findings and extend the observations to
the endogenous opioid peptides.

In addition, the action of morpi1ine \O:as

test.ed in solutions o-: altered ionic composition.

Z·!orp!"linG appeared to

be equally effective in solutions containing high pot.assi'lEn, low potas-

siurn and low chloride.

These results cannot bo taken as definitiv<: e'!i-

de nee against the involvement of these ions in the act ion o£

raur!_):hinc~

,.

since neuronal firing could still be inhibited by morphine even if the
ionic mechanism of its action involved one of these i.cns.

The driving

force for a potential change caused by morphine rr.ay bs shifted markedly
by changing the extracellular concentration of potassiu.:n or chloride.

If

the firing rate was dependent only on the potential of the cell, the effect produced by morphine on the firing rate might also be changed by
changing the driving force of the ion or ions involved.

Since t.hc" firing

frequency is not dependent only on potential, a change in the driving
force produced by changing extracellular ion concentration3 may not alter
the effect of morphine.

For example, it is possible that norphine causes

a large increase in conductance, which results in block<1de of propagation
of the action.potential by shunting the current through the nembranP.
The fall in membrane resistance would still occur in solu'c.ions 11hich
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markedly alter the driving force of the ion or ions invol·,red in the actLon of morphine.

The endogenous opioid peptides, met- and leu-enkephalin and
endorphin all inhibited neuronal firing in the myenteric plexus.

8-

These

inhibitions are considered to be opiate receptor mediated for the following reasons.

First, the effective concentration of agonists were low.

Second, the inhibition was blocked or prevented by lo,..;er concentrations
of the opiate antagonist naloxone.

Third, the active benzomorphan anta-

gonist Mr-2267 was effective in blocking the inhibition produced by these
peptides whereas an equal concentration of the inactive isc:ner Hr-2265
was ineffective.

The inhibition produced by the opioid peptides was not

blocked by phenoxybenzamine, propranolol or by solutions ir: which synap·tic transmission was assumed to be blocked.

Met-enkephalin was found ·to inhibit the firing rate of

my,~ntcric

neurons at. lower concentrations (about 10 times) than morphine and no:cmorphine.

However, morphine, met-enkephalin and B-endorphin were equally

effective in inhibiting the electrically induced contraction of t.he guineo:t
pig ileum myenteric plexus-longitudinal muscle preparatio:-1 {Lord, t·later-·
field, Hughes and Kosterlitz, 1977).

The metabolism of net-enkephalin is

one explanation for the differences found between the results obtained
using the contractile response and those obtained using extracellular recordings.

The effects of metabolism were studied on the cont:::-actile re-

sponse using enkephalin analogs which were more resista:1t to metabolic
degradation.

The analogs were up to 6 times more effective than met-

enkephalin in inhibi tL'lg the contraction and yet coillpared to r.-tet-enkephalin
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there was little change in the ability of the analogs to displace naloxone
from opiate binding sites (Lord et al., 1977).

Thus, it appears that in

that preparation,metabolism of met-enkephalin does decrease its effectiveness.

The effect of metabolism on the inhibition in firing of myznteric

neurons under the conditions of the present experiment are limited.

The

size of the tissue is small, so that the ail'.ount of metabolism is limited
by the relative lack of peptidases.

The tissue is continuously perfused

with fresh Krebs solution, and during the period of peptide application,
fresh peptide solution continuously perfuscs the tissue.

Under the condi-

tions .used for extracellular recording, the ganglia of the myenteric plexus are laid out flat such that they are directly exposed to the peptide
containing solutions.

It is also possible that the inhibition in fi:ring rate is mediated
by a different type of opiate receptor from the one
release of acetylcholine from the nerve terminals.

whic~

decreases the

There is mounting evi-

dence that the myenteric plexus contains a heterogeneous population of
opiate receptors (Lord et al., 1977).

Demonstration of separate popula-

tions of receptors using extracellular recording requires qua..'1titative
studies such as determination of

p~

values of antagonists and precise

determination of relative potencies of a series of agonists.
tative experiments are rendered impossible because there is

Such quanti~oo

much var-

iability inherent in the method of recording with extracellular suct.ion
electrodes (see 4.1.).

There is a large amount of variability among uni t.s in the response
to a given concentration cf a single 0piate or opioid peptide such that
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only general qualitative statements can be made about the relative potency
of a series of agonists.

A membrane stabilization of hyperpolarization was proposed as
being a possible mechanism of action (Dingledine and Goldstein, 1976).
SUbsequently, morphine \'las found to hyperpolarize a population of neurons
(North, 1976; North and Tonini, 1977).

However, the proportion of units

in which the firing rate is decreased is much larger than the population
of neurons in which a hyperpolarization was found.

O:l.e possible explana-

tion is that extracellular recording selects specifically the population
of neurons which have opiate receptors.

The cells •..,hich '...;ere r:.ost often

sensitive to the narcotics using intracellular electrodes '\·•ere the type
I cells (North apd Tonini, 1977).
type II cells (Nishi and North,

These cells are nore excitable t.han

1973~,

and it is likely that these cells

would fire more readily when stimulated by a large suction electrode.
Another explanation may be that extracellular electrodes record patentials which are only rarely recorded at the soma with intracellular electrades.

There is now evidence from experiments using iontophoret.ic ap-

plication of enkephalin that the hyperpolarization in the soma originates
in the processes (North, Katayama and Williams, 1979).

It is possible

that the firing recorded extracellularly originates from irritation of a
cell process close to the soma (the extracellular electrodes were usually
30-70 1Jffi in tip diameter) and that the hyperpolarization produced by opi-

ates at this site acts to inhibit the firing.

Another difference between the results obtained fron intracellular
and extracellular techniques is the occurrence of tac!1y;::hylaxis to the
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hyperpolarizing effect of the opiate and opioid peptides.

If the hyper-

polarization recorded at the cell soma was solely responsible for the inhibition in firing rate recorded extracellularly, then why is there little
sign of tachyphylaxis to the inhibition in firing rate produced by the
opiates or opioid peptides?

One possible explanation may be that impale-

ment of a neuron with an intracellular electrcde renders the cell unable
to respond to the opiates over an extended period of time.

Such a change

in the cell may be rela-ted to leakage of chloride ions from the microelectrode (North and Tonini, 1977).

It is also possible that impalement of

the neuron results in a slow change in the dendritic-soma conductance
ratio,

such that potential and resistance changes Hhich originate in the

prOCf:!Sses may be progressively attenuated when recording at the cell soma.
A swelling of the cell soma following impaleme:1t has been noted and could
result in changes in the dendritic-soma conductance ratio.

It is also

possible that another mechanism other than hyperpol::1rizat.ion causes tbe
inhibition in firing rate.

As previously discussed, one possible mech-

anism is a marked increase in conductance to some ion such as chlo::::ide or
potassium which results in blockade in propagation of an action potential
down a process at some point.

A decrease in resistance was seen in

al~ut

one half of the myenteric neurons which were hyperpolarized ru1d a measurement of input resistance was made (North, Katayama and \·lilliams, 1979) .
No change in resistance was ever noted in neurons which v1ere not hyperpolarized by opiates or opioid peptides.

This was taken as evidence indi-

cating that the opioid peptides act at a site a\.;ay fro::n the cell soma.
The occurrence of a hyperpolarization with a decrease in input resistance
in some cells and not others was perhaps due to variations from cell to
cell in the dendritic-soma conductance ratios.

The fact that a change in
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conduc:tance was never seen in the absence of a hyperpolarization may be
interpret.ed in at least two ways.
to the opiates of opioid peptides.

First, these cells are not sensitive
Second, these cells are sensitive but

have a ve1·y low dendritic-soma conductance ratio such that potentials in
the processes cannot be recorded in the soma.

The fact that an increase

in conductance-was never observed in the absence of a hyperpolarization
strongly suggests that the hyperpolarization is at least one mechani::;m
v1hich decreases neuronal excitability and an increase in conductance is a
second possible mechanism -v:hich is less often recorded in the cell soma.

Studies on the ionic mechanism of action of the opiates and opioid
peptides using extracellular recording techniques have been limi·ted as
previously described.

'I'he same studies using intracellular rE:cording

te::hniques have been limited by the number of cells which give reproducibl0
responsesi hm.,ever, a few isolated experiments have been done \vhich verify
the results obtained with extracellular recordings.

In one cell, the

hyperpola.ri:>:ation produced by met-enkephalin (300 nH) was not altered in
a solution containing low chloride (10 nM) and in two other neurons the
action of met-enkephalin {300 nM) was still present in solutions >vhich
were calcium-free (did not contain EGTA)
results).

{North and Williams, unpublished

Further experiments in solutions of altered ionic composition

are required to elucidate the ionic mechanism of the action of the opiates
and opioid peptides.

The inhibitions caused by the enkephalins and B-endorphin are
mediated through an action directly on the cell under study rJCcause they
persi~;t

in calciwn·-fxee solutions.

These experiments also indicate tha'...:
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calcium ions are not required for this action of opiates.

SL~ilar

re-

sults were obtained for the inhibition of firing produced by morphine
(DingledL~e

and Goldstein, 1975; 1976).

The proportion of units sensi-

tive to enkephalin was reduced in calcium-free solutions as was reported
when studying the action of morphine (Dingledine and Goldstein, 1976).
Although i t is not possible to distinguish absolutely different types
of units using extracellular recording, the appearance of morphine and
enkephalin insensitive units in

calcium~free

solutions strongly suggests

that the insr='nsi tive cells are the type II cells of the intracellular
classi-fication.

First, the excitability of type II cells has been shown

to increase in calcil.®-free solutions due to the removai of the calciumdependent slow after hyperpolarization follu.ving the spike (Nis!-'.i and
North, 1973; North, 1973).

Second, ty-pe II cells have been shown to b2

less sensitive to the hyperpolarizing action of morphine when studie-::1
using in·tracellular techniques (Nort.h and Tonini, 1977) .

Increasing the calcium ion concentration (10 rr::.!) always dec1:eased
the firing rate of myenteric neurons.

This inhibition •.·;as not mediated

byopiate receptors but through a stabilizing effect of the calcium ions
on the cell membrane.

There are at least two mechanisms by which calcium

can st.abilize the neuronal membrane to inhibit spike firing:

first, by

suppressing sodium activation (Koketsu, l9G5) and, second, by increasing
the int.racellular calcium concentration which increased potassiurn conductance (Krnjevic and Lisiewicz, 1972; North, 1973}.
ions in the action of opiates at other sites is

The role of calcium

some>vha'l~

conflicting.

Elevating the extracellular calcium ion concentration in. vivo has been
folU1d to overcome the action of mo:r:phine (Takemori, 1952; Yakunaga,
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Kancto and Hano, 1966).

On the other hand, decreasing calcium levels

with EGTA or lanthanum resulted in a potentiation of the antinociceptive
effect of morphine in rat (Harris, Loh and Nay, 1975).

The release of

transmitter substances from in vitro preparations which are sensitive to
the opiates is decreased by morphine (Paton, 1957; Schaumann, 1975; Henderson and Hughes, 1974).

Increasing the extracellular calcium ion con-

centration increases the release of transmitter from the nerve terminals
which are sensitive to opiates (Henderson and Hughes, 1974).

However,

this effect of calcium is common to all neurotransmission sites, not only
those-which are sensitive to opiates.

The action of calcium probably has

a much greater effect on the release of transmitter substances ir:. viYb
a'1d in vitro than on the stabilization of neuronal exci tn~ility and inhibition of firing which was studied in the present expcrLnsnts.

The physiological significance of the effects produced !Jy
phalin and S-endorphin remains to be determined.

E',nJ~e-

Concentrations c£

s-

endorphin as low as 3 nM were found to inhibit some myenteric nr:;uro'1s.
This concentration is about the same as that which was fou:r1d in the pla2ma
of rats after stressful stimulation (Guillemin et al., 1977).

Stress-

induced release of S-endorphin has not been measured in t.he guinea pig.
It seems unlikely that the myenteric plexus is a target orsan for hlood
borne B-endorphin since only a small proportion of myenteric neurons were
inhibited by concentrations in the 1-3 nN range.

Concentrations of met··

enkephalin of 3 nM were much more effective in producing an inhibition of
firing in the myenteric plexus.

Enkephalin has been

sho·w~n

to be contained

within the neurons of the myenteric plexus, and in view of its actions
upon single neurons, it seems possible that electrophysiological evidence
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for its release by electrical stimulation could be obtained,

Hm.,rever,

repetitive stimulation (0.1-10 Hz) for up to l min only rarely caused
any inhibition of neuronal firing and this was never affected by naloxone.
Repetitive stimulation more often caused .a longer lasting excitation.

It

is possible that naloxone-reversible inhibitions may have been occluded
by concomitant release of other transmitters.
tory response was not studied in detail.

The longer lasting excita-

It is possible that this exci-

tation is produced by release of one or another of t:he excitatory neuropcptides.

4. 3.

THE ACTION OF SOHATOSTATH;

Somatostatin is found in cell bodies and nerve terminals of the
myenteric plexus (Costa et al., 1977) and the present study shows that
it causes an inhibition in firing rate of single

~yenteric

neurons.

hibitions of firing rate were produced by soillatostatin in the

sa~e

Incon-

centration range as the effective concentrations of met-enkephalin.
units were also inhibited by concentrations of

so:-:~atostatin

found. to inhibit growth hormone release ( 3 ni<!)

(Brazeau et

Sorr.e

which \•lere
a~.

, 1973) •

These results may be taken as evidence in support of a physiological role
for somatostatin in the myenteric plexus.

The action of somatost.:..tin \vas

probably not mediated through an opiate receptor nechanism for two rea-·
sons:

first, naloxone never altered the inhibition in firing rate pro--

duced by somatostatin and, second, some cells which were not senc:;itj_vc
to high concentrations of enkephalin were found to be sensitive to lov7
concen·trations of somatostatin.

'rhe inhibition in firing produced by

somatostatin was not blocked by phenoxybenzamine or propra11olol and persisted in solutions which were calcium-free, indicating the action was not
due to release of an inhibitory transmitter and \-.'as not dependent en the
presence of extracellular calcium.

A population of neurons exhibited tachyphylaxis to the effects

of somatostatin.

This was more apparent at highAr concentrations.

How-

ever, even at higher concentrations, if the interval between applications
was extended, reproducible responses could be obtained.

The occurrence

of tachyphylaxis to somatostatin contrasts \·:.ith the effect.:s produced by
162

163

enkephalin which prQduced little or no sign of desensitization.

Similar

results were obtained with the electrically induced contraction of the
myente!.-ic plexus longitudinal muscle preparaticm (Guillemin 1 1976).
Somatostatin inhibitedthe contractile response and marked tachyphylaxis
to thiE inhibitory effect was noted.

The concentrations of somatostatin

(700 nM - 2 .1 ~M) used to inhibit the contractile response were much

higher than those effective in decreasing the firing rate of myenteric
neurons.

The inhibition of the contractile response to electrical sti-

rnulation by somatostatin was not affected by naloxor).e.

Furthermore,

during the periods Hhen the response to sornatostatin ''as desensitized,
the effect of B-endorphin was unchanged, which also indicates that somatostatin does n0t act via opiate receptors •

.:i:ontophoretic applicatiou of somatostatin (curre;·,ts up to 30 nA)
decreased the firing rat.e of cerebellar, cortical and
rons of 1.·at (Renaud et al., 1975) a..'1d neurons from

hypothal::L<•.i~

la-rti::-~a

neu-

I-III of the

spinal cord from cat Cr1iletic et al., 1977 i Randic and :-Iiletic 1 1978) •
The inhibition in firing rate produced by sornatostatin a·:: these sites,
as well as myenteric neurons 1 may be due to a membrane sta'>)ilization or
hyperpolarization.

Hmvever, in the in_ vivo studies, an indirect action

c2.nnot as yet be ruled out.

Using the sucrose gap method

0::1

the isolated

frog spinal cord, somatostatin was found t:o cause a hyperpolarization
recorded from the dorsal roots in solutions where synnptic transmission
was blocked (Padjen 1 1977).

However, the hype:r.polarization in frog spi-

nal cord required 100-1 1 000 times the concentrat.ion than that ,,;hich produced an inhibition in firing of myenteric neurons.

It r..ay be that the

frog spinal cord preparation is nn1ch less sensitive than myenteric neu-

rons or, possibly, the inhibition in firing is due to

so~e
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other mech-

anism and hyperp.).larizations are seen only at higher concentrations.

Iontophoresis of. somatostatin at other sites has caused an increase in neuronal excitability (Dodd and Kelly, 1978;
Friesen and Chernick, 1978).

~offe,

Havicek,

A depolarization and increased excitability

in response to somatostatin was found with intracellular recordings from
CAl and CA2 cells from slices of rat hippocampus (Dodd and Kelly, 1978).
An increase in firing rate \vas also seen in response to somatostatin in

s0nsorimotor neurons from rabbits record<.:!d in vivo (Iof:f:e et al, 1978).
In the study by Dodd and Kelly (1978), the iontophoresis electrode vms
filled with somatostatin (3 nK) dissolved in sodium acetate (5

nll·l,

pH'"'

7.0), ar1d a negative curren·t (196 nA) was used to eject the peptl.d:c;.

the other study, the iontophoresis electrode was fillec \·lith

somatosL:~tin

(5 nl-1) in distilled water (pH not indicated) and the peptice was
as a cation (l0-50 nA).

In no study was the a1nount of

ejected from the electrode measured.

In

~d

ect.ed

sonatos~at:in

It is possible that the pH of th=

solution in the electrodes may account for the different polarities of
current used in these studies.

The excitatory effects of somatostatin may be due to an indirect
action of somatostatin.

It is difficult to demonstrate a direct action

using iontophoretic application of somatostatin or any other peptide
using an in vivo system, and indirect effects were no::. c:onsidered in the
study using hippocampal slices (Dodd and Kelly, 1978).

4.4.

EXCITATORY PEPTIDES

4.4.1.

Substance P

Substance P caused an increase in firing rate in the majority of
myenteric neurons.

The excitation produced by substa11ce P was notal ten~d

by calcium-free solutions, solutions which contained nicotinic and muscarinic antagonists or solutions in which all sr.1ooth ::mscle movenents
were eliminated.

These results indicate that the action of substance P

is directly on the neurons from which recordings -;·;ere nade.

The effec--

tive concentration range (300 pH - 30 nM) in this preparation is cor:lpClra.ble with other in vitro preparations (e.g. contraction of the gui;:wa
pig .:..:.€.;.1..-:-,- ?..osell, Bja.::::-:croth, Chang, Yar:1aguchi,

~·Jans;,

rta.ckar, Fishe.r

and Folkers, 1977 and contraction of the guinea pig va;_; de£erer:::; - Zet:ler,
1977), and with the Kd (3 nM) for binding sites in brain ho:nogen2.tcs

using tritiated substance P (Nakata et al., 1978).

These corr0lations

may be taken as partial proof that the increase in firing rate produced
by substance P on myenteric neurons is mediated by a sii'lilar receptor.
It is difficult to compare the concentrations used in iontophoretic studies on single neurons in vivo with the concentrations of substance P
used in the present study.

However, substance P caused a depolarization

of motor neurons in the isolated spinal cord of frog (Konishi and Otsuka,
1974~)

and newborn rat (Konishi and Otsuka, 1974£) which required 30-100

times the concentration of substance P which ·..ras effective on the myenteric neurons.

There was some tachyphylaxis to the effects of substance P on
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myenteric neurons.
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Desensi tizat.ion and variable responses to iontophor-

etic application of substance P on central neurons has also been reported
(Krnjevic and Horris, 1974; Henry, Krnjevic and :-!orris, 1975; Davies and
Dray, 1976; Le Gall La Salle and Ben-Ari, 1977; Sastry, 1978a).

It is

difficult to determine, using extracellular recording techniques, the
mechanism of this apparent desensitization.

It is possible, for example,

that depolarization block may account for decreasing effects of substance
P.

The specificity of the action of substance P was tested
analogs (penta-substance P (7-ll) and substance P free acid).

TH:L th

two

Studies of

structure activity relationships of substance P on the depolarization of
newbora rat spinal mot:or neurons have demonstrated that even smal1 ch;mges
in the amino terminus of the substance P molecule drastic2lly alt.?rs the
biological activity (Otsuka and Konishi, 1977).

Removal of the firs'c 5

amino acid residues from the carboxy terminus did not alter the :hio1_ogical
potency significantly.

However, the activity dropped off markedly witn

further elimination of carboxy residues.

The penta-substa,ce P (7-ll)

analog was at least 50 times less potent than substance P on the rat spinal motor neurons (Otsuka and Konishi, 1977).

In the present. study, the

pentapeptide analog was about 30 times less active than substance P.

The

substance P free acid analog has not been studied in other preparations.
However, removal of the terminal methionine residue decreased the biological potency by 2,000 fold, as measured on the rat spinal motor neurons
(Otsuka and Konishi, 1977).

These results, &'1d those of the present study,

are consistent with the observation that small changes in the amino end
of the substance P molecule can markedly change its biological potency.
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Baclofen, a proposed substance P antagonist (Saito et al., 1975),
was ineffective on the substance P response in myenteric neurons and had
no effect on its own.

The action of baclofen at other sites has been re-

ported to be GABA-like (J<rnjevic, 1977).

Baclofen decreases the firing

rate of spontaneously firing neurons and blocks excitations produced by
acetylcholine and glutamate as.well as substance Pin the substantia
nigra (Davies and Dray, 1976), spinal neurons (Henry and Ben-Ari, 1976)
and. interpeduncular neurons (Sastry, 1978a).

It appears that baclofen

only antagonizes substance P effects when baclofen itself has a depressant action.

The present results show that substance P is effective in low
concentrations and these are similar to those L'1 which it binds to rat
brain homDgenates (Nakata et al., 1978).

These results are not inconsis-

tent v!ith a neurotransmitter or neuromodulator role of substance I' in thE:
myent.eric plexus.

Further study on the action of substance I' using int:L2.-

cellular techniques may provide more conclusive evidence on the role of
substance P in the my2nteric plexus (see 4.5.).
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4.4.2.

Neurotensin

Neurotensin produced an increase in the firing rate of myenteric
neurons similar to that caused by substance P.

The effective concentra-

tion range and the time course of action of neurotensin \•:ere both about
the same as for substance P.

The increase in the firing rate was not

affected by calciuin-free solutions or the presence of cholinergic a:.1tagonists.

There vlere some notable differences between the effects of neuro-

tensin. and substance P.

First, since the longitudinal smooth r:mscle was

not stimulated by neurotensin directly, higher concentrations could be
studied.

Second, t::1e increase in firing rate produced by neurotensin was

roo:::::e reproducible and did not exhibit tachyphylaxis as did the excitations
causecl. by substance P.

Finally, the population of cells which were sen-

sitive to ne•1rotensin ':.>as not the same as that for substFLnce P: tha·t is
to say, there were cells which were affected by substance n but not by
neurotensin and vice versa.

An increase in firing rate in response to neurot.ensin a.}_Ji_)lied by

iontophoresis has been repo1.-ted at several sites in the central nervous
system (frontal cortex, hippocampus, striatum and lateral thalamus)
(Zieglga'1sberger, Siggins, Brmvn, Vale a..'1d Bloom, 19 78) .

It is not pos-

sible to correlate the concentrations used in the present study with studies .,,hich used

iontop~oretic

application.

Hm1ever, the effective concen-

tration rang·e in the pYC:!sent study is in the sarne range (l-100 nH) as
that \-:hich contracts the guinea pig ilemn (Seqawa, Hosoka\·:a, Kitagn.wa and
Yajirna, 1977; Kitab<Ji and Freyc:tet- 1 1978).
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The physiological significance of the increase in firing rate
produced by neurotensin in myenteric neurons is not k..11::Y:m because the
peptide is not found in neurons of the plexus.

Neurote:-~sin

high concentrations in endocrine-like cells of the

ile~~

is found in

(Sundler, Alu-

mets, Hakanson, Carraway and Leeman, 1977; Sundler, Hakanson, Hammer,
Alumets, Carraway, Leeman and Zimmermru1, 1977).

It is possible that the

neurotensin released from these cells in response to local distension may
act as a local hormone which alters neuronal excitability.
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4.4.3.

VIP

VIP caused an increase in the firing rate of a population of myenteric neurons in a concentration range of 1 p:·I to 10 nH.

Th.e use of

higher concentrations was prohibited because the peptide was obtained in
small quantities (100 ng) which were lyophiled from a solution containing
0.02% BSA.

This excitation was a direct action on the neuron under study

since VIP was equally effective in solutions which were calcium-free and
in solutions which contained cobalt (1 mM).

Excitation of cortical neurons has been reported using ic·n·:::.ophoretic application of VIP (Phillis, Kirkpatrick a.'1d Said, 1978).

Also, in

this study, VIP and substance P were applied by superfusion to the isolated toad spinal cord preparation:

VIP was 2-3 times :aore potent ·than

substance P in depolarizing both the dorsal and

ventra~

roots.

However,

the effective concentrations of VIP and substance P were very high (VIP,
3-6 J.ll>l; substance P, 6-20 lJ..T\1) •
ing rate of

~ortical

It was implied that the increase in fir-

neurons was a result of a depolarizing action of VIP

similar to that on the toad dorsal and ventral roots.

The results from the iontophoretic experiments suggest that the
neurons were very sensitive to VIP since low concent-rations of VIP {300
l.IJ'.1 in 100 mM NaCl) vlere used in the iontophoresis electrodes.

port number of VIP under those conditio:1s must be very lor.·l.

The transThe increase

in firing rate produced by iontophoretically applied VIP often decreased
with repeated applications.

The results from the present study on myen-
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teric neurons indicate that VIP was effective at concentrations 100 fold
less than the effective concentration of substance P, although the popu-lation of myenteric neurons which were sensitive to VIP
than the population sensitive to substance P.
rate of myenteric neurons produced uy

VI~

'~Tas

much smaller

The increase in firing

added to the perfusing solution

tended to decline with repeated applica·tions of VIP as did the increase
in firing of cortical neurons produced by repeated iontophoretic applications.

VIP is an important peptide in the gut, in terms of the large
quantities which are contained within the nerve processes and cell somata
(Larsson et

~1:.·,

1976; Fux, Hokfelt, Said and t-lutt, 1977).

Its action on

the firing rate of rr,yenteric neurons may support a possible neurotransmitter or neuromodulator role in the plexus.

Hmvever, further study with

pure VIP is required to demonstrate clearly its possible physiolog:l.caJ.
significance.
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4.4.4.

The Action of All Three Excitatory Peptides 0::1 the Same Unit

The action of all of the excitatory peptides '.·:ere studied on the
same unit in order to determine if different populations of neurons could
be distinguished by their sensitivity to one or another of the excitatory

peptides (substance P, neurotensin, VIP).

The results indicate that there

are cells which have different sensitivity to these peptides.
large population of cells which are sensitive to more

tha~

There is a

one peptide.

HO'ivever, there is a significant proportion of cells which are sensiti•1e
to only one of the three peptides.

The number of cells sensitive to only

VIP v1as very small and this may be due to the use of only 10'.·1 concentrations of VIP.

Cells which were sensitive to v:tP were a1.so nore likely tc

be sensitive to substance P and/or neurotensin.

Units whic:-1 weYe sensi·-

tive to substance P only, were found most ofte-:1, follc'.·:ed
tive to only neurotensin.

l:;y

t.ho.::;e sensi-

Of the units sensitive to either substa.!1C:e P

or neurotensin, 33% were found to be sensitive to both peptiues.

The results indicate that there are popula'cions of neurons in the
myenteric plexus with varying sensitivity to the excitatory peptides.
This variation in sensitivity to the excitatory peptides ca'1not be as a
result of differences in the amount of suction used in the recording electrode or the size of the electrode since all three excitatory peptides
were tested on the same cell.

The demonstration of different populations

of cells which are sensitive to each of the excitatory pP.ptides may be
taken to indicate that these peptides have different fu::1ctional roles in
the myenteric plexus.

Clear demonstration that these peptides in fact
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have functionill roles in the

myentE:~ric

plexus a'dai ts t!1e development of

specific antagonists.

Demonstration of different populations of myenteric neuronsbased
on their sensi"tivity to the excitatory peptides also suggests that the
effects of these peptides are specific.

If the increase in firing rate

was produced by a non-specific mechanism, one might e;.,:pect that a cell
which was excited by substance P would also be excited by a peptide of
similar molecular weight such as neurotensin.

This type of study is not

possible when using iontophoretic application of pepi:ides since the trans-port number for most of these peptides is not knm·m.

In the case cf suh·-

stance P where transport number has been studied, there is ma:t·ked v.:uiation in transport number from one electrode to the next (j(i:njevic, Henry
and ::or::is, 1974,).

If the transport nwllber of the ot:J.er peptid9s is just

as variable, then comparisons of the sensitivity of units t:o a variety
of peptides administered by iont.ophoresis is impossible:: to interpre·t.

4. 5.

PEPTIDES IN THE l'1YENTERIC pu:;x·_;s

Iontophoretic application of the neuropept:i.des on to single neucle~r

rons in the central nervous system has yielded

effects on firing

rates in cells from various locations which contain tne specific peptide
under study.

Host of the effects produced by the peptides used in the

present study on single neurons in the myenteric plexus are the

s~~e

qualitatively as those which have been found in the central nervous system. -The action of endorphins has been studied at several sites in the
central nervous system and, in most of these studies, the action of t.he
opioid peptide was determined to, be mediated by

~.

opiate receptor be-

cause the inhibitions in firing are reversed or preve:--,teCi by a SJ?eciflc
antagonist such as naloxone.

With this exception, sp2<:ific a"ltagonlsts

for the ncuropeptides have not been described.

As a result, it is dif-

:=icult to resolve which putative neurotransmitt•2r could be involved in a
postsynaptic action in response to presynaptic sti::nulation, especially
when the mechanism of action of two substances is the

sa~e.

Experiments

using cross desensitization is one possible method by •..;:,ich to overcome
this problem.

Another possible approach is to use agents

~·Thich

deplete

specific neurotransmitters (such as p-chlorophenyl alanine in the case
of 5-HT, and capsaicin for substance P).

Problems with the specificity of

neurop~ptide

action in the ab-

sertce of specific antag:::mists can be eliminated in isolated preparations
by using structurally related analogs.

Iontop:-10re~..:.ic

logs, however, cannot be used quantitatively.
174

studies with ana-

At the present time, the
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action of neuropeptides has been described in several sites.

However,

the neurophysiological roles of these peptides in the central and peripheral nervous systems remains to be determined.

The presence of many of the neuropeptides in the gut may seem
odd at first.

However, demonstration of the presence of these peptides

in nerves and also in endocrine-like cells of the gut has supported the
theory that endocrine-like cells are the most primitive form of nervous
tissue (Pearse, 1978).

The endocrine-like cells in t::e gut share a num-

ber of cytochemical and ultrastructural properties >vi t:h cells which are
considered to be neuroendocrine (hypothalamus,
medulla)

(Pearse, 1968).

pituita~? ~~d

adrenal

Pearse (1968) referred to t!-lese cells as APUD

(amine precursor uptake and decarboxylation) cells based on their ability
to take up and decarboxylate amine precursors (5-hydroxyt:c']ptophan).
Some nerve cells also have this ability.

The embryolog.ical origin of

these cells has been shown, in some cases, to be from neuroectoderm
(Pearse and Polak,

1971~,£_).

Several of the neuropeptides have

b0~..:n

found in vesicles contained in APUD cells, neuroendocrine cells and in
nerves of the peripheral and central nervous systems.

In this way, the

neuropeptides appear to be another common link between the endocrine n.nd
nervo·us systems.

The endocrine effects of the hypothalamic peptides such as vasopressin, oxytocin and the releasing factors and possibly somatostatin
have been described, as have the actions of ma."1y of the gastrointestinal
peptide hormones such as gastrin, cholecystokinin, insulin and glucagon.
The physiological significance of the peptides contained within the ter-
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minals and varicosities of nerves remains to be

dete~ined.

sible that the neuropeptides are merely embDJological
no physiological role in later life.

re~ants

whichhave

On the other ha1d, studies of neu-

ropeptides may help to resolve questions concerning
transmitters at some sites

It is pas-

(for example,

t~e

nature of neuro-

the nature of the nonadrenergic

inhibitory transmitter responsible for the relaxation of the smooth muscle in various locations of the gastrointestinal tract).

In the presence

of atropine, the smooth muscle of the taenia coli relaxes (with a hyperpolarization) in response to nerve stimulation (Burns"':o::k, Cru;lpbell,
Bennett and Holman, 1963).

This hyperpolarization is abolished by tetro-

dotoxin and is m1changed by guanethedine or sympathetic
(Furness,

1969~,£_).

a purine nucleotide.

dener~ation

There is some evidence that the ::raDs:nitter may be
Adenosine triphosphate (ATP) h::/.?2::C::..:Jolarizes the

smooth muscle and is contained in nerve terminals of t::-:e taenia coli
(see review by Burnstock, 1972).
ever, has not been determined.

The identity of t!!e tra11smitter, howSince many of the neuropeptides are also

contained in the nerve terminals of the gut, and so::-:1e :1europept.ides are
kno,.ln to have actions directly on the smooth muscle (su}:)stance

.P

and neu-

rotensin), it is reasonable to think that a neuropeptide could be the
inhibitory neurotransmitter.

Another example where a neuropeptide may act as a net:rotransmi tter
or neuromodulator is in the myenteric plexus.

Substa1ce P has been sug-

gested to mediate a slow excitatory synaptic poter1tial seen in some myenteric neurons (Katayama and North, 1978).

A depolarization of myenteric

neurons associated with a decrease in potassium conduc-f:ance ·:;as found
with superfusion of substance P (3-100 nM).

Iontophoretic application
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also caused a slow depolarization (duration 10-100 s) in some neurons.
Stimulation of the nerves (10 Hz for 1 s) also caused a slo1v depolarization 1·1ith a similar time course.

The <lepolarization produced by nerve

stimula-c.ion was abolished in calcium-free, high magnesium (5 mH) Krebs
solution such that a synaptic mechanism was indicated, but was notaltered
by atropine (1 11M) or hexamethonium (100 ].1M) •

The slo-.-1 synaptic poten-

tial was also associated with an increase in resistance which probably
is due to a decrease in po·tassium conductance.

It is not possible to

say with complete certainty, but this evidence is suggestive that substance P is the transmitter at this site.

Other possible endogenous sub-

stances which may also be involved are VIP and 5-H'J.'.
these may

~elp

Studies such as

to determine the physiological significance of other neu-

ropeptides in the central as well as the peripheral nervous systems.

4. 6.

PROPOSALS FOR FUTU::<.E IW?.::C

The neuropeptides, met- and leu-enkephalin, 3-endorphin, somatastatin, neurotensin, substance P and VIP, had clear effects on the firing rate on neurons of the myenteric plexus.
1.

Since the neuropeptides are not di?t:!:'ibuted equally in various

areas of the gastrointestinal tract, studies of t::.eir !?o·tencies and of
the proportion of cells sensitive to the neuropsptides in different areas
of

th~

gut may answer questions about their physiological roles.

'I'his

study may also include extrinsic denervation si:1ce so::c2 of the peptides
(somatostatin, enkephalin and substance P) ma:z

origi:~5.~:e

L-1 cells out.<-:ide

the gut.
2.

T'ne action of these peptides on

mer:0r~~e

~r:operties

and syn-

aptic potentials of myenteric neurons s'cud.ied ·.d t.'-1 ir-.tra.:::ellular. electrades would enable the ionic mechanisms of actio:1 to be studied in detail.

Hith this method, iontophoretic application

o:

the pept.ides on to

various regions of the cell can be studied and the effE.cts produced by
this means of application can be compared to bath o.pplications of knaNn
concentrations of the peptides.
3.

In order to propose a neurotransmitter or neuromodulator

role for any of the neuropeptides in the myenteric plexus, several of
the required criteria have yet to be studied.
Table 13.

Yne3e are outlined in

Somatostatin, substance P, enkerhalin and VIP have been found

in nerves of the myenteric plexm;.

Eelease of e:-1:-:e;:;::alin from the rayen-

teric plexus by electrical stimulation has been studied with limited success.

Eel ease of substance P, somatostatin and

~::::P

fro:::\ the myenteric

178

179
plexus has not been reported.

Yne synthesis of enke?halin has

b~en

studied in the myenteric plexus but again, the synthesis of any of the
other neuropeptides at this site has not.

A mechanis:c. by

~·:hich

the ncu--

ropeptides are inactivated or removed from the effector site has not
been described for any of the endogenous neuro?eptides in the myenteric
plexus.

Finally, the action of each of the neuro?eptides must be mim-

icked by nerve stimulation.

This type of experiment is aided by specific

antagonists to compare the antagonism of the effect produced by an exogenously applied agent with the antagonism of the effect produced by nerve
stimulation.

Unfortunately, the only available a."l.tag:J.:-:ists to any of ·the

neuropeptides in the myenteric plexus are those -...ffiich act on the opiate
receptor to block the action of the opioid peptides.

Identification of

possible neurotransmitters is aided by cross-aesensit.i?.a.t:i.on

c.xperi;;~ent:s

between exogenously applied agents and the nerve mediateC: response.
Drugs vvhich deplete specific neurotransmit.ters from tl-,e nerve te:rrr.inals
are also useful.
techniques.

This type of experiment can be done using extracellular

H::::>wever, interpretation of the results can be

difficnlt~.

Intracellular recording offers em additional method b1 'h'hich to idz:ntify
neurotransmitter substances.

Using intracellular recordings, the ionic

mechanism of action of an exogenously applied agent can be compared t:o
the action and mechanism which results from nerve stimulation.

Even in

·the absence of a specific antagonist, the evidence provit1sd by intracellular recordings may strongly support or refute the neurotrail.smitter
role of Lhe neuropeptides in the myenteric plexus.

0

,..,

C(l

. which must be satisfied to prove a neuro·transmi t ter role for
The present state of cr~. ....... er~a
some neuropeptides in the myenteric plexus.

Table 13.

?cptidc
Enkcphalin

G·-endorphin

Substance

p

Presence in
Nerve Terminals

Release by Nerve
Stimulation

yes

.,

Synthetic
W:.z,chincry

l

yes

:-1echanism
of ~~omoval
llS

Action
inhibition
of firing
I hyperpolarization

E

ns

.ns

ns

ns

E

yes

ns

ns

ns

E

inhibition
of fir in

increase in
firing rate
I depolarization

Action Mimicked by
Nerve Stimulation
not found
not l'ound

ns

?
?

Neurotensin

no

ns

ns

ns

E

increase in
firing rate

ns

VIP

yes

ns

.n·-""

ns

E

increase in
firing rate

?

Somatostatin

yes

ns

ns

ns

E

inhibition
of firing:

abbreviations:

yes - shov.-n to be present
no - not present
?
- studied but still not clear
ns - not studied
E
extracellular recording
I
- intracellular recording

n:::;
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SUf!.HARY

Extracellular recordings from single myenteric neurons '\·lere mad.e
with large suction electrodes.

The origin and nature of the spontaneous

neuronal activity was thought to be somatic and induced by irritation of
the cell

b~;l

the large electrode.

ing observations.

This conclusion is based on the follo·,.r-

First, spontaneous acti vit:z· was only recorded frocn the

ganglia and not from the interconnecting strands Hhere there are few cell
bodies.

Second, no spontaneous activity was recorc1 ed ',·;i th small suction

electrodes or large electrodes without suction.

Third, cells which ex-

hibi ted a decreasing firing rate t-;ith increasing spike aJ.Ttplitude could be
induced to fire by increasing the suction or addinq
the tissue bath.

excitator~z

asents t.o

Spontaneously firing cells we:re rout.::inely recorded for

l-2 hr and sometimes for periods up to 6 hr.

Pre·;ious '.-;or.kers hi-ld shown

that mo.:::phine inhibited the firing rate in a stereosre:::ific naloxinc reversible manner, indicating this preparation as a usefl!l model to study
pharmacological agents.

A number of neuropeptides have been fmmd in nc.r:ves of the my;.;m-

teric plexus, including enkephalin, somatostatin, substance P and VIP.
The action of these peptides and neurotensin '.vas tested. on the firing
rate of myenteric neurons.

These peptides were tested in known concen·-

trations, in solut:.i:ms vrhich completely blocked synaptic transmission,
and in solutions containing various specific and non-specific pharmacological ant.agorlists.

The endorphins (met- and

leu-enkei)lv~lin

endorphin) :r-eversibly decreased the firing rate b:l

a:-~

•

.L

and

13-

oplaL.e recertor
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mechanism, at concentrations sirnilar to those which in:-tibi t the nervemediated contraction of the longitudinal muscle (3-300 nl·l) .

The time

course of the inhibition was immediate with the entry of the p2ptide into
the bath and washed out quickly with remov-al of the peptide from the bath.
In the same concentration range, somatostatin decreased the firing of
myenteric neurons.

The inhibition was of the

phalin, but in some

Q~its

s~ne

time course as enke-

there were signs of tachyphylaxis.

The inhi-

bition produced by somatostatin was not affected by opiate or adrenergic
antagonists.

Substa."1ce P and neurotensin produced marked increases in firing
in myenteric neurons.

The concentration range which produced an excita-·

tory effect (100 p:1 -

100 nl-1)

was in the same concentrations :r:ange as

that required to contract the guinea pig ileum.

There were so:ne signs of

desensitization to substance P with repeated applications \·;hereas the excitations produced by neuroter"sin were less likely to exhibit desensi tization.

The excitations produced by substance P and neurotensin \.Jere

thought to be relatively specific based on two studies.

First, two sub-

stance P analogs (substance P pentapeptide and substance P free acid) were
both markedly less active than substance P on myenteric neurons.

The bio-

logical activity of these analogs was also less than that of substance P
when tested on smooth muscle and spinal cord preparations.

Second, sub-

stance P and neurotensin affected separate populations of myenteric neurons.

That is to say, there were cells that were exquisitely sensitive

to substance P and relatively insensitive to

neurote~'1sin

and vice versa.

VIP also produced a."1 increase in firing of myenteric neurons but at concent.rations 100-1,000 fold less than the effective concentrations of sub-
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st.r>..nce P and neurotensin.

Repeated applications of '.'IP often resulte<l

in diminution of the response, implying some tachyp:!:l:t•lc:xis.

The popula-

tion of net:rons which is sensitive to VIP is also sensitive to substance
P and/or neurotensin: fe>·l cells were excited by VIP a:1d not by substance
P or neurotensin.
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APPENDIX A

Determination of spike amplitude recorded Hith large suction electrodes
on theoretical grounds.
Recording from the cell soma.
are made:

(1)

The follmving assumptions

(a)
(b)

'I'he cell diameter is 50 llffi.
A 50 ~ electrode is placed on the cell such that
it completely covers the cell.
(c) A perfect resistive seal is formed around the outside of the electrode.
(d) 'l'he action potential of the ce 11 is 70 mV with a
rise time of 1 ms.
(e) Capacitive current only is measured.
(f) l'Rmbrane capacitance-== lj.:Fjcm2.
The sur:!:ace area for capacitive current.
A=

2

nr· = 19.4 x 10

-6

em

2

Total capacitance.
C
C

membrane caracitance x surface area
1 ]JP/cm2 x 19.4 x 10-6 cm2 = 19.4 x lQ-6 ]JI'

'l'otal charge.
2

Q = C XV= 19.4 X l0-l (P)
Q == 1.36 x lo-12 coulombs
O.:rr~nt. generat~,d

7 X 10-

X

2

(V)

during rising phase of action :potential.

I~ Q/dt = 1.4

lO-l 2 (C)/l0-

X

3

=

1.4

X

10-

9 A

Pot:er1tial drop across an electrode (resistance 1 !'-1r2) •

V = I

X

R = 1.4

X

10

-9

X

1

X

10

6

=

1.4 mV

Under the given conditions, the potential measured dnring an
action potential would be L 4 mV. The conditions in rracti~~e are much
different. There is not a perfect resistive seal arounc1 the electrode:
in fact, it. is only 200-500 krl. 'l'his resistance is produced by t.he suction and. appears to be important because no activity (spontaneous or
evoked) ca.n be recorded without suction. Increasing the amount of suction increases the sealing resistance and also increases the size of the
spike recorded. Consideri.:1g that the resistive seal arou.r:td the electrode
is not peL[ect, it seems rea~;onable to assume that the spike amplitude
measured in practice must be smaller than the predicted value of 1.4 mV.
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(2)

Recording from a process.
made:

'l'he follov1ing assu."!lpt5.ons a::-_·e

(a)
(b)

Cell process is 1 ~ in di~"!leter and 50 ~ long.
The cell process spikes all along its length at
the same time.
(c) The spike is 70 mV and has a rise ti~e of l ms.
(d) A perfect resistive seal is made around the electrode.
(e) Capacitive current only is measured.
(f) Hembrance capacitance = lfJ}'/cm2.
The surface area for capacitive current.
A= TirL = 3.1 X 0.5 X 10-

4

X 50 X 10-

4

=

77.5

X 10-B

cm 2

Total capacitance.
C

=1

~/em

2

x 77.5 x 10

-8

=

7.75

X

lO-l 3 F

Total-charge.

Q= C

XV=

7.75 X 10

~3

X

7 X 10

~

=

5.4 X 10

~4

C

Current generated during rising phase of action pot<~ntial.
4
I = Q/dt = 5.4 X lO-l /l0- 3 = 5.4 X 10-ll A
across an electrode (resistance: 1 :-:-.~).
V = I X R = 5.4 X 10-ll X 1 X 10 6 = 5.4 X 10-S V

Po"te:-:.'::i.al

d~op

Under the asusmptions listed above, the anplitude of the spike
measured during an action potential in a process vrould be 54 )JV. Since
the resistive seal. around the electrode is not perfect (see appendix A-1),
a smaller potential is expected. In addition, the entire length of nerve
(SO pm) is not depolarized simultaneously, such that the estimated current
is actually smaller than that predicted. Since the ~":!plj_tude of spontaneous potentials ranged from SO pV (just over the noise level) to 500 )JV,
it is unlikely that these potentials originated from single cell processes but probably correspond to the action potential in somata.
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